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INTRODUCTION 
 
1. INTRODUCTION  
அரிது அரிது மானிடராய் பிறப்பது அரிது 
-அவ்வவயார ்
Human being is the most wonderful creature in the world. To born a human is 
said to be a boon. Humans, in all the aspects such as intelligence, cognitive faculties 
etc., finds no equal with other species. With his extra ordinary sixth sense he enjoys all 
the wonders and wealth of nature. He always has the choice to alter the source of life 
by making changes which may enhance his life and existence. At times the choices one 
makes in life can make his life a bane.  Sometimes certain things are imposed upon him 
of which he has no control. One such uncontrollable fate is the disease which might be 
nonfatal or fatal such as Cancer, AIDS, and Tuberculosis. 
 
“Medicine is a science of uncertainty and the art of probability”      
        - William Osler. 
 
“It is more important to know what sort of person has a disease than to know 
what sort of disease a person has”      
       -Hippocrates. 
 
Cancer is a major life threatening disease. It is also said to be a lifestyle disorder 
which is knowingly or unknowingly incorporated in our day to day activities. Lifestyle 
modifications due to the nature of the job, social environment, lack of physical activity, 
alcohol, smoking, stress, plastic products usage, junk food, culture, sleep disturbances 
cause severe impact in health and cause cancer.  
Cancer is believed to be derived from the Greek word, “KARNIKOS” which 
means crab or crayfish. “It stick to the part stuberner”. It comes from the appearance 
of the cut surface of a solid malignant tumor [1].  Researchers defined cancer as a disease 
characterized by uncontrolled or unregulated proliferation of cells with the potential to 
invade or spread to other parts through blood and lymphatic vessels. [2] 
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Cancer is the second leading cause of mortality. In India, Tumour is the third 
cause of mortality. There are more than 100 types of cancers. In no particular order, 
following are some types of cancer prevailing commonly among people: 
 Lung Cancer 
 Oral Cancer 
 Cervical Cancer 
 Breast Cancer 
 Colorectal Cancer 
 Uterine Cancer etc... 
Lung and oral cancers are affected mainly by undesirable habits such as alcohol, 
smoking and tobacco consumption. Smokeless tobacco such as chewing of betel and 
tobacco with snuff are most important risk factors. Cervical cancer starts in cervix and 
the lower narrow part of the uterus. Mostly, cervical cancers are triggered by the Human 
Papilloma Virus (HPV, especially HPV-16). Other factors including radiation, lack of 
oral hygiene, nutritional deficiencies, preserved or salted food are involved in the oral 
cancers [3]. Many women are affected by breast cancer because of irregular sleeping 
habits, late or increased maternity age, etc. Stomach cancer and colorectal cancer are 
caused mostly by the intake of unhygienic junk food and ulceration that is resulted from 
regular spicy foods. Such kinds of food habits are unhealthy. 
This dissertation deals with the significance of Oral and Cervical cancers and 
the ways to cure these dreadful diseases by means of Siddha Medicine. 
In this category, malignant tumours of the cervix ranks first in the female 
mortality rate. It is the fourth most common cancer in women with an estimated 528,000 
new cases in 2012. As per IARC Globocan 2012 there were an estimated 266,000 
deaths worldwide in 2012, which accounts for about 7.5% of all female cancer deaths.  
Almost nine out of ten (87%) cervical cancer deaths occur in the less developed regions. 
In India, nearly 122,844 women diagnosed with cervical cancer and out of this 67,477 
women die annually from this disease.[4] 
Cervical cancer remains to be the second most common cancer in women 
between the age group of 15-45 years.[5]  Sexually transmitted Human Papilloma Virus 
(HPV) infection is the most important risk factor for cervical intraepithelial neoplasm 
and invasive cervical cancer. [6] 
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HPV serotypes 16 and 18 account for nearly 76.7% of cervical cancer in India. 
HPV has been found to be a necessary but not sufficient cause for cervical cancer, of 
the more than 100 HPV types, 18 have been categorized as high-risk types, while the 
rest are low-risk types for cervical cancer [7]. 
HPV prevalence among cervical cancer patients in India has varied from 87.8% 
to 96.67%. Molecular studies have shown that HPV-16 and 18 are the two most 
common high oncogenic types found in invasive cervical cancer and among these, 
HPV-16 have been found more common. The Pap smear test is intended to detect the 
cells that can develop in the cervix of the uterus as a result of HPV. 
OSCC remains the major cause of mortality and morbidity in patients with head 
and neck cancers. There are about 14.1 million of new cases estimated and 8.2 million 
people die out of cancer every year, and 32.6 million people are living with cancer in 
2012 worldwide [8] 
Oral cancer is the most common cancer in India, as 4 in 10 of all cancers are 
oral cancers. Nearly 130,000 people succumb to oral cancer in a year which is 
approximately 14 deaths per hour. [9] 
In the last decades there were great advances in the diagnosis of cancer as well 
as in the fields of molecular oncology. However, the cure rate of most cancers remains 
low. In Modern system of medicine, the main strategies of treating patients with cancer 
are surgery, radiation and chemotherapy. Some of the most commonly used drugs for 
oral cancer are Cisplatin, 5-fluorouracil (5-fu) and other drugs such as carboplatin, 
Bleomycin, Methotrexate are also used. Prolonged usage of the drugs produces many 
side effects.[10] The current use of chemotherapy is accompanied with difficult side 
effects. It inhibits bone marrow stem cells proliferation leading to immune suppression. 
Radiotherapy, which is widely used in the world, is also accompanied by a great deal 
of side effects. Lymphocytes are most readily affected by radiation resulting in 
prolonged T-cell suppression. Other side effects such as, Alopecia, bone necrosis, lung 
fibrosis, skin devascularization, ulceration, nausea, vomiting, and renal damage are also 
associated with all types of conventional therapies. 
 
Cisplatin which is used to treat different types of cancer such as cancers of head 
and neck, cervical cancer, on small lung cancer produces certain ill effects like renal 
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damage, hearing loss especially, with high pitched sound, easy bruising, occasionally 
amenorrhea in female, loss of fertility, tinnitus, numbness or tingling sensation of 
fingers. 
Whereas 5-fluorououracil produces diarrhoea, redness and peeling on the palm 
of the hand and sole of the feet and occasionally blue tinged nails, sensivity of skin to 
sunlight, sore throat and blurred vision. [11] 
Bleomycin produces allergic reactions, fainting, confusion, breathing 
difficulties. 
Methotrexate produces birth defects, weakness, diarrhoea, and occasionally 
skin rashes, breathlessness, darkening or lightening of the skin, blurred vision, and loss 
of fertility. 
Mephalan is very effective multiple myeloma, used in ovarian cancer, produce 
bone marrow depression, infections, diarrhoea, arthralgia. mucositis, 
thrombocytopenia. Cytarbine produces leukopenia, thrombocytopenia, anemia, 
mucositis, thrombocytopenia bone marrow, Mylo suppression, Nausea, vomiting. 
 
Siddha medical system delivers huge like of treatments for different kinds of 
life threatening disease including cancer. Cancer is explained in the name of Putru 
(undermined growth) which gives the direct meaning and as Arputhapun (spectacular 
tumour) and Vanmeegam (pre-cancerous growth. Siddha physician consider some types 
of cancer growth with the symptoms of Vippuruthi(multifaceted growth their 
practice,Kazhalai,Pilavai etc. [12]. In ancient Siddha literature, oral cancer referred as 
“Kanna Putru” or “Vaai Putru” and cervical cancer referred as “Yoni putru”.[13] 
“Nature itself is the best physician”       
 -Hippocrates. 
 
“Each and every plant, a magnificent creation of nature, Has magnetical 
power of healing. 
-Bible 
Siddha Medical Science is one of the ancient Indian traditional medicine 
followed by Tamil speaking peoples worldwide. Unlike other medicine systems, siddha 
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system hubs not only the prevention and cure of a disease but also emphasizes in ‘kaya 
kalpa’ which is a way of making one’s body immortal.  The word “kaya” means body 
and “kalpa” means stone and the word “kayakalpa” means sturdy as a rock and ageless. 
The term Siddhi refers to a yogi state. Siddhars are said to be the yogis, having lived a 
complete life. [14]  Siddhar are well known practitioners in preparation of a herbo-
mineral formulations through a wide range of processing such as purification using 
herbal juice thereby reducing the toxicity of the metals.  
“Natural forces within us are the true healers of disease”. 
-Hippocrates 
The treatment aspects in Siddha system insists the usage of herbs at first 
followed by inorganic preparations such as paspam and chendurams as mentioned in 
the following lines. 
Nth;ghU jioghU  kpQ;rpdf;fhy;   
      nky;y nky;y gw;g nre;J}u ghNu” 
- Gjhu;j;jFz rpe;jhkzp [15] 
 
Pathangam is referred as sublimation. The process of sublimation by which 
solid substance such as camphor, Sulphur, Sub chloride of mercury, Corrosive 
sublimate, benzoin stc., are brought into the state of vapour by heat and condensed 
again into a solid by cold without melting them. 
 The product of sublimation is enriched with Nanoparticles which aids in 
targeted drug delivery and site specific action. Nano medicine is the application of 
knowledge of nanotechnology in science and medical procedures. It is a field of applied 
science devoted to the control and manipulation of matter on a scale smaller than one 
micrometer. Nano medicine are used globally to improve the treatment and lives of 
patients suffering from range of disorders, like cancers, auto immune disorders, 
degenerative disease, multiple sclerosis, asthma and emphysema. 
Nano medicine therefore can play an important role in ensuring enough of the 
drug enters the body and stays in the body for long periods and is targeted specifically 
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the parts that need treatment. Nano medicine has high bio availability, longer shelf life 
period, targeted action with minimal side effects.   
There are a wide variety of Nano medicines in siddha system which is being 
successfully used in routine clinical practice such as Velli parmam. Linga chendooram, 
kshya kulandhaga chenduram, Mupoora chendooram ,Thalaga parpam, Naga parpam 
etc.[17]. 
Bhramasthiram is one such medicine enriched with Nano particles. 
Bhramasthiram is a herbo mineral formulation consisting of four drugs, which is 
specified as an effective anti-cancer drug mentioned in siddha literature “The 
Pharmacopeia of Siddha Research Medicine”. 
Bhramasthiram is most powerful weapon accordingly in Hindu Mythology. It 
was said that when Bhramasthiram was discharged there was neither a counter attack 
nor a defense that could stop it. Over the coming years, the benefits of Nano medicine 
and new diagnostic tools will be felt by an increasing number of patients with 
considerable impact on global health. 
Nanoparticles have the potential to overcome certain limitations in conventional 
chemotherapy, like lack of solubility selectively and the drug resistance. Importance of 
Nano therapeutic drug delivery system include enhanced bio distribution, increased 
circulation of time of drug, prolonged half-life, increased intracellular concentration of 
the drug and many more. Eg Velli parpam dosage one in six part of tip of crow beak.[18] 
 
 
 
 
 
 
 
 
 
 
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 
An integrated approach is the need of the day to manage cancer using the growing 
knowledge gained through scientific development. The emerging integrative Nano 
medicine model of cancer treatment recognizes the importance of herbo mineral 
medicine which there drug literally evident as told by great scientists Siddhars. 
Therefore, the author is interested in validating anti-cancer and anti tumour, anti-
oxidant activities of “Bhramasthiram” through standardization, physico chemical, bio-
chemical analysis in in-vitro cell line studies. 
 
 
AIM AND OBJECTIVES 
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                                2. AIM AND OBJECTIVES 
 
AIM: 
The aim of this study is to establish the scientific validation of the Anti-cancer, 
Anti-tumor and Anti-oxidant activities of BHRAMASTHIRAM for Cancer. In the present 
medical world, there is a need for proper treatment for Cancer. The aim of this study is 
evaluation of a new drug for the management of cancer. 
 
OBJECTIVES: 
            The main objective of the present study is to highlight the efficacy of 
BHRAMASTHIRAM on  Cancer, the following methodology was adopted to evaluate the 
drugs and its standardization studies. 
 
 Collection of various Siddha and modern literature relevant to the study. 
 Identification of drugs in this formulation. 
 Preparation of BHRAMASTHIRAM as per the Siddha classical text. 
 Physicochemical and phytochemical investigation of the test drug. 
 Evaluate bio-chemical analysis of the test drug to derive acidic and basic radicals. 
 To estimate the present of elements, functional groups and particle size through 
instrumental analysis of the trial drug. 
 Evaluation of the Acute and 28 days repeated oral Toxicity of the test drug 
according to OECD guidelines. 
 Evaluation of the pharmacological study of the drug through the following activities 
 Evaluation of Anti-Cancer activity 
 Evaluation of Anti-tumor activity 
 Evaluation of Anti-oxidant activity of Bhramasthiram 
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3.REVIEW OF LITERATURE 
3.1 DRUG REVIEW 
 
3.1.1. GUNAPADAM ASPECT 
VEERAM (Savveeram) 
 Perchloride of Mercury, Mercuric chloride 
 Perchloride of Mercury was first used as a therapeutic agent for venereal 
diseases during the middle of the eighteenth century in western countries. But 
for many centuries the Perchloride of Mercury has been used in India for the 
treatment of various disorders. 
Synonyms: 
 Meenachimynthan, Kotchiveeram, Poovindhusevagan, Sarakku chunnam, 
Parangi Pasanam, Sarathin sathru, Parimithru 
 According to the above version the synonyms are Virpan, Aathi, Vellai 
chenduram, Sevagan, Pidaragan, Varagathinthalai 
Origin 
Veeram is one of the natural in 64 padanams. Naturally it is obtained in 
Himalaya hills. Now we use the artificial one. It is called as Savveeram. It is identified 
in seventh century and used for venereal diseases during the middle of the eighteenth 
century in western countries. 
Synthetic preparations (Vaippu) 
Ingredients: 
 Calomel   -  80 parts 
 Culinary salt   -  80 parts 
 Copper sulphate  -  40 parts 
 Alum    -  20 parts 
 Potassium nitrate  -  20 parts 
 Fuller’s earth   -  20 parts 
 Sulphate of iron  -  10 parts 
 Ammonii chloridum  -  5 parts 
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These ingredients are taken and triturated well and placed in a bottle its mouth is 
closed and sealed with a mud pasted cloth and burnt. After cooling, the per chloride of 
mercury is found to be deposited over the lid as a thick layer. 
 
Specialities  
 It is a very important drug for preparing Parpam, Chendooram and Guru 
  It is having the capacity to make kattu of 64 drugs 
  Make karam into kattu medicine form. 
 
Methods of purification and detoxification: 
Perchloride of mercury is as such quite toxic and it should be used only after 
purification and detoxification. Perchloride of mercury 35gm is consolidified with 
pepper decoction (Piper nigurm) for 6 hours. Then it is buried within the pepper 
poultice. Sodium chloride 650 gm and camphor 35 gm are mixed well and kept in a 
mud pot in which the above poultice is buried and burnt for some hours with low 
intensity fire to get the purified form of perchloride of mercury. 
 
Method I 
Camphor is mixed with tender coconut water and placed in a mud pot. 
Perchloride of mercury is tied in a cloth and soaked in the pot without touching the 
water and the pot is burnt for half an hour. 
 
Other Method of Purification 
Method II 
Alum 35 gm and Camphor-35 gm. are powdered well and mixed together. 
Perchloride of mercury 35 gm is taken single piece and consolidified by the above 
mixture gradually. Perchloride of mercury is carefully watched not to become fume. 
 
Properties and actions of Veeram 
Characters  
Taste   :  Bitter and salty 
Potency   :  Hot  
Pirivu   :  Pungent 
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It has got body improving tonic and antiseptic and ulcerogenic properties. 
Panchabootha Amsam:  Theyu 
“அப்பனே”! னேயுோன் வீர மாகும்” 
According the Veeram is Appubootham in “pasanathil Panchapootham” 
In Pasanapirivil Veeram considered as a Theyu (fire) Bootham. 
 Veeram is classified as a Theyu sarakku in panchabootha sarakku and also the  
 Karasarakku, and peesasarakku. 
The following five have been specifically mentioned as Pancha boodha paadaanam 
in the text “Pacchai Vettu 16”. 
1. Earth  -  Prithivi :  Arithaaram 
2. Water  -  Appu   :  Savveeram 
3. Fire  -  Theyu  :  Gowri 
4. Air  -  Vayu   :  Vellai 
5. Sky   - Vinn   :  Lingam 
 
“அரிதாரம் பிருதிவியே ோகி நிற்கும் 
     ஆனததாரு  சவ்வீர மப்பு  வாகும் 
தபரிதான த ௌரியோ யதயு வாகும் 
  பின்னுயமார ்தவள்ளளயோ வாயு வாகும் 
அரிதான  லிங் மா  ாச   மாகும் 
   அருந்திோேப் பசள்சேதா ோட லாகும்” 
    -குணப்பாடம் தாதுவகுப்பு 
 
 
However, in Nandheesar’s Kalaignanam the panchaboodha Paadaanas have 
been mentioned in different way. 
 
Substances Antagonist to Veeram (Sathru sarakku) 
 Iron (Irumbu) 
 Magnet (Kantham,) 
 Tablesalt (kalluppu,) 
 Potassium nitrate (Vediuppu), 
 Zinc (Thuththanagam)  
 Egg white (Muttai vellai karu) 
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Substance Synergetic to Veeram: Copper (Thurusu) 
Actions 
 Alternative (Udalthetri) 
 Antibiotic (Kiruminasini) 
 Anti-septic (Azhugal agatri) 
 Caustic (Punnundakki) 
 
General properties (Pothu gunam) 
“பாடியனன் பிற ்குமுப் பத்தி ரண்டு 
பாங் ான  தாதுவுளடப்  தபேளர ்  ய ளு 
வீடியனன் வீரதமாடு ளவ ்கிரனந் தந்தான் “ 
“தாதுதான் தந்திரமாே் சித்தர ்ளவதத் 
சாங் மாம்  யபளரயினிச ் சாற்ற ் ய ளு 
த ாங்கிதேன்சவ்  வீரங்ய ாழித் தளல ்த ந்தி” 
       -யபா ர ்7000 
 “குன்மதமாடு குட்டம் த ாடிேவனி லதத்ிரட்டு 
துன்மாங்  கிசப்தபரு ்குஞ்  சூளலயநாே் -வன்ளமயுறு 
 ாமிேப்புண்  ணாதிேயநாே்  ணடாற்சவ்  
வீரதனனுஞ்  சாமிநா மத்ளதயுச ்சரி” 
 
Savveeram is used to cure the following disease Gastric ulcer, leprosy, severe 
vadha diseases and morbid growth of flesh, throbbing pain associated diseases, venereal 
diseases, bubo in the groins occurs to the female and male due to forcefulness of 
sexually contact as explained in the above Tamil verse. This is also for various types of 
eye diseases. 
Dose 
 2 - 4 mg 
 Dose above 4 mg will be toxic. 
Method of administration of Veera Jayaneer: 
 The perchloride of mercury and Ammonii chloridum (650 mg each) are taken 
and dissolved in 500 ml of purified water and administered up to 30 drops. 
 
MAHAVEERA MEZHUGU 
Dose: Equivalent to the size of 1-2 pulse grain 
Indication 
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Vatha diseases and venereal diseases. 
Dietary restriction   Milk and rice. 
 
VEERA MAATHIRAI (THIRI THODA MATHIRAI) 
 If given with suitable adjuvants the diseases like fever caused due to the 
derangement of three gunmams will be cured. 
 Instead of milagu decction, Nochi Surasam (Vitex negundo) is also used by 
which running nose and shivering fevers are cured. 
 
SAVVEERA CHENDOORAM (Hydrargyrm perchloride) 
 If given in sufficient quantity it cures, fever, delirium, severe vatha 
diseases, cholera, soolai etc. 
VEERA RASA PARPAM 
Dosage: 488 mg or required minimum quantity with jaggery. 
 
VEERA NEER (For External application) 
 It is used as a disinfectant and for cleaning the ulcers. 
 
VEERA KALIMPU 
 4.2 gram of Veeram is ground with 17.5 gm of butter and the paste is used to 
cure urticaria and to apply on the ulcers. 
 
VEERA KALIMPU (AMIRTHA VENNAI-AMIRTHA MEZHUGU) 
 It can be applied on die ulcers like Cancer or Carbuncle of chest 
 Clean the ulcers using the water boiled with tamarind leaves. 
 It is also used as local application on all swellings, boils etc. 
As the Amirtha mezhugu contains more quantity of butter than Veera Kalimbu it cures 
the inflammation. 
JAYAVEERA RANA SINGI KAYIRU 
Adjuvant: Pure water 
Indications 
 Ulcers, ringworm, pimples, syphilis, scabies, carbuncles, cancer of penis, piles, 
scrofula, venereal ulcer, anorectal syphilis and different kinds of eye diseases. 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 14 
 
 
 
OTHER PREPARATIONS 
1. Veera sanjeevi mathirai 
Dose   : Ulunthu alavu (65gms) 
Indication  : Sanny, Suram.  
2.Maha koda surimathirai 
Dose  : 65gms 
Indications :  Vettai, sanny, visa noi 
3. Veeraparpam patchai vettu 
Dose   :  50mgs- 3days- 6 times 
Indications  :  Pun,vellai,kiranthi,katti,soolai .  
4. Ramabana chenduram 
Dose  :  Arisi edai 
Indications  :  Vayu,Veekam,Suram, Megam.  
 
5. Thanvanthri sandamarutha chenduram 
Dose   :  Pana edai (480 mg) 
Adjuvant  :  Honey 
Indications  :  Sunny13, kuttam, Mahotharam, Peeligai, Gunman, Vaginal  
cancer.  
6. Vadha marutha melugu 
Dose  :  Milagalavu 
Adjuvant  :  Jaggery 
Indications :  Mudakku ,Vadham ,Soolai,Pandu, Epilepsy,Parisavayu.  
 
7. Chandamarutha chenduram 
Dose   :  Panavedei (480 mgs) 
Adjuvant :  Honey. 
Indication  : 13 Sunny, Peeli, vadham, Fistula, perumpadu  
8. Veera paspam  
Dose   :  Panavedei 
Adjuvant  :  Honey 
Indications  :  Sunny, Thosam, kabakatti,vayu.  
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 15 
 
 
 
Uses of Veeram [20] 
1. Veera jayaneer  -  Dose 30 drops 
2. Mahaveera mazhugu -  Dose 65 - 130 mgs 
3. Veera mathirai (Thurthada mathirai) 
Dose   :  Milagalavu 
Adjuvant  :  Notchi decoction 
Indications  :  Running nose, kulir suram,Fever 
Saveera chendooram 
Dose   :  50-100 mgs 
Indication  :  Suram, sanny, pithavanthi, pedigai, soolai 
Gurupathangam 
Dose   :  1/2 Arisiedai (30mgs) 
Adjuvant  :  Palm jaggery, Dry ginger paste 
Indications  :  Mehvayu, various types of ulcers, check cancer, soolai noi 
Navalogamelughu 
Dose   :  1/2 -1 kundri (65-130mgs) 
Adjuvant  :  Palmjaggery, Dry ginger, Butter 
Indications  :  Fever, Chunny, Mehanoi, Giranthi pun 
Pattu karuppu 
Dose  :  2-4 Arisiedai (130-260mgs) 
Indications :  Suram, mehasuram, oedema, epilogsy 
External use of Veeram 
Veera neer 
Veeram : 65mg 
Water  : 240 ltr 
 Veera kalimbu  - Apply on the ulcers 
 Pilavaikku pasai  - Apply on the carbuncles 
 Veera pugai   - 3 days and 6 times 
Indication  -  Giranthipum,Araiyapu non curable ulcers 
 Veera pugai   - Cures the oozing ulcers 
 Veera powder  - Cures the chronic ulcers 
 Venkarapodi  - 18 kuttam, thimir, snakebite, ulcers, piles,  
                                                 syphilis 
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 Manjal karaseelai - Piles, marpani, neerabeelai, Thimir, karanai katti 
 
Punpuraikku pugai 
Dose  :  4.1 gms 
Smoke curves soolai and ulcers 
 
Moolam pavathiram punnukku pugai 
Dose  :  4.1gms 
smokes cure piles, fistula, ulcers. 
 
Tholaiyu mennar sirodhararo - Kustarogam, soolai, kaikal mudakku,        
                                                                       pun, Vadha karappan 
Akkinipilasthiri   -  Curves all types of ulcers. 
 
Other preparation 
 Vanga chunam, Thalaga parpam 
 Ghanthaga thailam, Ayaveera chendhooram 
 Vaanmezhugu, Thirumoorthi pathangam 
 Megavirana kalimbu, chandamaarutham 
 
Signs and Symptoms 
The toxic symptoms of mercury chloride are Taste of verdigris, Ulcerative 
stomatitis, Ulcerative gastritis, Vomiting, Watery diarrhea, Puffiness of face, Fissures 
on the skin with serous fluid oozing, Morbid thirst, Hiccough, Syncope, Ptyalism, 
Ulcerative laryngitis Dysphagia, Ulcers in the stomach, Dysentery, Pharyngitis, 
Throbbing pain in the hypochondral region, Unconsciousness, Convulsions, Death. 
Antidotes 
1. 20 ml of Tribulus terrestris juice should be given to the victim in the morning and 
evening daily. 
2. Paste of the Indigofera tinctoria root bark in the dose of a size of Solanum pubescens, 
dissolved in 80 ml of lukewarm water should be consumed twice daily. Decoction 
of the above drug is also given as an antidote for the poison. 
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3. 20 ml of juice of Vemonia cinerea consumed twice daily which also acts as an 
antidote. 
4. This poison can be neutralized by drinking coconut toddy. Since the period of 
treatment is not     mentioned, all the above prescriptions can be continued till the 
toxic effects disappear. 
5. White yolk of the egg (unboiled) mixed with water or milk should be given often. 
6. Tender coconut water also neutralizes the toxicity of Mercuric chloride [20]. 
 
3.1.2 MODERN ASPECT OF HYDRAGYRUM PERCHLORIDE 
Properties 
Mercury(II)chloride or mercuric chloride is the chemical compound with the 
formula Hgcl2. 
This white crystalline solid is a laboratory reagent and molecular compound. 
 
PHYSICAL PROPERTIES [21] 
Molecular formula  :  Hgcl2 
Molar mass   :  271.52g/mol 
Appearance   :  white solid 
Melting point    :  277ºc,549k,529F 
Boiling point    :  304ºc,577K,579F 
Density    :  5.44g/cm2 
Vapour pressure   : 1.3mm Hg 
Refractive index   : 1.859 
Storage temperature   :  Store at room 
 temperature 
Solubility    :  H2O          Figure1 . Hydragyrum perchloride          
Form    :  Powder  
Water solubility  :  7.4g/100ml                              
Solubility  :  Soluble in alcohol, ether, acetone, ethyl acetate,  
slighty soluble in benzone, CS2 
Acidity(Pk2)   :  3.2 
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Stability    :  Stable, but moisture sensitive and light sensitive 
   Decomposes in sunlight  
 
STRUCTURE 
Crystal structure  :  Orthogonal 
Coordination geometry :  Linear 
Molecular shape   :  Linear 
Mercuric chloride is not a salt but a linear triatomic molecule, hence its tendency 
to sublime. In the crystal, each mercury atom is bonded to two close chloride ligands. 
 
Preparation 
Mercuric chloride is obtained by the action of Chlorine on Mercury by addition 
of Hydrochloric acid to a hot, concentrated solution of Mercury (I) compounds such as 
the nitrate. 
 
HgNO3+2HCl HgCl2+H2O+NO2 
 
Heating a mixture of solid Mercury(II) Sulphate and Sodium Chloride also 
affords volatile HgCl2, which sublimes and condenses in the form of small rhombic 
crystals. 
 
 
APPLICATIONS 
 Mercuric chloride is a catalyst for the conversion of acetylene to vinyl chloride, 
the precursor to polyvinylchloride. 
 It is used as a depolarizer in batteries 
 It is being used in plant tissue culture for surface sterilization of explants such 
as leaf or stem nodes. 
 Mercuric chloride is occasionally used to form an amalgam with metals 
mercury(II) chloride was used as a photographic intensifier. 
 Syphilis was frequently treated with mercuric chloride before the advent of 
antibiotics.it was inhaled ingested injected and applied topically. 
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3.1.1. SIDDHA ASPECT OF KARIYUPPU (SODIUM CHLORIDE): 
Synonyms:  
             Sotruppu, Kadaluppu, Veettuppu, Ilavanam, Samudra lavanam. 
Chemical name:  
              Sodium chloride 
Actions: 
 Stomachic 
 Laxative 
 Emetic 
 Anthelmintic, Febrifuge  
General properties (Pothu gunam): 
“msj;jpYiw ey;Yg; gdy;thjk; khw;Wq; 
 Fsj;JNeha; jd;idf; fisAq;- fpisj;jfg 
 MRila ty;iyNeha; m\;lFd;k Kk;Nghf;Fq; 
 fhrpdpAs; khNj foW” 
- gjhHj;j Fzrpe;jhkzp 
 
Pitha vatham, lymph adenitis, tumour, kapham, liver disorders, 8 types of 
gastric ulcer, indigestion, distended abdomen, vayu and retention of urine will be cured. 
Appetite will be increased.  
Purification 
 Common salt-1 part, vinegar(or)pure water-7 part, common salt is dissolved in 
pure water or vinegar filtered. The filterate is boiled till it reaches semi 
consistency, then little amount of lemon juice or butter milk is added to it and 
isolated. the same process is reapeted for 10 times to get the purified. 
 It is also purified by plantain stem juice, sea water and rain water. 
Other preparations 
 Uppu parpam 
Dose  :  ¼ th size of a dhal for 32 days 
Adjuvent :   Honey or warm water. 
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Indication :  Throbbing, Head ache, Mental disorder, Menorrhagia,   
ascites with   pain and syncope due to excess kapha. 
 
 Uppu chenduram 
Dose  :  65 mg to 130 mg, with suitable adjuvant. 
Indication :   Indigestion, Gastric ulcer. 
 
 Kariyuppu Thiraavagam 
Dose  :  5 drops 
Adjuvent : water 
Indication  : Dyspepsia, Indigestion, Vadha disease, weakness. 
 
Medicinal uses 
 The salt is placed and heated at the pricked sites of the pile and thorn, the 
toxicity will be cured. 
 Equal ratio of salt and tamarind are dissolved in water and boiled and the 
mixture is taken in semi-solid consistency and applied over the swelling and 
sprain by which hematoma will subside. 
 It is also used as one of the ingredients in tooth powders. 
 Insects entered in the ear, generative organs, anus will come out on spraying the 
salt water. 
 Dissolved salt water is given through the rectum to remove the worms in the 
large intestine. 
 
3.1.2. MODERN ASPECT OF SODIUM CHLORIDE 
Vernacular names 
Sanskrit name   : Lavana, Samudra Lavana, Dronilavana 
English name     :  Common salt, table salt, muriate of sodium, muriate of  
    soda. 
Arab                  :  Milhus, Aajin. 
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Pers                 : Namake-khurdam 
Hindi name      : Namak, Lun Nun 
Duk                  : Nimak 
Bengali name   : Nimok,  
Gujarati name  : Lesu  
Telugu name    : Mithun        Figure: 2  Sodium chloride 
Tamil name  : Uppu,   
Malayam name  :  Uppu    
          
 Sodium chloride is obtained when the sea water evaporates by isolation. 
Common salt is cultivated in the eastern coast of Tamil nadu, Cheyyur, Choonam bedu, 
Marakkanam, Athira pattinam, Arumuga neri and Tuticorin. 
Physical characters 
Colour      -  White, pale and ash colour. 
Odour       -  No characteristic odour    
Taste         -  Salty in taste 
Solubility -  Soluble in water, in soluble in alcohol 
Actions   
 Stomachic, 
 Laxative 
 Emetic, Anthelmintic 
 Febrifuge  
General properties 
It is one of the essential substance of our body. It Is excreted from the body by 
sweat, tears and urine. Deficiency may lead to many diseases like anemia, G.I tract 
infections, excessive thirst and skin diseases. The sea salt contains a little amount of 
iodine and prevents goitre. When sodium chloride is taken in small amounts, stimulates 
appetite and causes thirst. When a concentrated solution is applied over the cut wounds, 
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it produces irritation and inflammation. It also controls the secretion of the respiratory 
tract. Sodium chloride is mainly excreted through the urine.  
Medicinal uses 
 The salt is triturated with water and applied on the site of the poisonous bite to 
reduce the poison. It is dissolved in water and instilled as drops to minimize the 
poisonous effect of the poison. 
 One spoon table salt is dissolved in 546ml of hot water and gargled to reduce 
inflammation of throat and gingivitis. 
 It is used to give fomentation for swelling and pain. The salt is bundled and 
dipped in a cloth and dipped in boiling oil applied over the swelling when it is 
warm. 
 An isotonic solution of sodium chloride in sterile water is given as intravenous 
infusion in case severe diarrhea, with dehydration. 
 If the salt is placed and heated at the pricked sites of the pile and thorn, the 
toxicity will be cured. 
 Equal ratio of salt and tamarind are dissolved in water and boiled and the 
mixture is taken in semi-solid consistency and applied over the swelling and 
sprain by which hematoma will subside. [23] 
 
 
GUNAPADAM ASPECT  
 
Puliyaarai (Oxalis corniculata) 
 
Synonyms:   Pulikkeerai,Puliyakkerai.  
Vernacular Names  
English  :  The indian sorrel 
Malayalam  :  Pulli-yarala  
Kannada  :  Pullam-purachi-sappu  
Telugu  : Pulli-chintaku,Pullacinta 
Sanskrit  :  Changeri 
Hindi   :  Amboti pi-datti 
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Parts used  :  Leaf 
Taste   :  Sour  
Character  :  Coolent  
Division  :  Sweet  
 
Action   
 Stomachic, 
 Refrigerant 
 Diuretic,  
 Astringent  
 
 
 
General Character  
 
“பிதத் மே ் மறும்  யபருலகின்  மானிடர ்்கு 
நித்தமருள்  வாத பம்  யநருயமா- தமத்தனயவ 
மூல ் கிராணிேறும்  மூல  வுதிரமறூங் 
ய ாலப் புளிோளர ்கு.” 
      -அகத்தியர் குணவாகடம் 
 
    
Indications       - 
Piles, diarrohoea and anti-dote for insect’s bite.  
 
Medicinal uses 
  The leaf decocation is used to treat fever, tumour, eye disease, skin warts, 
Molluscum, ulcer, Reduce the toxicity of datura. [24] 
 The plant rubbed down with water, boiled and the juice of white onions 
added, the mixture is applied to the head in bilious headaches. 
 The fresh juice of leaf and decoction of jujube fruits and ginger, alkaline 
water and curdled milk butter make a oil used to treat for prolapse of the 
rectum. [25] 
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Oxalis cornuculata 
 
Taxonomical classification  
 
Kingdom :  Plantae  
Clade  : Angiosperms 
Clade  : Eudicots 
Clade  : Rosids 
Order   : Oxalidales 
Family  : Oxalidaceae 
Genus   : Oxalis 
Species  : Oxalis cornuculata 
                   Figure 3  Oxalis cornuculata 
Distribution  
Throughout India, upto 3000m in all moist exposed localities. 
 
Description: 
A diffuse annual or perennial procumbent or more or less erect creeping acid 
herb,6-25 cm in height, entire, cuneate at the base. 
Stems 
 Stems are prostrate to sub erect to 40cm long, slender, turnched, often rooting 
at nodes, covered with spreading flexible hair, 
 
Leaves        :  leaves with three leaflet, alternate, sometimes appearing almost  
whorled on short lateral stems, green or purple 
Petiole  : 05-1.7cm long, with spreading flexible hairs 
Stipules : Usually 2-3mm long, broad with free truncate apex, nearly  
glabrous to densely covered in long hairs 
Flowers : yellow, axillary or sub umbellate 
Inflorescence :  1-5 flower 
Fruits  :   Loculicidal cylindrical capsules 
Seed  : Numerous, dark brown, transversely striate 
Parts used  : Whole plant 
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Chemical constituents  
Different parts of the plant especially root contain various compounds such as 
β-sitosterol, botulin,4-hydroxybenzoic acid, ethylgallate, methoxyflavones, apigenin 
and 7-o-β-D glucopyranoside, flavonoids, tannins, phytosterols, phenol, glycoside, 
fatty acids, galacto-glycerolipid and volatile oil. The leaves contain flavonoids, 
isovitexine and vitexine-2”-o-Beta-D-glucopyrunoside. malic acid from stem, tartaric 
acid citric acid from stem, leaves. It is rich source of essential fatty acids like palmitic 
acid, oleic, linoleic, linoleic and stearic acids [26] 
Macroscopy 
Type  : Trifoliate 
Colour  : Light green 
Shape  : Obcordate 
Margin : Entire 
Apex  : Emarginatge 
Base  : Symmentrical 
Odour  : Characteristic 
Taste  : Pleasantly sour taste 
Arrangement : Alternate 
Size  : Width about 1.4cm to 1.6cm 
Length  : 0.8cm to 0.9cm 
Surface : Upper-Smooth dark green 
Lower  : Smooth pale green 
Texure  : Hairy [27,28] 
Microscopy 
 The leaf is thin with less prominent midrib. The lamina is uniform in thickness 
and the lateral veins do no project beneath the surface of the lamina [29] 
 
Powder microscopy 
Presence of epidermal trichomes, calcium oxalate crystals and stomata. 
 
Nutrional Composition [30] 
The leaves have been found to be rich in moisture, total carbohydrate, crude 
protein, crude lipid hence it can be alternative vegetable during emergency. The leaves 
of Oxalis corniculata Linn. exhibit rich in mineral contents like  
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Table 1.Nutritional parameters 
Nutritional parameter Quantity 
Moisture 82.42+-0.5 
Carbohydrates 24.67+-0.5 
Crude proteins 22.28+-0.5 
Crude lipids 23.75+-0.5 
Sodium  1.12+0.02% 
Potassium  2.17+0.31% 
Calcium 2.510.08% 
Nitrogen 3.5610.70% 
Magnesium 0.25+0.03% 
  
these mineral components are vital in regulating various metabolic pathways in 
human body [31].  
 
Properties and uses  
The plant is sour, astringent, thermogenic, cooling , anodyne ,anti-
inflammatory, digestive, carminative, liver tonic, diuretic, febrifuge, antibacterial, 
vermifuge, astringent, dysmenorrhea, styptic, hepatitis antiseptic, anthelmintic, 
dysentery, and burning sensation, It is also useful in dyspepsia, haemorrhoides, anemia, 
tympanitis, fever, dysentery, diarrhea, scurvy, corns, warts, excrescence of the skin, 
inflamed ulcers, cephalalgia, oththalmopathy, toxicity, cardiopathy, haemorrhages,, 
amenorrhea, strangury, hepatopathy and burning sensation.  
Hypoglycemic, antihypertensive, chronotropic effect, uterine relaxant, anti-
psychotic, CNS stimulant, ant yeast, inotropic effect, smooth muscle relaxant. The plant 
is traditionally used as remedy for convulsions in children and for healing fractured 
bones (Mohamd and Mir, 2000; Kirtikar and Basu, 1975; Ameenahet al., 1993) 
 The plant has an acid taste, due to the presence of acid oxalate of potassium to 
which is due its property in domestic use of removing ink-spots or iron-stains 
from linen. 
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 The fresh leaves juice is believed to relieve the intoxication of datura it is also 
believed, on application to remove fibers over the cornea or opacities if the 
cornea. 
 The plant is rubbed down with water, boiled and the juice of white onions added 
the mixture is applied to the head in bilious headaches. 
Vellai Saranai(Trianthema decandra) 
 
Synonyms  :  Vellai saranai, vellaisaradai, sakthisattaranai, virichakam 
Vernacular Names  
English  : Spreading hog weeds  
Malayalam  :  Tavizhama 
Telugu  : Tella-ghhaijeru  
Sanskrit  :  Punarnava 
Duk   :  Bees-khupra  
Parts used  :  Leaf,Root  
Taste   :  Bitter  
Character  : Heat  
Division :  Pungent, Diuretic 
Action  : Expectorent, Laxative 
 
Gerneral character  
“வித்திரிதி மூலம் விழிப்படலம் மாரப்ு  
ததத்ு  சுவாசங்  தனி ் ருப்ளப - யுற்ற 
 ருசச்ிதறச ் தசே்சூசி   ாவா த மும்யபாம் 
விருசச்ி த்தின் யபளர  விரி.” 
     -அ த்திேர ்குணவா டம் 
Indications  
Various uterine diseases, Kapha diseases, Tumours, Piles, Asthma, Swelling, 
Pterigium.  
Medicinal uses  
 The root is used to treat with scabies, Ulcers, Sinusitis, Tinea infections, 
Leucorrhea, Scrotal swelling. 
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 The root juice mixed with Tabernaemontana divaricate juice treat with eye 
diseases. 
 The leaf decoction is used to treat with eczema. 
 
                                   Trianthema decandra 
Taxonomical classification 
Kingdom  :  Plantae  
Subkingdom :  Tracheobionata  
Super Division :  Spermatophyta  
Division  : Magnoliophyta 
Class  :  Magnoliopsida  
Subclass  : Caryophyllidae 
Order  : Caryophyllales  
 
Family  : Aizoaceae           Figure 4. Trianthema decandra 
Genus  : Trianthema 
Species  : decandra 
 Distribution 
 Distributed in tropical and subtropical regions. 
Description 
Structurally the plant is glabrous, branched, and prostrate weed with branches, 
glabrous with a firm tap root up to 2mm long. 
Stem                     :  The stems are fleshy, prostrate, and often reddish in 
colour and usually are slightly angular, pubescent and 
branched. 
Leaves  :  Green in colour, succulent, oval, opposite, unequal in  
size 
Stem : Herbaceous, sparsely branched, procumbent angular        
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      Petiole :  0.5 to 3 cm long, ovate to oblong shaped, green color 
Flowers  : Small 5-lobed, pink, purple or white in colour 
Fruits  :  Represents cicumscissile capsules, partly exerted from 
    the persistant perinathand contain 2-8 seeds. 
      Seeds  :  kidney shaped, approximately 2mm in diameter, hairless,  
are brownish to black in colour. 
Root  : Cylindrical, gradually tapering measuring up to 8cm  
long. [33] 
 
Chemical constituents 
The presence of carbohydrates, glycosides, flavonoids, alkaloids, steroids, 
Saponins and alkaloid like punarnavine, Trianthemol, 15hydxoxymethyl-
2,6,10,18,22,26, heptamethyl1-14-methlene-17, trianthemine, sitosterol, stigma sterol, 
triaconitene neolignan, leptorumal, and ecdysteiods. 
 
Properties and uses 
Trianthema decandra is used in India for treatment of variety of ailments. It is used 
as a single drug in form of dried powder or decoction for jaundice, liver diseases, 
anemia, cough, headaches, epilepsy, odema, asthma etc.  As the whole plant possess 
diuretic indicated in anasarca, cystitis in case of dribbling of urine, in dropsy, edema 
and ascites.   
 The roots are used for Cathartic, epilepsy. 
 The leaf juice is dropped in each nostril in headache, migraine, abdominal gas. 
 The decoction of leaves is given for regularized the cycle. rheumatism, edema 
 The root paste is applied for ulcers, itching, poor eyesight, night blindness. 
 
Macroscopic strucuture 
Aerial part :  pale green colour 
Odour  : Characteristic strong 
Taste  : Bitter& disagreeable [35] 
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Table 2. Nutrional parameter [34] 
Nutritional Parameter Quantity(mg/g±SD 
Moisture  80.0± 2.2 
Ash 348.0±6.2 
Total lipid 20.0c±0.6 
Saponifiable lipid 11.2±0.8 
Non saponifiable lipid 8.8a±0.2 
Total protein 91.9±3.2 
Fiber 430.0±8.2 
Carbohydrate 30.d±1.2 
Energy (kcal/100 g) 76.01 
Vitamin A 0.81±0.2 
Vitamin b2 2.02±0.3 
Sodium 44.00±1.4 
Potassium 51.60±5.2 
Zinc 0.20±0.02 
Copper 0.02±0.1 
Iron 6.44±0.4 
Manganese 0.04±0.01 
Nickel 0.03±0.006 
 
 
 
Antaratamarai (Pistia stratiotes) 
 
Synonyms   :  Aagayathamarai  
Vernacular Names  
English   : The water –lettuce (Tropical Duckweed) 
Malayalam   :  Kodda-pail,Akasa-tarma 
Kannada   :  Anthar-gange 
Telugu   : Anthar-tamarai,Agasa-tarma 
Sanskrit   : Kumbhika,Vari-parni 
Hindi    :  Jal-kutbhi  
Parts used   :  Leaf, root  
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Taste    : Bitter  
Character  : Heat  
Division   : Pungent  
Action   : Refrigerant, Demulcent 
Laxative, Emollient 
General character 
“அழுகிரந்தி குட்டம் அடரந்்த ரப்பான் 
புழுவுறும ்  கூடுமுதற்  யபாகும்-அழ ாரும் 
இந்திரநீ ல ் ருங் ண் ஏந்திளழயே! எப்யபாதும் 
அந்தர ் தாமளரோ லாே்.” 
    -அ த்திேர ்குணவா டம் 
Indication 
It cures leprosy, eczema, hemorrhoids, dysentery, cough and various 
inflammation. 
Medicinal uses 
 Leaf paste is externally applied for pile, prolapse and inflammation. 
 Leaf boiled with vinegar, squeezed out the water, and then the extract is banded 
it cures leprosy, eczema, leaves with coconut milk and rice used for dysentery. 
 
 
Pistia stratiotes 
 
Taxonomical classification 
Kingdom  :  Plantae  
Clade  :  Angiosperms 
Clade  :  Monocots 
Order  : Alismatoles 
Family  :  Araceae  
Subfamily  : Aroideae 
Tribe  : Pistoia  
        Figure 5 Pistia stratiotes 
Genus  : Pistia 
Species  : stratiotes      
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Distribution  :  Distributed in tropical and subtropical regions. 
Description 
P. stratiotes is a free-floating, stoloniferous plant with sessile leaves in rosettes. 
Leaves pale-green, up to 20 cm long and 10 cm wide, mostly spathulate to broadly 
obovate with a rounded to truncate apex, with 7-15 prominent veins radiating fanwise 
from the base of both surfaces, in particular the lower surface, covered by a dense mat 
of white woolly hairs.  
 
Inflorescence  
Axillary, solitary, ascending; spathe 1.3-1.5 cm long, convolute and adnate to 
the spadix below, spreading above, whitish; spadix with a single pistillate flower at 
base, and with 2-8 staminate flowers flowers are above, shorter than the spathe. Flowers 
unisexual, the perianth wanting; stamens 2; ovary 1-locular, with numerous ovules, the 
style slender, the stigma penicillate. 
Fruit  :  Thin-walled,  
Seed   : cylindrical, rugulose 
Part used : Whole plant 
 
Chemical constituents 
Stigmasta-4,22-dien-3-one, stigmasterol, stigmasteryl stearate, and palmitic 
acids. Plant gave 2-di-C-glcosylflavones of vicenin and lucenin type, anthocyanin-
cynidin-3-glucoside, luteolin-7-glycoside and Mono-C-glcosyl flavones – vitexin and 
orientin. 
 The High level of acid detergent fibre, cellulose, hemicellulose and lignin 
present. 
Medicinal uses [37]    
 The Plant is bitter, pungent flavored having cooling, laxative property.  
It is useful in “Tridosha,” fever, and diseases of blood.  
 The root is laxative, emollient, and diuretic. Leaves infusions have been 
mentioned in the folklore to be used for dropsy, bladder complaints, kidney 
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afflictions, hematuria, dysentery, and anemia, plant is considered antiseptic, ant 
tubercular, antitussive, demulcent, the plant is used as an anodyne for eyewash.  
 The ash of plant is applied to the ringworm of the scalp. Leaves are used in 
eczema, leprosy, ulcers, piles, and syphilis.  
 The ash mixed with rose water and sugar they are given for cough and asthma. 
 Juice of leaves boiled in coconut oil is applied externally in chronic skin 
diseases. 
 
Table 3.Nutritional parameters[36] 
Nutritional Parameter Quantity 
Crude protein 8.62% 
Total Nitrogen 1.32 
Ether extract 1.16% 
N-free extract 46.62% 
Ash 21.12% 
Crude fiber 19.13% 
Potassium 5.56 
Calcium 3.24% 
Magnesium 1% 
 Phosphorus 0.26% 
Sodium 0.61% 
Iron 0.26% 
Copper 42ppm 
Zinc 181ppm 
 
 
PALM JAGGERY [38]  
 Palm jaggary is almost like a jaggery that is made out of sugarcane juice. 
  Palm jaggery is made from the extract of palm tree in southern India.  
 It has an intense, earthy taste or reminiscent of chocolates in taste.  
 The palm jaggery obtained after processing is darker and richer in colour.   
 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 34 
 
 
 
 It is slight salty to taste but much healthier of the two. Due to its cooling 
effects over human body, it is of high value. These trees are also known as 
toddy palm tree or palmyra tree.  
 
Synonyms 
Tamilnadu : Karupatti 
Karnataka : Thaati bella 
Mangalore : olebella 
                     
                Figure 6 Palmyra tree 
 Jaggery is a rich source of many vital minerals that are required by the body for 
normal growth and functioning. Jaggery is used since ancient times to treat 
problems such as dry cough, common cold and asthma. It is beneficial in 
treating conditions like indigestion and constipation. 
 Jaggery helps in promoting relaxation of muscles, nerves and blood vessels, thus 
enhancing their functions. 
 Jaggery is a rich source of iron and is therefore, very good for anemic people, 
as it increases the hemoglobin level in the blood.  
 Jaggery has strong antioxidant properties and protects our body cells from the 
damage caused by free radicals. 
 Jaggery has the ability to purify blood and helps in regulating the liver function. 
A mixture of jaggery and dry ginger powder taken with warm water can stop 
hiccups.  
 Jaggery may be used in the creation of alcoholic beverages such as palm wine. 
  Jaggery is used in natural dying of fabric and in hookahs in rural areas of 
Pakistan and India.         
 Jaggery helps in regulating blood pressure and also helps the body to get rid of 
all the toxins.  
 Jaggery has potassium content that may help in reducing bloating and water 
retention.  
 It cleanses the respiratory tract, intestines, food pipe, lungs, and stomach. It also 
helps to wipe out the toxins from the body, leaving you healthy and fit. 
 Relieves Constipation, reduce the weight. Helps to migraine. 
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     Table 4. Nutritional parameter of palm jaggary 
Nutrition parameter Quantity 
Protein 0.35% 
Fat 0.17% 
Minerals 0.74% 
Carbohydrates 90.60% 
Calcium 0.06% 
Phosphorus 0.06% 
Iron 2.5%(mg/gm) 
Nicotinic acid 5.24(mg/100 gm) 
Vitamin B1 24.0(mg/100gm) 
Riboflavin 432.0(mg/100gm) 
Vitamin C 11.0(Mg/100gm) 
 
 
 
 
 
 
Figure 7 Palm Jaggary 
 
3.2. DISEASE REVIEW 
3.2.1. Siddha Aspect of the Disease 
Hippocrates (ca. 460 BC – ca. 370 BC) described several kinds of Cancer, 
referring to them with the Greek word Karkinos (Crab or Crayfish). This name comes 
from the appearance of the cut surface of a solid malignant tumour, with "the veins 
stretched on all sides as the animal the crab has its feet, whence it derives its name" [39]. 
 In Siddha system of medicine, Cancer is referred to Vippuruthi or Putru. Putru which 
gives the direct meaning and as Arpudham and Vanmeegam. Generally, a chronic 
tumour or swelling or ulcer is first identification of Putru in Siddha system.  
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Tumours grow gradually and finally look like a Putru or cauliflower.For the pupose of 
diagnose and treatment  following reference books evaluates great ideas about Cancer. 
 
“புற்று யநாளே தமௌனப்பள வன் 
மளறந்திருந்து த ால்லும் பள வன்” 
    -திருமந்திரம் 
1. YugiVaidhiyaChinthamani 
2. AnubogaVaidhiyaNavaneetham 
3. Pulipani 500(40) 
4. Agathiya Vaidhiya Vallathi 
5. Agathiyavaithiyavallathi 60(41) 
6. Anubogavaidhiyabhramaragasiyam 
7. Agathiyavaithyagandam 
great Siddhar Agatthiya in his Vaidhiya Vallathi 600 had explained cancer and its 
different categories. 
“யபா ்குயம திமிரவ்ாத மண்ளடசூளல புற்றுடயன 
ய ட்குயம அளரோப்பு பவுத்திரத்ளத ் ய ள் 
தண்டு சூளலதோடு லிங் ப் புற்யற” 
-அ த்திேர ்ளவத்திே வல்லாதி 
 
 “நாமப்பா ருங்கிரந்தி யோனிப்புற்று 
ஆமப்பா ருவழி ்குங் கிரந்தி லிங் ப்புற்று” 
-யூகி ளவத்திே சிந்தாமணி 
 
“இருபுடரி நுனி நாசி சிலந்தி புற்று 
தடரச்ிலந்தி படரச்ிலந்தி அல்குல் புற்று 
பின் ரப்பான் முங் ரப்பான் அண்டப் புற்று 
துணிவாத உந்திப்புண் துளடயில் புற்று 
கீழ்நா ்கு யமல்நா ்குப் புற்றுப் யபாயம”  
-புலிப்பாணி 500 
 
The unique saint Pulipani also dealt with different type of cancer in his Pulipani 500. 
 
   “ஓயமனி குழிப்புற்று யோனிப்புற்று 
   ஒளிவான இடிப்புற்று ன்னப்புற்று” 
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Theriyar vaitihyam1001 
“விளறயியறன் மு ் ரத்தின்  ரப்பான் புண் ள் இடிப்புற்று குறிப்புற்று 
யீரல்புற்று 
விளறயுயறன் யுடி ரப்பான் குறவுகுஷ்டம் வீசச்ுடயன புறவீசச்ு விஷ நீரப்்புற்று 
ளபேப்பா புற்றுவள  தேல்லாங் டட்ும் பே ்குமப் பாரசபற்பம் பரிந்து பாயர. 
 
        -அ ஸ்திேர ் ண்ம ாண்டம் 
In this medical system of life, the cancerous growth and tumors are headed as 
Arputha viranangal and Arputha kattigal.According to Yugimamunivar Vaithiya 
Chinthamani 800 part I, some kinds of cancer clarified under different systemic 
diseases. 
Yugi classifications of diseases are compared with Modern system of medicine 
by names of symptoms for quick and easy approach (42). 
For example,  
 Ukkarasoolai is understand as prostatic cancer 
 Vilperuvayiru can be compared with Testicular cancer 
 Mamisamagotharam and Kalperuvayiru as cancerous growth within the 
abdomen. Cancer is considered as Vippuruthi. 
Causes  
 Taking excessive amount of salt and pungent. 
 Taking large quantity of fish and meat. 
 Making sleep in day time. 
 
 
Types of Vippuruthi:             
Vippuruthi is classified into seven types, 
Curable type of Vippuruthi: 
          1. Karpa Vippuruthi 
          2. Kuvalai Vippuruthi  
          3. Pitha Vippuruthi 
          4. Oodu Vippuruthi 
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Incurable type of Vippuruthi: 
          1. Santhu Vippuruthi 
          2. Sethuma Vippuruthi 
          3. Vatha Vippuruthi [43]. 
 
 Karppa Vippuruthi: 
 Gastric regurgitation 
 Pain in side and lower abdomen 
 Dryness of skin 
 Lower abdominal swelling like pregnancy 
 Head ache 
 
 Kuvalai Vippuruthi: 
 Pain in lower back, anal region and side of the chest 
 Fever with shivering 
 Cough with expectoration 
 Abdominal pain and swelling 
 
 Vatha Vippuruthi:  
 Pain and swelling in the lower abdomen, this swelling looks like a frog 
 Fever, Wound in the abdomen 
 Pus discharge from the wound and abdominal distension 
 
 Pitha Vippuruthi: 
 Hematemesis 
 Paleness of the skin 
 Burning sensation all over the body 
 Shivering 
 Mental disorder 
 Hiccup 
 Tastelessness of the tongue 
 Fever 
 Dehydration 
 Hematoma and abdominal pain 
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 Sethuma Vippuruthi: 
          Small tumour and abscess in the abdomen, abdominal pain, fever, cough and 
swelling of the body. 
 
 Santhu Vippuruthi: 
          Swelling in the side of the abdomen, this swelling is characterized by  
 Shining 
 Hardness 
 Cool and itching 
 
 Oodu Vippuruthi: 
 Fever 
 Blackish discolouration of skin 
 Abdominal pain 
 Giddiness 
 Vomiting 
 Diarrhoea and body pain.   
 
The great Siddhar Agatthiya in his Vaidhiya Vallathi 600 had explained cancer and 
its different categories. 
 
 For example,  
 Ukkarasoolai is understand as prostatic cancer 
 Vilperuvayiru can be compared with Testicular cancer 
 Mamisamagotharam and Kalperuvayiru as cancerous growth within the 
abdomen. 
Appearance: 
Cancerous growth appears like, 
 Solid tumor -  Kazhalaikatti 
 Spreading ulcer 
 Initially like warts then growth develops as turtle shell with oozing. 
 Hyper pigmentation of skin, affects hair follicles and destroys entire body. 
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Classification: 
Cancer classified into 3 types according its spreading nature (Metastasis) 
 Skin and its structures 
 Muscles  
 Blood vessels and bones 
Causes  
 Vitamin and mineral deficiency 
 Increased sexual activity 
 Prolonged starvation, Excessive use of tobacco  
 Excessive intake of hot and spicy food 
 Taking excessive amount of salt and pungent food stuffs 
 Taking large quantity of fish and meat 
 Sleeping in the day time. 
                                                    Yoni Putru 
Yoni means birth passage. This is cervix of uterus. So the cancer of cervix is 
known as Yoniputru. It is also called Karuppai kazhunthu putru. 
Symptoms 
 Growth in cervix appearing like small grains. 
  Discharge like honey 
 Hardening of surface 
 Profuse bleeding  
 Constipation 
 In some patients discharges with intolerable foul smell. 
 Oliguria and anuria, Administration of diuretics causes haematuria. 
Discharges classified into 3 types 
1. Viscous yellowish discharge 
2. Yellow discharge with mucous 
3. Bloody discharge due to non-healing cervical ulcer and cancer of cervix. 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 41 
 
 
 
The SiddharYugi in his Vaidhiya Sinthamani mentioned the symptoms of Yoniputru 
in different types as follows, 
Kuruthiyoni (44a) 
” திறமான வுபத்திரவ மதி ங் ாணும் 
             ததளிோத ரத்தமுடன் சீழ்நீரப்் பாே்சச்ல் 
 றமான நுளரயுடயன யநாயுண்டாகும் 
            டினமாஞ் சளதயுடயன குத்தல் ாணும் 
நிறமான மஞ்சளுடன் சயரா ந்தான் 
             நிளலோது வல்குலியல புழுயவா தமத்த 
மலமான தசால்லதுவு முளுதத்ாற் யபால 
              மஞ்ளஞோ னிறம்யபால் மச ்கும் பாயர.” 
                                     -யூகி முனி 
 
Profuse bleeding with mucous, micro ulcers like pits on the wall of cervix, 
discoloration of os. 
Kuruthicheezhyoni (45): 
“பாயரதாமன் யவதளன மி வுண்டாகும் 
         பாங் ான சீழுடன் ரத்தங் ாணும் 
சீயரதான் ஒழு ்குடன் நாற்றமாகும் 
          சிதறியே பலயபத வண்ணங் ாட்டும் 
யநயரதா நிதம்பத்தின் ஸ்தனந் தன்னில் 
           தநடிதான யரா த்ளத யமவச ்தசே்யும் 
யவயரதான் தசான்னபடி சிகிசச்ா சாரம் 
          விரித்திட்டர ்யூகிமுனி விள ் ந் தாயன.” 
                                   -யூகி முனி 
Bleeding with mucous sometimes in multicolor, foul smelling discharge with 
bad odour, spread to whole uterus. 
Mamisamagotharam(44b): 
“யபா ் ான மாமிசந்தான் வளரந்்து மீறி 
        தபாருமியே அடிவயிற்றில் ல்ளலப் யபாலத் 
தா ் ான சடந்தானு முலரந்்து வற்றி 
        தவி ்குயம ேடி ் டிதான் ண்ணீர ்யதடி 
வா ் ான மதுரதமாழி குளறிப் யபசி 
        வாே்வுதா னடி ் டி ்கு யமயல யநா ்கும் 
நீங் ான மலசலமிதில் மாமிசங் ாணும் 
       யநரான மாமிச மய ாதரத்தி யனயர.”  
                                         
There are various treatments available especially for Yoniputru, vaai putru in 
Siddha medicine. 
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3.2.2 Modern Aspects of Cancer 
Cancer known medically as malignant neoplasia, is a broad group of diseases 
involving unregulated cell growth. In Cancer, cells divide and grow uncontrollably, 
forming malignant tumours, which may invade nearby parts of the body.  
The Cancer may also spread to more distant parts of the body through the 
lymphatic system or bloodstream. Not all tumours are Cancerous; benign tumours do 
not invade neighbouring tissues and do not spread throughout the body. There are over 
200 different known Cancers that affect humans. 
 
History: 
Cancer has existed for all of human history. The earliest written record 
regarding Cancer is from circa 1600 BC in the Egyptian Edwin Smith Papyrus and 
describes Cancer of the breast. Hippocrates (ca. 460 BC – ca. 370 BC) described several 
kinds of Cancer, referring to them with the Greek word Karkinos (Crab or Crayfish).  
This name comes from the appearance of the cut surface of a solid malignant 
tumour, with "the veins stretched on all sides as the animal the crab has its feet, whence 
it derives its name." Galen stated that "Cancer of the breast is so called because of the 
fancied resemblance to a crab given by the lateral prolongations of the tumour and the 
adjacent distended veins". Celsus (ca. 25 BC – 50 AD) translated Karkinos into the 
Latin Cancer, also meaning crab and recommended surgery as treatment. Galen (2nd 
century AD) disagreed with the use of surgery and recommended purgatives instead. 
These recommendations largely stood for 1000 years. 
In the 15th, 16th and 17th centuries, it became acceptable for doctors to dissect 
bodies to discover the cause of death. The German professor Wilhelm Fabry believed 
that breast Cancer was caused by a milk clot in a mammary duct. The Dutch professor 
Francois de la Boe Sylvius, a follower of Descartes, believed that all disease was the 
outcome of chemical processes, and that acidic lymph fluid was the cause of Cancer. 
His contemporary Nicolaes Tulp believed that Cancer was a poison that slowly spreads, 
and concluded that it was contagious. 
The physician John Hill described tobacco snuff as the cause of nose Cancer in 
1761. This was followed by the report in 1775 by British surgeon Percivall Pott that 
Cancer of the scrotum was a common disease among chimney sweeps. With the 
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widespread use of the microscope in the 18th century, it was discovered that the 'Cancer 
poison' spread from the primary tumor through the lymph nodes to other sites 
("metastasis"). This view of the disease was first formulated by the English surgeon 
Campbell De Morgan between 1871 and 1874. [45] 
Epidemiology of Cancer: 
         Nearly seven lakh Indians die of Cancer every year, while over 10 lakhs are newly 
diagnosed with some form of the disease. According to the latest World Cancer Report 
from the World Health Organization (WHO), more women in India are being newly 
diagnosed with Cancer annually. As against 4.77 lakh men, 5.37 lakh women were 
diagnosed with Cancer in India in 2012.  
         In terms of Cancer deaths, the mortality rate among men and women in India is 
almost the same. While 3.56 lakh men died of Cancer in 2012 in India, the 
corresponding number for women was 3.26 lakh. One in every 10 Indians runs the risk 
of getting Cancer before 75 years of age. 
          Cancer of lip and oral cavity has emerged as the deadliest among Indian men 
while for women, it is breast Cancer. The top five Cancers in men are lip/oral cavity, 
lung, stomach, colorectal and pharynx, while among women they are breast, cervix, 
colorectal, ovary and lip/oral cavity.  
         The global Cancer burden jumped to 14.1 million new cases in 2012, with WHO 
saying the marked increase in breast Cancers must be addressed. The International 
Agency for Research on Cancer (IARC) 2012 estimated 14.1 million new Cancer cases 
and 8.2 million Cancer-related deaths occurred in 2012, compared with 12.7 million 
and 7.6 million, respectively, in 2008.  
         The most commonly diagnosed Cancers worldwide were those of the lung (1.8 
million, 13% of the total), breast (1.7 million, 11.9%), and colorectum (1.4 million, 
9.7%). The most common causes of Cancer death were Cancers of the lung (1.6 million, 
19.4% of the total), liver (0.8 million, 9.1%), and stomach (0.7 million, 8.8%).  
         Projections based on IARC 2012 estimates predict a substantive increase to 19.3 
million new Cancer cases per year by 2025, due to growth and ageing of the global 
population. More than half of all Cancers (56.8%) and Cancer deaths (64.9%) in 2012 
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occurred in less developed regions of the world, and these proportions will increase 
further by 2025 [46].        
Cervical cancer has emerged as a second most common cause of cancer deaths 
among Indian women aged between 15 and 44 years, according to a report by Spain-
based international public health institution Institute Catalàd’ Oncologia (ICO) 
Information Centre. 
On an average, India reports about 122,000 new cases of cervical cancer 
annually, with around 67,500 women succumbing to the disease, accounting for 11.1% 
of total deaths related to cancer. Cervical cancer comes next to breast cancer in terms 
of mortality rate in Indian women. The two preventive strategies for cervical cancer 
include screening and vaccination. The report says just 3.1% women in India get 
screened, leaving a large population vulnerable to death from the disease. 
 
Causes:  
Cancers are primarily an environmental disease with 90–95% of cases attributed 
to environmental factors and 5–10% due to genetics. Only 5–10% of all cancer cases 
can be attributed to genetic defects, whereas the remaining 90–95% have their roots in 
the environment and lifestyle. The lifestyle factors include cigarette smoking, diet (fried 
foods, red meat), alcohol, sun exposure, environmental pollutants, infections, stress, 
obesity, and physical inactivity. 
 The evidence indicates that of all cancer-related deaths, almost 25–30% are due 
to tobacco, as many as 30–35% are linked to diet, about 15–20% are due to infections, 
and the remaining percentage are due to other factors like radiation, stress, physical 
activity, environmental pollutants etc.   
It is nearly impossible to prove what caused a Cancer in any individual, because 
most Cancers have multiple possible causes. For example, if a person who uses tobacco 
heavily develops lung Cancer, then it was probably caused by the tobacco use, but since 
everyone has a small chance of developing lung Cancer as a result of air pollution or 
radiation, then there is a small chance that the Cancer developed because of air pollution 
or radiation [47].  
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 Fig.No 8. Cause of cancer 
 
 
 
Other Medical Factors  
As we age, there is an increase in the number of possible cancer-causing mutations 
in our DNA. This makes age an important risk factor for cancer. Several viruses have 
also been linked to cancer such as, 
 Human Papillomavirus (a cause of cervical cancer) 
 Hepatitis B and C (causes of liver cancer) 
 Epstein-Barr virus (a cause of some childhood cancers) 
 Human immunodeficiency virus (HIV)  
 Anything else that suppresses or weakens the immune system - inhibits the 
body's ability to fight infections. 
 Increases the chance of developing cancer. 
 
        There are five broad groups that are used to classify Cancer. 
 Carcinomas are characterized by cells that cover internal and external parts of 
the   body such as lung, breast, and colon Cancer. 
 Sarcomas are characterized by cells that are located in bone, cartilage, fat, 
connective tissue, muscle, and other supportive tissues. 
 Lymphomas are Cancers that begin in the lymph nodes and immune system 
tissues. 
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 Leukemias are Cancers that begin in the bone marrow and often accumulate in 
the bloodstream. 
 Adenomas are Cancers that arise in the thyroid, the pituitary gland, the adrenal 
gland, and other glandular tissues [48]. 
 
Individual types of cancer 
There are said to be over 200 different types of cancer. Some of the cancer types 
are as follows, 
 Anal cancer 
 Bladder cancer 
 Bone cancer 
 Breast cancer 
 Cervical cancer 
 Colon cancer 
 Colorectal cancer 
 Endometrial cancer 
 Kidney cancer 
 Leukemia 
 Liver cancer 
 Lymphoma 
 Ovarian cancer 
 Pancreatic cancer 
 Prostate cancer 
 Stomach cancer 
 Testicular cancer 
 Thyroid cancer 
 Vaginal cancer 
 Vulvar cancer 
Metastasis: 
        Metastasis is the general term used to describe the spread of cancer cells from the 
primary tumor to surrounding tissues and to distant organs and is the primary cause of 
cancer morbidity and mortality. It is responsible for about 90% of cancer deaths. 
Metastasis involves a series of sequential and interrelated steps.  Metastatic cells also 
establish a microenvironment that facilitates angiogenesis and proliferation, resulting 
in macroscopic, malignant secondary tumors. Although systemic metastasis is 
responsible for about 90% of cancer deaths. [49]  
 
 
Head and neck Cancer: 
          Tumours of the head and neck are the sixth most common malignancy in the 
world, with a yearly incidence of more than 500,000 cases, and it comprises 
approximately 4% to 5% of all new Cancers and 2% of all Cancer deaths (100,000 per 
year).  
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Most patients are older than 50 years, and incidence increases with age; the 
male-to-female ratio is 2.5:1. Approximately 34% of oral and pharyngeal Cancers 
present as localized disease, 46% present as loco regional (i.e., locally advanced or 
involving regional lymph nodes) disease, and 10% present as metastatic disease. Ninety 
percent of these Cancers involve squamous cell histology. 
  The most common sites are the oral cavity, pharynx, larynx, and hypopharynx. 
Nasal cavity and paranasal sinus Cancers, salivary gland malignancies, and various 
sarcomas, lymphomas, and melanoma are less common. 
Site-specific head and neck Cancers: 
Oropharynx cancer 
The subsites of the oropharynx are (1) the anterior surface of the soft palate, 
including the uvula; (2) the posterior pharyngeal wall; (3) the anterior and posterior 
tonsillar pillars; (4) the tonsils and tonsillar fossas; and (5) the posterior one-third of the 
tongue, which lies between the circumvallate papillae and the vallecula. The lingual 
surface of the epiglottis is part of the supraglottic larynx. The mucosa of the oropharynx 
consists of stratified squamous epithelium. 
Pathology 
Most oropharyngeal cancers are squamous cell carcinomas, Deep infiltration is 
common. Minor salivary gland cancers and lymphomas-particularly non-Hodgkin's 
lymphoma involving the tonsil and other parts of Waldeyer's ring-also arise in this area. 
Tumors of the parapharyngeal space may also present as oropharyngeal swellings, 
causing the mucosa of the lateral pharyngeal wall or soft palate to bulge. These are most 
often retromandibular parotid tumors or neurogenic tumors (eg, neurilemmoma, 
neurofibroma, or paraganglioma) 
Cancers of the tonsillar region drain primarily to the upper and mid jugular chain 
nodes and to the submandibular nodes (levels I, II, and III). Posterior triangle lymph 
nodes (level V) become involved following involvement of the jugular chain nodes. 
The overall incidence of cervical lymph node involvement from cancer of the 
oropharynx is approximately 70%. Bilateral cervical lymph node metastases are 
common (50%). 
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Clinical Findings 
Cancer of the oropharynx usually present with ulcerating cancers. Cervical 
lymph node metastases are a common presenting sign. Approximately 70% of patients 
with tongue base cancers present with advanced cancer, compared with only 35% of 
patients with cancer of the oral tongue. Tongue base cancers can spread laterally to 
involve the mandible, anteriorly to involve the oral tongue, and inferiorly to involve the 
vallecula and supraglottic larynx. Cancers of the tonsillar region readily extend to the 
mandible. They can also infiltrate the pterygoid muscles, producing trismus. This is an 
important presenting symptom, and it may limit access for examination. Referred 
otalgia is common with deeply infiltrating cancers. 
 
B. Management of Neck Metastases 
Cervical lymph node metastases are treated by radical or modified neck 
dissection. If the neck is clinically free of cancer, an elective supraomohyoid neck 
dissection or radiation therapy is appropriate. If the primary cancer is treated by 
radiation therapy, the cervical lymph nodes at risk are included in the radiation field. If 
the primary cancer is treated surgically, an elective neck dissection is appropriate. If 
postoperative radiation therapy is planned for the primary cancer site, it is reasonable 
to include the neck in the radiation field instead of performing an elective neck 
dissection. Initial (induction, neoadjuvant) chemotherapy using cisplatin, fluorouracil, 
and paclitaxel, singly or in combination, gives response rates of up to 80%, but these 
responses are rarely of long duration. 
Hypopharynx 
            Over 95% of hypo pharyngeal cancers are squamous carcinomas, which usually 
present as infiltrating ulcerative lesions.Cancer of the hypopharynx has a high 
propensity for lymphatic invasion, with most patients having cervical lymph node 
metastases at the time of initial presentation.  
The hypopharynx-especially the piri-orm sinus-must always be examined in an 
adult with cervical lymph node metastases and no obvious primary cancer site. Occult 
cervical lymph node metastases (ie, clinically negative but histologically positive) are 
also common, causing the overall incidence of cervical lymph node metastases at 
presentation to be approximately 75%.  
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 49 
 
 
 
Clinical Findings 
The most common site for hypopharyngeal cancer is the piriform sinus, 
accounting for 60% of cases. The postcricoid region is affected in 25% of patients and 
the posterior pharyngeal wall in 15%.  
The chief symptoms of hypopharyngeal cancer are pain, dysphagia, and weight 
loss. Pain can be localized to the site of the cancer or can be referred to the ipsilateral 
ear. Direct laryngopharyngoscopy and biopsy are necessary. 
 
Salivary gland cancer 
The paired major salivary glands consist of the parotid and submandibular 
glands. Minor salivary glands are widely distributed in the mucosa of the lips, cheeks, 
hard and soft palate, uvula, floor of mouth, tongue, and peritonsillar region; a few are 
found in the nasopharynx, paranasal sinuses, larynx, trachea, bronchi, and lacrimal 
glands. 
 
Pathology 
A variety of site-specific and systemic diseases can affect the salivary glands. 
Tumors of salivary gland tissue constitute about 5% of head and neck tumors and affect 
major salivary glands five times more often than minor salivary glands. The incidence 
of malignancy among salivary gland tumors varies inversely with the size of the gland. 
About 15% of parotid tumors, 50% of submandibular gland tumors, and 90% of minor 
salivary gland tumors are malignant. 
Since 70% of salivary gland tumors occur in the parotid and 85% of these are 
benign, the majority of salivary gland tumors are benign. These tumors are thought to 
originate from two cell types: intercalated and excretory duct cells.  
The most common benign salivary gland tumor is the benign mixed tumor or 
pleomorphic adenoma, which accounts for 70% of parotid tumors and 50% of all 
salivary gland tumors. Mixed tumors are more common in women than in men, with 
the peak incidence in the fifth decade. They are slow-growing and lobular and may 
become very large without interfering with facial nerve function. Although mixed 
tumors are benign, they will recur after surgery unless they are completely removed. 
Warthin's tumor (papillary cystadenoma lymphomatosum), the next most common 
benign tumor, accounts for about 5% of parotid tumors. Warthin's tumors are usually 
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cystic, typically occur in men in the sixth and seventh decades, and are bilateral in about 
10% of cases. They occur almost exclusively in the parotid gland and have a typical 
histologic appearance, consisting of a papillary-cystic pattern with a marked lymphoid 
component. Oncocytomas are benign tumors composed of large oxyphilic cells called 
oncocytes.  
Mucoepidermoid carcinoma is the most common parotid cancer. These tumors 
are categorized as high-grade, intermediate-grade, or low-grade cancers. Adenoid 
cystic carcinomas, which are uncommon in the parotid, have a great propensity for 
perineural invasion and local recurrence. Patients with this cancer tend to have 
protracted illness, with recurrences appearing 15 years or more after treatment.  
Approximately 70% of all minor salivary gland cancers occur in the oral cavity, 
principally on the hard palate. [50] 
Oral Cancer:  
           Oral Cancer is one of the most common head and neck malignancies. Oral 
Cancer is a general term for oral cavity Cancers. It occurs in the majority, where 
squamous cell carcinoma, which is called the mucosa mutate. In clinical practice, oral 
Cancer, including Cancer gums , tongue , hard and soft palate, carcinoma of the 
mandible , oropharynx, lip Cancer and maxillary sinus. Cancer occurs in the facial skin 
and mucous membranes of oral cavity and so on.  
 
 Causes of Oral Cancer:  
 Long-term habit of tobacco, alcohol 
 Poor oral hygiene: 
 Long-term stimulation by foreign body: 
 Malnutrition: 
 
Vitamin A deficiency can cause oral mucosal epithelial thickening, hyperkeratosis 
with the occurrence of oral Cancer. Demographic studies show that countries with low 
intake of vitamin A high incidence of oral Cancer. There is also an inadequate intake 
of trace elements considered relevant, such as low Zinc content of foods. Zinc is 
indispensable for the growth of animal tissue elements, Zinc deficiency may lead to 
mucosal epithelial damage, and create favorable conditions for the occurrence of oral 
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Cancer. Inadequate plant protein and animal protein intake may be associated with oral 
Cancer.  
 
There are four stages of oral cancer. 
 Stage 1: The tumor is 2 centimeters (cm) or smaller, and the cancer hasn’t   
   spread    to the lymph nodes. 
 Stage 2: The tumor is between 2-4 cm, and cancer cells haven’t spread to the   
       lymph nodes. 
 Stage 3: The tumor is either larger than 4 cm and hasn’t spread to the  
lymph nodes, or is any size and has spread to one lymph node, but not 
to other parts of the body. 
 Stage 4: Tumors are any size and the cancer cells have spread to nearby tissues,  
  the   lymph nodes, or other parts of the body [51]. 
 
Associated lesions:  
The relationship between oral Cancer and precancerous lesions: 
            White ulcers or blisters inside the buccal mucosa occurs, often occurs as 
pressure sores, poor sleep or eating habits (such as insufficient fruits), in general will 
heal within two weeks. If it is not cured in two weeks, must be examined to rule out the 
possibility of epithelial cell carcinoma.  
 
Changes in the oral mucosa color: 
            Normal epithelium pink, red or a white color of polarization is not normal. If 
red with white, it is more serious situation, another example of the tongue appears dark 
red with white dot like, highly suspicious of Cancer.  
Ulcer: 
            Over more than two weeks of oral mucosal ulcer has not yet healed.  
Clinical manifestations:  
 Lumps, nodules 
 White, smooth scaly plaque appeared  
 Red patches, ulcers, inflammation and other symptoms distinct can’t be cured             
for a longer period 
 Repeated oral bleeding for no apparent reason  
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 Numbness, burning, or dryness of mouth for no apparent reason  
 Unusual difficulty in speaking or swallowing [52]. 
Diagnosis: 
When neck mass is the first presentation, the primary site can be located and 
biopsied in approximately 80% of cases. If no primary site is obvious, tissue diagnosis 
can be obtained by fine needle aspiration (FNA) biopsy of the node, with sensitivity 
and specificity approaching 99%. A non-diagnostic FNA does not rule out the presence 
of tumour. 
Computerized tomography scan (CT scan) remains the primary imaging study 
for evaluation of metastatic adenopathy. Magnetic resonance imaging (MRI) may 
complement the CT scan. Positron emission tomography (PET) scans are being used 
more frequently to detect tumours that are not obvious on other scans.  
Laryngoscopy and nasopharyngoscopy should be performed. With occult 
primary tumours, directed biopsies of the nasopharynx, tonsil, base of tongue, and 
pyriform sinus should be performed. Bilateral tonsillectomy will sometimes reveal the 
source of an occult Cancer  
Panoramic radiograph. 
This is a rotating, or panoramic, x-ray of the upper and lower jawbones to detect 
cancer or evaluate the teeth before radiation therapy or chemotherapy. This is often 
called a Panorex. 
Bone scan 
A bone scan uses a radioactive tracer to look at the inside of the bones. The 
tracer is injected into a patient’s vein. It collects in areas of the bone and is detected 
by a special camera. Healthy bone appears gray to the camera, and areas of injury, 
such as those caused by cancer, appear dark. This test may be done to see if cancer 
has spread to the bones. 
Prevention:  
1. Avoid unnecessary prolonged illumination, prevent the emergence of lip Cancer 
2. Avoid smoking and drinking 
3. Patients wearing dentures 
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a. Found that tissue under dentures pain, inflammation, should seek 
immediate medical attention. Strive to achieve early detection of Cancer, 
early diagnosis and early treatment, and insisted regularly checked.  
4. Balanced diet 
5. Do not drink and eat hot water and food, to avoid irritation of oral tissues 
6. Unplug the tooth residual root and crown 
7. Good wear dentures, does not stimulate tissue  
8. Develop good oral hygiene habits 
9. Regular brushing. Pay attention to nutritional balance, timely treatment    
 
      
Four symptoms of oral Cancer to be alert:   
  If the mouth turns white, brown or black, it means a change in mucosal epithelial 
cells. Especially the oral mucosa becomes rough, thickened or showed induration, 
appeared oral leukoplakia , erythema, is likely to be Cancerous.  
Unhealed ulcer: 
Oral ulcers of the course is generally not more than two weeks, if the burning 
sensation, pain and other symptoms brought the matter still more than two weeks, to be 
alert to the possibility of oral Cancer.  
Obvious pain: 
         Intially generally painless or only partial exception sense of friction, ulceration 
obvious pain, with further violations of the nerve tumor, can cause ear and throat pain.  
Lymph nodes: 
         Multiple oral Cancer to nearby lymph node metastasis to the neck, and sometimes 
the primary lesion is small, and even the symptoms are not obvious, but they found a 
lymph node metastasis of Cancer cells. Therefore, such a sudden neck lymph node, 
need to check the mouth.  
Dysfunction: 
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          Zhang closed the tumour may infringe muscles and temporomandibular joint, 
resulting in the opening and closing movement is restricted                              
 
Cervical cancer 
Cervical cancer is the most common cancer in women aged 35 and below. 
Cervical cancer is a type of cancer that occurs in the cells of the cervix. The cervix is 
the organ connecting the uterus and vagina.  It is usually a slow- growing cancer that 
may not have symptoms but can be found with regular pap tests. 
This is a procedure in which cells are scraped from the cervix and looked at 
under a microscope (53).  
 
 
 
 
 
 
 
Cervical cancer is not thought to be hereditary. In 99.7% of cases, cervical 
cancers are caused by persistent infections with a virus called high-risk human 
papillomavirus (HPV). HPV is a very common virus transmitted through skin to skin 
contact in the genital area. Around four out of five sexually active adults (80%)  
will be infected with some type of HPV in their lives. While HPV infection is common, 
cervical cancer is rare (54). There are two types of cervical cancer. Squamous cell 
carcinomas (80% to 90%) and adeno carcinomas (5% to 20%). If the cancer has signs 
of both types, it is called mixed carcinoma. Early detection and treatment of cervical 
cancer is important to improve survival.                                         
 Predisposing Factors (56) 
 Average age 35-45 years 
Figure 9 Cervical cancer 
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 Coitus before the age of 18 years 
 Multiple sexual partners 
 Delivery of the first baby before the age of 20 years 
 Multiparty with poor birth spacing between pregnancies. 
 Poor personal hygiene 
 Poor socioeconomic status 
 Previously, exposure to smegma from uncircumcised partners was considered 
an important for lower incidence of cancer cervix amongst the Jews and 
Muslims. 
 Smoking and alcohol 
 Contraceptive pill- long term use of some common contraceptive pills slightly 
raises a women’s risk. 
History of Cervical Cancer (55) 
Table 5.  History of Cervical Cancer 
Year/ 
Period 
Key developments 
19th 
century 
Cervical cancer is identified as a sexually transmitted disease. At the end of the 
century, surgery is introduced for treating the disease. 
Early 20th 
century 
Epidemiologists discover that cervical cancer is common in female sex workers and 
also common in women whose husbands have a high number of sexual partners or were 
regular customers of prostitutes. 
1920s Papanikolaou develops his eponymous technique. The colposcope is developed. 
1940s Pap smear screening begins.  
1980s 
First concrete evidence that specific Human Papillomavirus (HPV) types are linked 
to cervical cancer. Tobacco use is linked to cervical cancer. 
2000s 
First Human papilloma virus (HPV) vaccine is released. Several nations introduce the 
vaccination, such as United States, Canada, Australia and Japan. 
Recent 
years 
Today, cervical cancer is both the fourth-most common cause of cancer and the fourth-
most common cause of death from cancer in women. In 2012, approximately 528,000 
cases of cervical cancer occurred, with 266,000 deaths. This is about 8% of the total 
cases and total deaths from cancer. About 70% of cervical cancers occur in developing 
countries. 
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 Women with STD, HIV infection, herpes simplex virus 2 infection, HPV 
infection (16, 18, 31, 33) or condylomata have a high predisposition to cancer. 
 Immuno suppressed individuals (following transplant surgery) 
 Women with pre invasive lesions 
 Women who do not come for regular health check-up and pap test. 
 
Human papillomavirus (HPV) 
Human papilloma virus (HPV) is an 
extremely common virus. HPV is the 
most widespread of all sexually 
transmitted viruses. four out of five (80%) 
of the world's population will contract 
some type of the virus once in their life. 
There are over 100 identified types of 
HPV and each different type has been 
assigned a specific number. 
   Figure 10. Show Human papilloma virus    
The majority of HPV types infect the skin on external areas of the body, including 
the    cause verrucas on the feet. hands and feet.  
 
 Around 40 of the HPV types affect the genital areas of men and women 
  including the skin of the penis, vulva, anus and the linings of the vagina, cervix         
  and rectum. 
  Around 20 of these types are thought to be associated with the development of 
cancer. The World Health Organization (WHO) International Association for 
Research on Cancer (IARC) defines 13 of these 20 types as oncogenic (cancer 
causing). 
 These high-risk types of HPV are 
 HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68. A person infected 
with a high-risk genital HPV will show no symptoms. 
 In addition, there are nine HPV types that may also be associated with the 
development of cervical cancer, these are HPV 26, 53, 64, 65, 66, 67, 69, 70, 
73 and 82. 
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 The remaining genital HPV types have been designated low risk as they do not 
cause cervical cancer but they can cause other problems, such as genital warts 
(57). 
 
 
Pathology 
 
Pap smear in invasive cancer shows tadpole cells, haemorrhage and necrosis in 
the background. It is customary to identify two types of cancers of the cervix. The first 
and more common variety is the epidermoid carcinoma. It arises from the stratified 
squamous epithelium of the cervix and accounts for almost 80% of all cancers in the 
cervix.      
The second variety endocervical carcinoma arises from the mucous membrane 
of the endocervical canal, accounts for 20% of all cervical cancers.      Histologically, 
95 percent of cervical cancers are squamous carcinomas and only 5 percent are 
adenocarcinoma.  
 
This is because the columnar epithelium of the endocervix often undergoes 
squamous metaplasia. Endocervical cancers of the cervix have recently increased in 
incidence because of prolonged use of oral combined contraceptive pills and   
progesterone’s which have profound effect on glandular epithelium. 
 
  The malignant cells are endometroid, adenocarcinoma, clear cells and 
adenosquamous. Squamous cell cancers of the ectocervix appear as proliferative 
growths, ulcers or as flat indurated areas. The common proliferative or cauliflower-like 
growth is vascular, friable and bleeds on touch.  
 
It undergoes ulceration and necrosis, which is associated with an offensive foul 
smelling vaginal discharge. The leucorrhoeal discharge is often blood stained. 
Histologically, the tumor is graded as well-differentiated or ill-differentiated. The 
endocervical growth remains confined to the cervical canal for a long time causing a 
barrel-shaped enlargement of the cervix, and only at a late stage it protrudes beyond the 
external cervical os and becomes visible.  
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The mode of spread of the cancer is by continuity or by continuity, by lymphatic 
spread or through vascular embolism to distant sites like lungs, liver, bones, kidneys 
and brain. Ovarian metastasis occurs in only 1 percent 
 
Figure 11. HPV infection 
 
 
Stages of Cervical cancer 
  
Stage I 
 Carcinoma strictly conflicted to the cervix IA Micro 
invasive carcinoma, not exceeding 5.0mm. 
 IA1 Measured stromal invasion of less than 3.0mm in depth.  
 IA2 Measured stromal invasion between 3 and 5mm in depth.  
 IB Clinically visible lesion confined to the uterus 
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 IB1 Clinically visible lesion 4.0cm. 
 IB2 Clinically visible lesion more than 4.0cm in dimension. 
 
Stage II  
 Cancer spread beyond the cervix, but not to pelvic wall or lower third of the 
vagina. 
 IIA Tumor without parametrical invasion. 
 IIB Tumor with parametrical invasion. 
 
Stage III  
 Tumor extends to the lateral pelvic wall, involves the lower third of vagina, 
and/or causes hydronephrosis or nonfunctioning kidney. 
 
Stage IV  
 Tumor spread to the pelvic organs or distal metastasis.  
 IVA Tumor involves bladder and rectum. 
 
 IVB Widespread tumor with distant metastasis.                    
Differential Diagnosis: 
 Tubercular ulcer 
 Syphilitic ulcer 
 Fibroid polyp 
 Sarcoma of the cervix 
Diagnosis (58) 
The earlier cervical cancer is diagnosed the more successful treatment can be done. 
Regular cervical screening can save thousands of lives every year. 
 Cervical smear test 
 HPV DNA Test 
Additional tests including 
 Biopsy  
 Colposcopy 
1. Punch biopsy 
2. Endocervical curettage 
 Cone biopsy, LLETZ  
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 Blood tests  
 Examination under anesthesia (EUA) 
 CT scan, MRI, Pelvic ultrasound  
Treatment 
      The management of patients with head and neck Cancer is complex. The choice of 
treatment modality depends on the stage and site of disease. Patients with locally 
advanced disease should be evaluated (prosthodontics, nutrition, speech, and 
swallowing) by a multidisciplinary team including otolaryngologist or head and neck 
surgical oncologist, radiation oncologist, medical oncologist, dentist, and personnel 
involved in rehabilitation before treatment is initiated. In general, either surgery or 
radiation is effective as single-modality therapy for patients with early-stage disease 
(stage I or II) for most sites. The choice of modality depends on local expertise, patient 
preference, and functional result. For the 60% of patients with locally advanced disease 
(stage III, IV, and M0), combined-modality therapy is indicated [59]. 
 
Surgery 
The nature of the surgical procedure is determined primarily by the size of the 
tumour and the structures involved. Extensive surgeries and those involving function 
of the tongue. Frequently require mucocutaneous flaps or microvascular free flaps to 
achieve a more functional reconstruction. 
Resectability depends on the experience of the surgeon and the rehabilitation 
team. In general, a tumour is unresectable if the surgeon believes that all of the gross 
tumour cannot be removed or that local and distant control will not be achieved after 
surgery even with adjuvant radiation therapy. Generally, involvement of the skull base, 
pterygoid, and deep neck musculature, and of the major vessels portends a poor 
outcome with surgery as a primary modality. 
Cervical lymph node dissections may be elective or therapeutic. Elective neck 
dissections are done at the time of surgery in patients with necks that are clinically 
negative when the risk of a positive lymph node is at least 30%. Therapeutic neck 
dissections are done for clinically obvious masses. This surgery is now rarely performed 
because of excessive morbidity, especially loss of shoulder function. The modified 
radical dissection preserves one or more of the non-lymphatic structures. In selective 
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neck dissections, only certain levels of lymph nodes are removed on the basis of the 
specific lymphatic drainage from the primary site.  
 
Radiation therapy [63] 
Radiation therapy uses high energy x-rays or radioactive particles to kill cancer 
cells. Radiation therapy may be used for cervical cancer. 
The two types of radiation therapy most often used to treat cervical cancer include: 
1. External beam radiation 
2. Brachytherapy 
 
1.External beam radiation 
One way to give radiation is to aim x-rays at the cancer from outside the body. 
This is called External beam radiation therapy (EBRT). Each radiation treatment lasts 
only a few minutes, but getting you into place for treatment usually takes longer. The 
procedure itself is painless. 
When radiation is used as the main treatment for cancer, EBRT is usually 
combined with chemotherapy (called concurrent chemoradiation). Often, a low dose of 
the chemo drug called cisplatin, but other chemo drugs can be used as well. The 
radiation treatments are given 5 days a week for a total 6 to 7 weeks. The chemotherapy 
is given at scheduled times during the radiation. The schedule is determined by which 
drug is used. EBRT can also be used by itself to treat areas of cancer spread or as the 
main treatment of cervical cancer in patients who can’t tolerate chemoradiation. 
Possible side effects of EBRT 
Side effects of external beam radiation therapy for cervical cancer can include: 
 Fatigue (tiredness) 
 Upset stomach 
 Diarrhea or loose stools (if radiation is given to the pelvis or abdomen) 
 Nausea and vomiting 
 Skin changes 
 Radiation cystitis 
 Vaginal pain 
 Menstrual changes 
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 Low blood counts 
1.Brachytherapy 
Brachytherapy or internal radiation therapy, puts a source of radiation in or near 
the cancer. This type of radiation only travels a short distance. The type of 
brachytherapy used most often to treat cervical cancer is known as intracavitary 
brachytherapy. The radiation source is placed in a device in the vagina (and sometimes 
in the cervix). This is often used in addition to EBRT as a part of the main treatment 
for cervical cancer. 
There are two types of brachytherapy: 
 Low-dose rate (LDR) brachytherapy  
 High-dose rate (HDR) brachytherapy  
 
Possible short-term side effects of brachytherapy 
Since the radiation only travels a short distance with brachytherapy, the main 
effects of the radiation are on the cervix and the walls of the vagina. The most common 
side effect is irritation of the vagina. It may become red and sore and there may be a 
discharge. The vulva may become irritated as well. 
Brachytherapy can also cause many of the same side effects as EBRT, such as 
fatigue, diarrhea, nausea, irritation of the bladder and low blood counts.  
Long term side effects of radiation therapy 
 Vaginal stenosis 
 Vaginal dryness 
 Weakened bones 
 Swelling of the legs 
 
Chemotherapy: 
          Until relatively recently, chemotherapy was used mainly for palliation of patients 
with locally recurrent or disseminated disease without proven survival advantage. 
Combination chemotherapy yields higher response rates but has increased toxicity and 
no proven survival advantage when compared with single agents. The choice of single-
agent or combination chemotherapy depends on the patient's preference and 
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performance status. The combination of Cisplatin and infusional 5-Fluorouracil (5-FU) 
produces a 70% response rate and a 27% complete remission (CR) rate in 
chemotherapy-naive patients. 
          Platinum-based chemotherapeutic regimens and the single agent methotrexate 
are the most commonly used regimens for metastatic disease. Carboplatin may be 
slightly less active than Cisplatin for head and neck squamous Cancer, but Carboplatin 
combinations with other chemotherapy agents are generally better tolerated than those 
with Cisplatin.  
          Both Docetaxel and Paclitaxel have shown antitumor activity. Several dosing 
schedules for Paclitaxel have been investigated. Three-hour infusions are probably the 
best balance between theoretically optimum exposure and tolerable toxicity. Docetaxel 
is usually administered at doses of 60 to 100 mg per m2 every 3 to 4 weeks. 
         The role of chemotherapy has expanded significantly over the last decade because 
of the results of clinical trials incorporating chemotherapy in multimodality regimens 
for previously untreated disease. 
Induction Chemotherapy: 
Induction chemotherapy followed by definitive radiation therapy in patients 
responding to chemotherapy has been studied for organ preservation in patients with 
locally advanced Cancers of the larynx and of the hypopharynx. No significant survival 
difference has been demonstrated for chemotherapy followed by radiotherapy 
compared to surgery followed by radiotherapy in these patients. For laryngeal Cancer, 
concomitant Cisplatin and radiation therapy leads to better local control. Presently, 
induction chemotherapy followed by radiation therapy can be considered standard only 
for patients with previously untreated locally advanced squamous Cancers in the 
hypopharynx.  
Concomitant chemoradiation: 
The rationale for concomitant chemoradiation is based on experimental 
evidence of synergism between chemotherapy and radiation that is theoretically 
mediated by interference of chemotherapy with multiple intracellular radiation-induced 
stress-response pathways involved in apoptosis, proliferation, and DNA repair.  
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The finding that certain chemotherapeutic agents (e.g., Cisplatin, 5-FU, 
Taxanes, and Hydroxycarbamide) can induce radiosensitivity and increase log cell kill 
for radiation supports this treatment strategy.  
Cisplatin, the most extensively evaluated drug in recent large randomized trials, 
has the advantage of not having mucositis as toxicity, although as a radiation enhancer, 
it does increase radiation-induced mucositis. 
Adjuvant Chemotherapy: 
A large randomized study in resected patients with stage III or IV disease 
compared adjuvant radiation therapy with adjuvant chemotherapy followed by 
radiation. Patients with low-risk disease did not benefit from adjuvant chemotherapy.  
Adjuvant concomitant cisplatin and radiation in patients at high risk for 
recurrence after surgery has been studied both in Europe and in the United States. Both 
studies found a possible benefit in disease-free or overall survival for patients receiving 
concomitant cisplatin and radiation [60]. 
As a part of the main treatment for cervical cancer 
For some stages of cervical cancer, the preferred treatment is radiation and 
chemo given together (called concurrent chemoradiation). The chemo helps the 
radiation work better.  
Options for concurrent chemoradiation include: 
 Cisplatin given weekly during radiation. This drug is given into a vein (IV) 
about 4 hours before the radiation appointment. 
 Cisplatin plus 5-fluorouracil (5-FU) given every 4 weeks during radiation. 
 Sometimes chemo is also given (without radiation) before and/or after 
chemoradiation 
 
Side effects of chemotherapy  
Chemo drugs kill cancer cells but also damage some normal cells, which can lead 
to certain side effects. Side effects depend on the type and dose of the drugs and the 
length of time you are treated.  
 Nausea and vomiting 
 Loss of appetite 
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 Loss of hair 
 Mouth sores 
 Fatigue (tiredness) 
Because chemotherapy can damage the blood-producing cells of the bone marrow. 
This can result in: 
 An increased chance of infection (from a shortage of white blood cells) 
 Bleeding or bruising after minor cuts or injuries (because of a shortage of blood 
platelets) 
 Shortness of breath (due to low red blood cell counts) 
When chemo is given with radiation, the side effects are often more severe. Nausea, 
fatigue and problems with low blood counts are often worse. Diarrhea can also be worse 
if chemo is given at the same time with radiation and the following side effects can 
occur, 
 Menstrual changes 
 Neuropathy 
 Increased risk of leukemia 
Other side effects are also possible. Some of these are more common with certain 
chemo drugs. Many side effects are short-term and go away after treatment is 
completed, but some can last for a longer time or even be permanent.  
 
Targeted therapy / Immunotherapy [61]  
 Targeted therapy is a type of treatment that uses drugs or other substances to 
identify and attack specific cancer cells without harming normal cells. 
 Monoclonal antibody therapy is a type of targeted therapy that 
uses antibodies made in the laboratory from a single type of immune 
system cell.  
 Bevacizumab is a monoclonal antibody that binds to a protein called vascular 
endothelial growth factor (VEGF) and may prevent the growth of new blood 
vessels that tumors need to grow. Bevacizumab is used to treat cervical cancer 
that has metastasized (spread to other parts of the body) and recurrent cervical 
cancer. 
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Vaccines: 
       A number of infectious a gents cause Cancer. Hepatitis B and C are linked to liver 
Cancer, some human papilloma virus (HPV) strains are linked to cervical and head 
and neck Cancer, and Helicobacter pylori is associated with gastric Cancer and 
lymphoma. Vaccines to protect against these agents may reduce the risk of their 
associated Cancers. The hepatitis B vaccine is effective in preventing hepatitis and 
hepatomas due to chronic hepatitis B infection. Public health officials are encouraging 
widespread administration of the hepatitis B vaccine, especially in Asia, where the 
disease is epidemic.  
A four-valent HPV vaccine (Gardasil) is 100% effective at preventing 
infection. The vaccine is recommended for girls and women ages 9–26 years. 
Reduction in these HPV types could prevent >70% of the cervical Cancers worldwide 
[62] 
 Cervix 
Produced by GlaxoSmithKline, is designed to protect against HPV types 16 and 
18 only Both vaccines are licensed in the UK. The NHS currently uses Gardasil to 
vaccinate girls. 
 There is also a third vaccine called Gardasil 9.  
 This protects against high risk HPV types 16, 18, 31, 33, 45, 52 and 58, as well 
as HPV 6 and 11. Gardasil 9 has been approved for licensing by the Committee 
for Medicinal Products for Human use of the European Medicines Agency.  
 The vaccination is free for all girls from the age of 11 in Scotland and 12 in the 
rest of the UK up to their 18th birthday, but only girls aged 11 to 13 in Scotland 
and 12 to 13 in the rest of the UK will be routinely offered the vaccine. 
  The vaccination is given to girls at this age because their immune systems are 
at their strongest before puberty begins and the vaccination works best when the 
immune system is strong. 
 Both Gardasil and Cervix protect against the two highest risk HPV types. 
However, unfortunately, women can be infected with more than one type of 
HPV. Having the vaccine will provide protection against 70% of all cervical 
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cancers and it will also prevent most of the more serious precancerous cervical 
changes (classed as moderate or severe cervical abnormalities). 
 
Prevention of cervical cancer (60) 
There are a number of measures that can be taken to reduce the chances of 
developing cervical cancer. 
 Human papillomavirus (HPV) vaccine 
 Safe sex and cervical cancer 
 Cervical screening, Having fewer sexual partners 
 Delaying first sexual intercourse  
 
3.3 PHARMACOLOGICAL REVIEW 
Our great Siddhars explained many medicinal preparations to cure the life 
threatening Cancer disease and a few medicines for cancer are listed here, 
Herbal origin: 
Compound herbal preparations 
Pills: 
 Chithiramoolaakuligai (64)  
 Maha Kodasoozhi Mathirai 
 Aswaganthathi vadagam 
Chooranam 
 Vallathy Chooranam 
 Megaroga Chooranam  
 Garudakodi Chooranam 
 Sorkkamara Chooranam 
 Karanthai Chooranam(65)  
Mineral and metal origin: 
Siddhars identified and worked on many metal and mineral preparations which 
had anti-cancer activity. 
Parpam: 
 Thambira Parpam (66)  
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 Gandhaga Poora Parpam (67) 
 Kariya Parpam 
 Rasa Parpam [68]  
 Naga Parpam [69] 
 Thalaga Parpam 
 Sandarasa Parpam 
 Sootha Parpam [86] 
Chendhooram: 
 Panchapadana Chendhooram (70) 
 Swaranapushpa Rasa Chendhooram (62b) 
 Muthu Chendhooram (71) 
 Kandhaga Chendhooram 
 Gowri Chinthamani Chendhooram 
 Linga Chendhooram 
 Rasa Chendhooram[71a] 
 Thambira Chendhooram  
 Pavala Vanga Chendhooram [70 b] 
 Kalameganarayana Chendhooram (72) 
 Navachara Chendhooram [73] 
 Naga Chendhooram (74) 
 Namachivaya Chendhooram (75) 
 Narayana Chendhooram (76a) 
Nei: 
 Chitramoola Nei (77)  
 Kukkil Nei [78a] 
 Thengai Nei 
 Vallarai Nei 
Ennai: 
 Perungaya Ennai [82] 
 Singi Thylam [79a] 
 Mega Santhanathy Thylam 
 Chinthamani Ennai 
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 Meganathi Ennai 
 Visha Rajanga Thylam 
 Pachai Thylam [79 b] 
 Sengathari Thylam [80a] 
 Mega Rasanga Ennai [80b] 
 Puda Thylam [78b] 
 Gandhaga Thylam (74b)  
 Sengottai Thylam 
 Vipuruthi thylam[82] 
Mezhugu: 
 Rasagandhi Mezhugu[67] 
 Kanaga Linga Mezhugu [83a]  
 Vaalai Rasa Mezhugu 
 Gandhaga Mezhugu (84) 
 Korasanai Mezhugu 
 Veera Mezhugu [74a] 
Kattu: 
 Poorakattu (85) 
Pathangam:  
 Lingapathangam (83c) 
 Gurupathangam [83b) 
 Putru pathangam 
 Veera Rasa pathangam [87] 
Others: 
 Rana Pugai [80b] 
 Veelai seelai [80c] 
 Kulirntha pachai 
 Chithiravallathi Legium 
 Veelai seelai [88] 
 Kandharasa villai 
Siddha drugs for Yoniputru 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 70 
 
 
 
Pills: 
 Chitramoola Kuligai  
 
Chooranam: 
 Karanthai chooranam  
Parpam: 
 Thambira Parpam 
 Velli Parpam 
 Gandhaga Parpam 
 Karuvanga Paarpam 
 Rasa parpam 
Chendhooram: 
 Muthu Chendhooram  
 Namachivaya Chendhooram 
 Swarnapushpa Rasa Chendhooram 
 Kalamega narayana chendhooram 
 Pancha padana chendhooram  
 Muthu chendhooram 
Thylam: 
 Chitramoola Nei 
 Vallarai Nei [79c] 
 Megathu Ennai 
 Gandhaga Thylam 
 Sathrusangara Ennai 
 Perungaya Ennai 
 Meganathi Thylam 
Mezhugu: 
 Vithu Rasa Mezhugu [76b]  
 Korosanai Mezhugu 
 Rasaganthi Mezhugu 
 Gandhaga Mezhugu 
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 Amirtha Nandhi Mezhugu 
  Korosonai mezhugu 
 Markandeya Mezhugu 
   Korosanaimezhu 
Kattu: 
 Poora Kattu 
Pathangam: 
 Linga pathangam 
 Guru pathangam 
 Putru pathangam [90] 
Kirutham: 
 Vallarai kirutham [76 b] 
Others: 
 Gandha Rasa Villai [74c] 
 Megam pokkum Rasagandhi [86b]  
 Soolai Kudori [74d] 
 Rana pugai [89] 
 
ANTICANCER DRUGS- MODERN ASPECT 
 The drugs which prevent neoplasm are known as anticancer drugs. They also 
called antineoplastic drugs 
 They may be divided into two classes 
 Cycle specific 
           Cycle specific drugs act only at specific points of the cell’s duplication cycle, 
such as anaphase or metaphase 
 Non- cycle specific 
           Drugs may act any point in the cell cycle, in order to gain maximum effect, anti-
neoplastic drugs are commonly used in combinations. 
 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 72 
 
 
 
Classification [91] 
1. Alkylating agent 
2. Antimetabolites 
3. Natural origin 
From plants 
From micro organisms 
4. Hormones 
5. Miscellaneous 
Precautions 
 Because antineoplastic agents do not target specific cell type, they have a 
number of common adverse side effects. 
 Hair loss is common due to the effects on hair follicles 
 Anaemia 
 Immune system impairment 
 Clotting problem caused by destruction of the blood forming organs, leading to 
reduction in the number of red cells, white cells and platelets. 
Interactions 
 Anticancer drugs may interact with a number of other medicines. When this 
happens, the effects of one or both of the drugs may change or the risk of side effects 
may be greater. 
Table 6. Anticancer Drugs [92] 
Generic (Brand 
Name) 
Clinical Uses Common Side Effects 
To Drug 
Cisplatin (Platinol) Treatment of head and neck 
cancer, bladder, uterine, testicular, 
ovarian cancer. 
Renal toxicity and 
ototoxicity 
Fluorouracil 
(Adrucil)  
Treatment of breast cancer, head 
and neck cancer, colorectal cancer, 
cervical stomach cancer, 
pancreatic cancer. 
CNS damage, cardio 
toxicity, anaphylaxis, 
encephalopathy 
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Altretamine 
(Hexalen) 
Treatment of advanced ovarian 
Cancer 
Bone marrow depression, 
nausea and vomiting 
Asparaginase 
(Elspar) 
Commonly used in combination 
with other drugs; refractory  acute 
lymphocytic leukemia 
Liver, kidney, pancreas, 
CNS abnormalities, 
Bleomycin 
(Blenoxane) 
Lymphomas, Hodgkin’s disease, 
testicular cancer 
Hair loss, stomatitis, 
pulmonary toxicity, 
hyperpigmentation of 
skin. 
Carboplatin 
(Paraplatin) 
Palliation of ovarian cancer Bone marrow depression, 
nausea and vomiting 
Carmustine Hodgkin’s disease, brain tumours, 
multiplemyeloma, malignant 
melanoma 
Bone marrow depression 
,nausea and vomiting 
Chlorambucil 
(Leukeran) 
Chronic lymphocytic leukemia, 
non-Hodgkin’s lymphomas, Breast 
and ovarian cancer 
Bone marrow depression, 
excess uric acid in blood 
Cyclophosphamide 
(Cytoxan) 
Hodgkin’s disease, non-Hodgkin’s 
lymphomas, 
neuroblastoma.ovarian, and lung 
cancer, acute lymphoblastic 
leukemia in children 
Bone marrow depression, 
hair loss, nausea and 
vomiting, inflammation 
of the bladder. 
Cytarabine 
(Cytosar- U) 
Leukemias occurring in adult and 
children 
Bone marrow depression, 
nausea 
&vomiting,diarrhoea, 
stomatitis 
Methotrexate 
(Trexall, 
Rheumatrex) 
Breast cancer, lung cancer, 
leukemia, osteosarcoma 
Hepatotoxicity, renal 
failure, myelopathy 
Melphan Multiple myeloma,Ovarian cancer Bone marrow depression, 
Infections,diarrhoea,panc
reatitis 
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Diethylstilbestrol 
(DES) (Stilbestrol) 
Breast cancer in post-menopausal 
women, prostate cancer 
Hair loss, nausea and 
vomiting, oedema, excess 
calcium in blood; 
feminizing effects in men 
Ethinyl estradiol 
(Estinyl) 
Advanced breast cancer in post- 
menopausal women, prostate 
cancer 
Excess calcium in blood, 
anorexia, oedema, nausea 
and vomiting; feminizing 
effects in men 
Mitomycin 
(Mutamycin) 
Bladder, breast, colon, lung, 
pancreas, rectum cancer, head and 
neck cancer, malignant melanoma 
Bone marrow depression, 
nausea and vomiting, 
diarrhoea, stomatitis, 
possible tissue damage 
Mitoxantrone 
(Novantrone) 
Acute nonlymphocytic leukemia Cardiac arrhythmias, 
laboured breathing, 
nausea& vomitting 
Paclitaxel (Taxol) Advanced ovarian cancer Bone marrow depression, 
hair loss, nausea& 
vomiting, hypotension, 
allergic reactions, slow 
heart action, muscle and 
joint pain. 
Pentastatin (Nipent)  Hairy cell leukemia unresponsive 
to alpha-interferon 
Bone marrow depression, 
fever, skin rash, liver 
damage, nausea and 
vomiting 
Prednisone 
(Meticorten) 
Used in adjuvant therapy palliation 
of symptoms in lymphomas, acute 
leukemia Hodgkin’s disease 
May be toxic to all body 
systems 
Streptozocin 
(Zanosar) 
Islet cell carcinoma of pancreas Nausea and vomiting, 
toxicity to kidneys 
Tamoxifen 
(Nolvadex) 
Advanced breast cancer in post-
menopausal 
Nausea and vomiting, 
ocular toxicity, hot 
flashes 
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Teniposide 
(Vumon) 
Acute lymphocytic leukemia in 
children 
Bone marrow depression, 
nausea and vomiting, hair 
loss. 
Vinblastine 
(Velban) 
Breast cancer, Hodgkin’s disease, 
metastatic testicular cancer 
Bone marrow depression, 
neurotoxicity 
Ifosfamide Head and cancer, 
bronchogeniccancer   
ccancer,bronchogenic,breast,testic
ular,bladder,osteogenic carcinoma, 
some lymphomas. 
Haemorrhagic 
cystitis,less alopecia,less 
emetogenic. 
Decarbazine(DTIC) Malignent melanoma, Hodgkins 
disease 
Nausea,vomiting,Flu like 
sysmptoms,neuropath 
and mylosuppression 
Procarbazine Hodgkin’s disease,brain tumour Males sufferm from 
sterility,vomiting,leucope
nia,thrombocytopenia. 
Fludarabine Chronic lymphatic leukemia,non 
Hodgkins lymphoma, 
Fever,chills,myalgia,arth
aralgia and 
vomiting,mylosupression
. 
Estramustine Metasttic prostate cancer, Myelo supression and 
estrogenic 
adverseeffects.viagynaec
omstia,impotence,fluidret
ention,angioedema. 
 
PHARMACOLOGICAL REVIEW OF CANCER: 
 Cancer is one of the thrust area for which effective drugs at comfortable 
prices are not available as yet probably due to lack in understanding the cancer 
Patho physiology. For such a dreadful disease anti-cancer drugs have been 
developed from a variety of sources ranging from natural products (plants and 
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microbes) to synthetic molecules.  
 
The pharmacological screening of plants, minerals and animals is an essential 
mean for the invention of new, harmless and effective drugs. Over 50,000 plants have 
therapeutic virtues in the world, and around 80% of human use medicines based on 
plants and salts at least once in their life, Medicinal plants and mineral shave diversified 
chemical constituents which are important for the discovery of new active molecules 
against many types of cancer.  
Nowadays it has become mandatory to monitor the quality of life of patients 
while in treatment of cancer. It is healthy aware that the quality of life of cancer patients 
treated with chemotherapeutic drugs are very much affected even long time after 
withdrawal of drugs. Therefore, the challenging task at this moment is to identify the 
quick and novel methods that can identify and develop molecules, which can be of 
therapeutic value in human cancers. 
 
 For this purpose, both, the in vitro and in vitro models are employed for 
systematic screening of an anticancer drug.  This necessitates screening of a large 
number of compounds. For this purpose, both in-vitro and in-vivo models are employed 
for systematic screening of an anticancer drugs. [93] 
 
 
INVITRO METHODS: 
  
In studies in vitro cytotoxicity on cell line, various cell staining methods are 
used in order to indirectly estimate the number of viable cells present after treatment. 
An ideal test in assessing cell proliferation and cytotoxicity should have as main feature 
in vitro: be simple, fast, efficient, economical, reproducible, sensitive, safe, and 
effective as far viable cell population and do not show interference with to evaluate the 
compound. 
 
ADVANTAGES [94]: 
 Reduce the usage of animals 
 Testing the ability of the compound to kill the cells by taking the advantage of 
various properties of cell 
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 Able to process the large number of compounds quickly with minimum of 
quantity. 
 Range of concentrations used is comparable to that expected for in vivo studies. 
 
DISADVANTAGES 
 Difficulty in maintaining the culture 
 Show negative results for the compounds which gets activated after metabolism 
and vice versa 
 Impossible to ascertain the pharmacokinetics. 
 
How to culture cell line 
 Tumor cell line derived from several cancer types. 
 Adaptable to a suitable growth medium. 
 Show reproducible profile for growth and drug sensitivity. 
 The lines were prepared and preserved using regents such as DMSO during 
freezing. 
 Thawing- bringing the freezed ampoule to room temperature by slow agitation. 
Cell lines for cancer 
There are plenty of cell lines are available for research purpose. Only very few 
are listed [95].                         
 Table 7. Cancer cell lines 
S.no Cell name Tissue  Species  
1 UM-UC Bladder Human  
2 FM3A Breast Mouse  
3 C 170 Colon Human 
4 SHP 77 Lung Human 
5 RAG Kidney Mouse 
6 HF 1 Liver Rat 
7 MEWO Skin Human 
8 TT Thyroid Human 
9 OV Ovary Human 
10 C 6 Neural(Gluialtumor) Rat 
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ASSAY [96] 
For energy metabolism and autophagy 
 FAD assay 
 ATP assay 
 Lysosome detection 
 Mitochondrial membrane potential assay 
 Reactive oxygen species test  
For nuclear signaling, DNA damage and cell proliferation 
 P53assay 
 Topoisomerase II assay 
 P21assay 
 Cell proliferation assay 
 Mdm2 assay 
For inflammation, angiogenesis and metastasis 
 Cytokine and chemokine assay 
 STAT 1,2,3,6 assay 
 COX-2 activity assay 
 LDL uptake assay 
For apoptosis, pyroptosis and necrosis 
 Caspase 1 assay 
 Bax assay 
 Cytolysis assay 
For cancer signaling pathway and phenotype 
 ERK assay 
 c- AMP assay 
 c- Jun test 
IN VIVO MODELS: 
 Many animal species develop cancers spontaneously and are valuable for 
understanding the biology of sporadic cancer development in humans. The major use 
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of spontaneous cancer models is to compare the biology with human, in these animals 
are increasingly valuable for cross- comparison of response or resistance to clinical 
agents used for patients [97]. 
Animal models 
1. Mouse cancer models 
         a. GEM – Genetically Engineered Mouse Models 
                   a. Inbred mice (systematic sibling mating) 
                    b. Transplantation models 
 Allograft models (syngeneic tumor tissuse derived from same genetic mouse) 
 Xenograft models (actual human cancer cells or solid tumors are transplanted 
into host mouse) 
 Carcinogen induced and spontaneous models 
 Digestive system cancer induced by polycyclic aromatic hydrocarbons 
 Chemically cancer induced by Cadmium and Arsenic. 
 Radiation-skin cancer by ultraviolet radiation; leukemic changes by ionizing 
radiation. 
I. Rat cancer models 
a. Genetically altered rats 
i) Treat embryos with DNA damage causing chemical 
mutagen. Frequently N-Ethyl-N-nitrosourea(ENU) is 
used. 
ii) Insertion of mutagenesis strategies (Retro viruses) 
iii) Transgenic strategies (pronuclear injection of DNA)- 
quickly developed and more effective models 
b. Inbred rats. 
 
II. Other laboratory animal models 
a. Hamster 
b. Rabbits 
c. Zebrafish 
 
III. Other animal models  
a. Dogs 
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b. Cats 
c. Goats 
d. Horses  
e. Pigs 
There is also work done with various species, such as baboons, chimpanzees, 
macaques, marmosets and tamarins. 
Oral cancer cell lines 
 Hep 2 (Human epithelial type 2 cells) 
 FaDu 
 SCC-4 
 OEC-M1 
 KB  
Cerviacl cancer cell lines 
 HeLa (HPV 16) 
 SiHa (HPV 18) 
 C 33A (HPV Negative) 
 CaSki 
Induction of cervical cancer in animal models: 
 Cervical neoplasia is induced in mouse by an extract of varicella zoster virus 
infected cells (HPV or Herpes simplex virus type 2 DNA) 
 Genomic HSV 2 DNA was isolated from infected HE p2 cells and separated 
from host cell DNA by Cesium chloride density gradient centrifugation.  
 The DNA was applied to mouse cervix for period of 80 to 100 weeks. Should 
be examined monthly to detect abnormalities. 
 
3.4. PHARMACEUTICAL REVIEW: 
PADHANGAM: 
Concept and Terminology: 
          “Padhangam” is a sublimate. A number of organic and inorganic materials are 
capable of sublimation. Thus mercury as an element and red sulfide of mercury etc. 
sublime as known to us are from the medicinal drugs of inorganic nature. Camphor is  
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an organic substance that sublimes. Similarly, several other constituents of vegetable 
drugs sublimate [93]. 
In the preparation of the medicines sulfur, mercury, cinnabar, corrosive 
sublimate, calomel and white arsenic are inorganic substances that are sublimated and 
hence the suffix Padhangam to these medicines. 
 
Method of preparation:  
Sublimation process: 
 The process of preparation involves the heating of the sublimating constituents 
in a suitable set up which is described under the individual preparations. 
 In the conventional set up of the sublimation contrivance, a heat resistant pot 
is used as the container for the drug ingredients. When using pots, two identical 
pots of appropriate dimensions and capacity should be selected and checked 
for neat contact of rims when juxtaposed.  
 The ingredients from which the sublime materials to be prepared are placed in 
the small pot. The juice of the leaf which will attract the deposition of the 
sublimated product is applied on the inner surface of the big pot.  
 The big pot is placed over the small one in such a way that their mouths oppose 
each other. The gap between the rims is covered by seven layers of clay 
smeared cloth and is allowed to dry.  
 This setup is placed on the oven and heat is applied, by burning fire wood. In 
the application of heat, there gradations are recognized.  
 These three stages, mild, moderate and intense are best understood and 
mastered with some experience. 
 It is said that, if the flames are convergent and resemble a single tongue of 
flame as in a lamp, it is mild fire (Deepakkini). If several such tongues of flame 
lick the vessel and diverge like the flower of lotus, it is moderate 
(Kamalakkini).  
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 If the multiple tongues of flame fill the oven and enrich the sand bath. It is the 
intense stage of fire (Katakkini). 
 These stages of fire should be manipulated and followed as prescribed in the 
method of preparation. 
 The heating is maintained for 12 hours.When the setup has cooled down, the 
final product is taken out and the clay tape winding cut out.  
 The material that has sublimed in upper bowl is gently tapped with suitable 
beater or lifted with a spatula. The sublimate collected should be finely ground 
in a mortar. 
 
Leaves used for applying the juices on the inner surface of the pot favouring 
deposition: 
 Leaves of Datura metal (oomathai elai) 
 Leaves of Erythrina veriegata (kalyana murungai elai) 
 Piper beetle (vetrilai) 
 Leaves of Coccinia grandis (kovai elai) 
 Leaves of Ocimum sanctum (thulasi elai) 
 Leaves of Acalypha indica (kuppaimeni elai) [98] 
 
SHELF LIFE 
            The Padhangam are said to retain their potency for 10 years. 
 
PRESERVATION AND STORAGE 
             To be stored in a clean, dry and air tight glass containers. 
 
SPECIAL EXPERIMENT 
 In a glass bowel containing water, sprinkle pinch of Padhangam and place a 
whole black gram on it.  
  If Padhangam bears the entire weight of grain and doesn’t sink in the water, the 
preparation method was perfect. 
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Table 8. ANALYTICAL SPECIFICATIONS OF PADHANGAM (RASAYOGA) [99] 
S. NO TEST 
1 
Description 
Colour 
Odour 
2 Identification – chemical 
3 Particle size – 200 to 300 
4 Loss on drying 105
0 C 
5 Total ash 
6 Acid – insoluble ash 
7 Water soluble ash 
8 Assay of element 
9 Ayurvedic specifications 
10 Lusterless (Nishchandrica) 
11 Fine enough to enter the crevices of finger (Rekha purnatva) 
12 Floats on water (Varitara) 
13 Smokeless (Nirdhoom) 
14 Tasteless (Niswadu) 
15 Irreversible (Apunarbhav) 
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3.5. LATERAL REVIEW 
 
Pistia stratiotes 
1. Methanalic extract of Pistia stratiotes leaves showed antimicrobial activity 
against both gram positive and gram negative Bacteria. highest zone of inhibition 
was observed at 1000mg/ml concentration against klebsiella species [100].  
 
2. Methanalic extract of pistia stratiotes has shown highest antioxidant property, the 
reducing power of methanol extract indicates presence of some compounds in 
pistia stratiotes extracts which can donate electron and could react with free 
radicals to convert them into more stable products and to terminate radical chain 
reactions. increased absorbance of reaction mixture indicates increase reducing 
power of extract [101 
 
3. Pistia stratiotes leaves possess antifungal properties the use of plant in folk 
medicines for the treatment of various diseases [102]. 
 
4. Methanalic extract of whole plant is able to lower the level of thyroid hormones. 
May regulate the hyperthyroidism [103]  
5. Pistia stratiotes, shows with 30 days’ the digestion time at temperature of 
29.5,33.0 and 37.5 c respectively. The average methane content was 58-68%.is 
very suitable for biogas production [104] 
 
6. The plant extract of Pistia stratiotes exhibited the anthelmintic activity in dose 
dependent manner giving shortest time of paralysis and death with 50 mg/ml 
concentration [105] 
7. The Methanalic extract of Pistia stratiotes was tested by acetic acid –induced 
writhing model in mice at dose of 250 and 500 mg kg of body weight, the extract 
produced about 35.80 and 47.94% writhing inhibition in test animals. [106] 
8. Pistia stratiotes showed significant anti diarrhoeal activity against castor oil-
induced diarrhoea as compared with the control dosage 250 and 500 mg kg body 
weight. [106] 
Oxalis cornuculata 
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1. Oxalis cornuculata Linn. showed the significant antifungal activity against A. 
niger by suppressing the fungal mycelial growth by 71 to 86%  for after three days 
of incubation [107]. 
2. Methanol extracts of whole plant of Oxalis cornuculata using Eisenia foetida at 
three different concentrations (100, 200 and 400 mg/ml) the time of paralysis and 
death time was observed as 11.33 and 41.33, respectively [108]. 
3. Ethanolic extract of Oxalis corniculata having nematotoxic activity against 
phytoparasitic nematodes. In another research has revealed the ethanoic extract of 
Oxalis cornuculata after 7 days of incubation period the immobility of the 
nematode was observed under the light microscope and that confirm the 
nematocidal activity of this plant [109]. 
4. The alcoholic and petroleum ether extract of whole plant of Oxalis corniculata has 
been evaluated for its wound healing activity at the dose of 300 and 500 mg per kg 
showed significant wound healing activity by producing an increase in wound 
contraction rate, wound breaking and significant decreases in epithelization period 
[110].  
5. Petroleum ether and ethanol extracts of the whole plant of Oxalis corniculata L 
was administered orally at the dose level of 100 and 200 mg/kg body weight from 
day 1 to 7 of pregnancy to evaluate the anti-implantation activity. showed 
significant anti-implantation activity when laparotomised on day 10, it was 
maximum of (76.42%). The pregnant rats which received the treatment from day 
8 to 14 of pregnancy showed abortifacient activity and it was maximum of 
(78.55%) with high dose of petroleum ether extract [111]  
 
6. Methanol extract of Oxalis corniculata Linn. (whole plant) antiulcer potential at 
the dose levels of 125, 250 and 500 mg/kg.  It possesses significant antisecretory 
and antiulcer effects and justify the traditional usage of this herb to treat peptic 
ulcer [112] 
7. The aqueous extract of the Oxalis cornuculata has been tested for the inhibitory 
potential against procaine pancreatic amylase. At a concentration of 100μg/ml 
exhibited a maximum inhibition of 89.27% (IC 50 value 68.08±0.06) oxalis 
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cornuculata, are a good source for controlling postprandial hyperglycemia, a major 
problem in type-II diabetes [113] 
 
8. Oxalis corniculata identified several compounds that showed anti-amoebic 
activity in axenic cultures of E. histolytica. These were characterized by nuclear 
magnetic resonance, infrared and mass spectrometry as (i) Oc-1, a mixture of 
saturated fatty acids C24 to C28; (ii) Oc-2, a mixture of long-chain alcohols C18 
to C28; and (iii) Oc-3, a single compound that was a galacto-glycerolipid (GGL). 
Of the different compounds that were obtained, the strongest anti-amoebic activity 
was found in GGL [114].  
9. Ethanolic extract of Oxalis corniculata Linn. at doses of 200 and 400mg/kg body 
weight evaluated for its anti-nociceptive activity in diabetic neuropathy rats. 
Diabetic rats were showed significant reduction in tail flick latency by 49% in hot 
water tail immersion test and decreased paw withdrawal by 40% in hot plate test 
by the end of 5th week [115]. 
10. The anti-diarrhoeal activity of aqueous and methanolic extracts of Oxalis 
corniculata Linn. was evaluated on castor oil induced diarrhoea in rats and on 
small muscle intestinal transit at orally administered doses of 160,320 and 640 
mg/kg of body weight. [116] 
11. Methanolic extract of Oxalis corniculata leaves at doses of 200 and 400mg/kg 
body weight were screened for antiepileptic activity. In MES model, MEOC 
showed significant reduction in duration of hind leg extension with 200 mg/kg 
dose and effect was dramatically reduced with 400mg/kg. [117] 
12.  The hepatoprotective activity of ethanolic leaves extracts of Oxalis corniculata 
(200 and 400 mg/kg) were evaluated against thioacetamide-induced 
hepatotoxicity. Oral administration of Oxalis corniculata aqueous and ethanolic 
leaves extract at 400 mg/kg resulted in a significant reduction in SGOT 
(146.42±2.54 and 136.75±1.37 IU/L respectively), SGPT (81.96±3.15 and 
72.05±2.33 IU/L respectively), GGTP (16.6±0.49 and 15.02±0.68 IU/L 
respectively), ALP (241.86±3.94 and 202.42±5.37 IU/L respectively) and total 
bilirubin (0.226±0.00 mg/dL 0.288±0.01 mg/dL respectively. [118] 
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13. The hypolipidemic and antioxidant activities of leaves of Oxalis corniculata Linn. 
extracts showed a significant decrease in total cholesterol, triglycerides, LDL and 
MDA in blood. On the other hand, HDL, CAT and SOD were increased 
significantly [119].  
 
14. Oxalis corniculata Linn. has steroidogenic activity and this natural chemical can 
be safely used as it does not alter the functioning of organs which is proved by its 
action on one of the endocrine organ-adrenal gland, which functions normally in 
the extract treated female albino rats [120] 
15. Antitumor activity of ethanolic extract of Oxalis corniculata against Ehrlich 
ascites carcinoma on Swiss mice was carried out at the doses of 100 and 400 mg/kg  
increased significantly (p<0.05 and p<0.01) [121]   
 
16. The hypolipidemic and antioxidant activities of leaves of Oxalis corniculata 
extract was given at a dose of 500 mg/kg showed a significant decrease in total 
cholesterol, triglycerides, low density lipoprotein (LDL) and Malondialdehyde 
(MDA)in blood. On the other hand, high density lipoprotein (HDL), catalase 
(CAT) and Superoxide dismutase (SOD) were increased significantly [122]. 
 
Trianthema decandra 
1. Leaf extract of Trianthema decandra exhibit central analgesic properties, 
since it exerted a significant and dose dependent effect on chemical (acetic 
acid  and thermic heat) painful stimuli from the respective doses of 100 and 
200 mg/kg such an efficacy on these two stimuli is characteristic of central 
analgesic like morphine, while peripheral analgesic (paracetamol and 
aspirin) and known to be inactive on thermic painful stimuli. [123]  
 
2. The anti-inflammatory properties of chloroform extract of Trianthema 
decandra showed maximum inhibition of 58.36% at the dose of 200 mg/kg 
after 3 hrs of drug treatment in carrageenan induced paw oedema. [123] 
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3. The antimicrobial properties of chloroform extract of Trianthema decandra 
were studied against Gram positive, Gram negative bacteria  and fungi by 
disc diffusion assay. Wound healing properties were determined using the 
excision wound model. [124] 
 
4. Plant extracts on α-amylase inhibition assay (non-pre-incubation method) 
was adopted for evolution of anti-diabetic activity of Trianthema decandra 
Chloroform extract was found to have most inhibitory effect on α-amylase 
with 60 % inhibition at 3 min. Ethyl acetate extract was found to have 
inhibitory effect on α-amylase with 47.48 % inhibition at 3 min. [125] 
 
 
5. The hepatoprotective activity of roots of Trianthema decandra aqueous 
extracts was evaluated against carbon tetrachloride induced hepatotoxicity 
the roots aqueous extract at the doses 100 ,200mg/kg has controlled the liver 
damage caused by carbon tetrachloride. [126] 
 
6. Leaf extract of Trianthema decandra. essential oil showed the Diameter of 
Inhibition Zone (DIZ) ranging from 19 ± 0.01 to 24 ± 0.05 mm at a 
concentration level of 1 mg/disc in all the twelve strains tested. The minimal 
inhibitory concentration (MIC) of essential oil against bacterial and fungal 
strains was in the range of 625–1250 μg/ml [127]. 
 
 
7. Trianthema decandra showed Aphrodisiac activity in a dose dependent 
manner. The medium and high dose treated groups showed significant 
increase in the number of mounts, thrusting and decrease in the latency.The 
Aphrodisiac activity of aerial parts of Trianthema decandra and may be 
attributed to elevation of Testosterone, Adrenergic, Cholinergic & 
Dopamine levels [128] 
 
 
8. Alcoholic extract of Trianthema decandra Linn., at various doses using 
experimental induced stress models in Mice and Rats. The phyto fragments 
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found during GC-MS analysis might also contributed to the Adaptogenic 
activity of alcoholic extract of Trianthema decandra [129] 
 
Hydragyrum perchloride 
1. VRP and PMC drugs, inhibited proliferation of MCF-7 breast cancer cells in 
time and dose dependent manner. Concentration VRP and PMC drugs increased 
from 10 – 50 μg/mL, and the percentage of inhibition increased from 63.62% to 
90.16% for VPR at 24 to 48 h and 65.03 % to 70.51 % for PMC at 24 to 48 h of 
these two drugs subjected to the test, VPR was more efficacious since it affected 
viability of the cells its statistically significant at the level of P < 0.05. [130] 
 
2. Amongst various concentration of drug(VM) tested 500 UG/ml showed 
maximum absorbance of 0.53 0.01. The Veera Mezhugu possess both 
antioxidant anti-cancer potentials justifying scientifically administration in 
cancer. [131] 
 
3.  The Kodasuri veeravaippu possess inhibition of the synthesis of arachidonic 
acid metabolites via inhibiting COX-2. Kodasuri veeravaippu possess 
significant anti-inflammatory activity on both acute and chroic inflammation. 
[132] 
4. “Kodasuri veeravaippu” showed good inhibitory activity on almost all the 
bacteria used. Gram positive bacterial strain, Staphylococcus aureus and the 
gram negative strain Escherichia coli were found to be more susceptible to the 
test drug “Kodasuri veeravaippu” by showing inhibition zone of 30mm and 
22mm respectively. [133] 
 
5. The Ayaveera chendooram is good anti vatha effect   treating for 
vathasthambam.at the dosage 130mg twice a day with honey.[134] 
 
6. Anti-atherosclerotic activity of Pavala chendhooram the dosage of 50mg for a 
period of 6months. 
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7.  Anna Pavala Chendhooram reduced the plasma cholesterol reduced up to 65% 
and the HDL level was increased. The atheroma formation was also inhibited 
sphingomyelin levels. [135] 
8. Hemostatic activity of Pavala parpam treated with dose 500mg/kg body weight. 
The blood showed marked reduction in both bleeding and clotting time. [135] 
 
9. Hepato-protective activity of Kodi pavala chunnam   for its hepatoprotective 
activity in experimental rats. Liver damage was induced by CCl4 in Wister rats. 
The liver damage was assessed by hematological and biochemical parameters. 
Showed near normal levels in hematological, biochemical parameters which 
indicate the hepato-protective activity. [135] 
 
10. The drug Pavala parpam was evaluated for ant osteoporotic activity in 
experimental rats.  The drug treated group received Pavala parpam 65 mg/kg 
body weight, twice a day for 16 weeks.  The decreased femoral weight and 
density were significantly reversed in animals treated with Pavala parpam. The 
cortical bone morphometric indices also revealed raised medullary. width and 
cross-sectional area in treatment group. The combined cortical thickness and 
cortical and periosteal area ratio are also increased compared to sham operated 
animals. [135]  
 
 
11.  Amirtha vennai (external application) used for all skin disease. [136] 
 
12.  Kanakalinga karpura mezhugu.  Mezhugu was investigate with scientific 
parameters to reveal many ascertained drugs for present day refractory diseases 
like cancer, rheumatoid arthritis, thyroid disorders, bronchitis, benign growths, 
adenitis and swellings. [137] 
 
MATERIALS AND METHODS 
 
 
ANTI-CANCER ACTIVITY OF  BHRAMASTHIRAM  Page 91 
 
 
 
 4. MATERIALS AND METHODS 
SELECTION OF THE DRUG: 
For this present study, the Herbo-mineral formulation “BHRAMASTHIRAM” 
was taken as the compound drug preparation for cancer mentioned in the classical 
Siddha literature “The pharmacopeia of Siddha Research Medicines” written by 
Dr.M.Shanmugavelu, Dr.G.D.Naidu L.I.M.,H.P.I.M. published by G.D. Naidu 
president, I.L.W.A. ltd, printed at I LWA press,Coimbatore-18.[138] 
 
Table 9. MINERALS INGREDIENTS 
S.NO NAME OF DRUGS CHEMICAL NAME QUANTITY 
1 Veeram Hydragyrum Perchloride 70gm(6 Thola) 
2 Kariyuppu Sodium chloride 3kg(6 lbs) 
 
 
Table 10. HERBAL INGREDIENTS 
S.NO DRUG NAME BOTANICAL NAME QUANTITY 
1 Vellai Saranai Trianthema decandra 30kg 
2 Puliyarai Oxalis cornuculata 2kg 
3 Aagayathamarai Pistia stratiotes 6kg 
 
Collection of the raw materials: 
 All the raw materials were purchased from R.N.Rajan country drug store, 
Parrys corner, Chennai. 
 Fresh plant material Agayathamarai were collected from, Thirumangalam      
       Village, Kancheepuram dist. 
 Pulliyarai were collected from kolli hills. 
 Vellai saranai collected from Vanthavasi Hills, and ABS garden Salem. 
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Identification and Authentication of the drug: 
The raw materials were identified and authenticated by the experts of 
Gunapadam, Government Siddha Medical College, Arumbakkam, Chennai- 106. The 
specimen sample of each raw material has been kept in the PG Gunapadam department 
individually for future reference. 
 
Purification of the drugs 
Purification process was done as per classical Siddha literature [16] 
 
4.1. Purification of Raw drugs 
1. Purification of Veeram (Hydragyrum perchloride) 
Materials Required: 
 Camphor 
 Tender coconut water 
 Perchloride of mercury  
Procedure: 
Camphor is mixed with tender coconut water and placed in a mud pot. Per 
chloride of mercury is tied in a cloth and soaked in the pot without touching the water 
and the pot is burnt for half an hour. 
2. Purification of Kariyuppu (Sodium Chloride) 
 Common salt -500gm 
 Sea water    -1 lit 
Procedure: 
Common salt is dissolved in sea water and filtered. The filtrate is boiled till it 
reaches semi consistency state. It is dried in day light and it attains the solid state as 
purified salt. 
3. Purification of Aagayathamarai (Pistia stratiotes) 
Removed the olden leaves and washed with water. 
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4. Purification of Vellai Saranai Leaves (Trianthema decandra) 
Removed the olden leaves and washed with water. 
5. Purification of Puliyarai Leaves (Oxalis Cornuculata) 
Removed the olden leaves and washed with water. 
4.1.2. Preparation of the trial drug – Bhramasthiram [138] 
       Minerals materials: 
1. Veeram (Hydragyrum Perchloride)  - 70gm 
2. Kariyuppu (Sodium chloride)             -       Sufficient quantity(3.kg) 
Plant materials: 
3.Vellai Saranai(Trianthema decandra)      -  Sufficient quantity(25 kg) 
4. Puliyarai (Oxalis coriculata)    - Sufficient quantity (1 kg) 
5. Aagayathamarai (Pistia stratiotes)     -       Sufficient quantity (6 kg ) 
 
PROCEDURE: 
 A mud pot was taken. Into which Vellai saradai (Trianthema decandra) leaves 
are spread into a thin layer. 
 Then 1/8 part of the salt was spread over the leaves, by layers. 
 This process was repeated alternatively with the same quantity of leaves and salt.  
  The mud pot was filled with three layer of leaves and 3/8part of salt. 
 Similarly, the rest of the leaves and salts were spread one over the other so as to 
be arranged in eight such layers. The top most layer should be the leaves.  
 The mud pot was covered with a lid and then sealed with the seven layers of mud 
pasted cloth and let dried. 
 It was subjected to calcination using cow dung cakes which is about 8-10 times 
the weight of the kavasam. 
 It is then cooled and the product (salt) was collected carefully. 
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 The process of ignition was repeated for about ten times, fresh leaves of Vellai 
saradai is to be used each time. 
 Then the product of ignition was divided into 10 equal parts. The first part was 
placed in the kalvam and rubbed with the juice of puliyarai leaves and made into 
a paste.  
 The above paste used as kavasam for sealing the savveram mass and dried in the 
hot sun. 
 The above process was repeated with the remaining 9 parts and dried for 10 days. 
 Then, the veera kavasam was placed in an Erippu chutty (earthenware) and is 
covered with a suitable lid and then subjected to pudam (calcination). 
 It was ignited with low flame Deepakini & Kamalakini each for about 1 Saamam 
(3 hours).  
  Then it was followed by iginition with high flame(kadaagini) for about 6 hours. 
 It was then allowed to cool. After that the pot was unsealed and pathangam was 
collected carefully. 
 Finally, the mixture was collected, weighed and kept in an air tight container and 
was labeled as BA. 
 
Dosage    :  1/2-1 grains (32.5-65 mg) 
Form of Medicine      :   Padhangam (sublimation) 
Route         :   Enteral (oral) 
Time of Administration :   Two times a day in empty stomach. 
Adjuvant         :  Jaggery 
Indications                  :  Putru (cancer), leprosy, skin disease, Vadha  
Disease. 
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Analysis as per AYUSH guidelines: 
 
1.Floating on Water: 
       A pinch of BA gently placed on the still surface of water in a vessel, did not sink 
immediately. It was found that the Padhangam particles floated over the surface of 
water indicated lightness of the trial drug. 
2. Lines on fingers: 
Padhangam in well prepared form should be fine. When taken between thumb 
and index finger, the fine powder will fill up the lines of the finger print.  
A pinch of BA was taken in between the thumb and index finger and rubbed. It 
was found that the BA entered into the lines of the finger, and was not easily washed 
out from the lines, confirmed its fineness. 
3. Irreversible reaction: 
 The well prepared Padhangam does not reversible to its metallic state when 
heated with a mixture of cane jaggery, hemp powder, ghee and honey. A pinch of BA 
was taken and mixed with cane jaggery, ghee and honey. It was observed that the BA 
did not reversible to its metallic state. 
4. Tasteless:  
The well prepared Padhangam should be completely tasteless. Presence of any 
taste like sweet or bitter indicates incomplete preparation which needed another 
calcination process. When a small amount of BA was kept on the tip of the tongue, no 
specific taste was found 
5. Lusterless: 
If any shining particles present in Padhangam, it indicates that the Padhangam 
was not manufactured properly and contains unchanged substances like minerals, 
metals and other toxic substances. There should be no shining particles present in the 
well manufactured Padhangam. The BA was taken in a Petri bowl and observed for any 
luster in daylight through magnifying glass. No luster was observed in the Padhangam. 
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4.2. DRUG STANDARDIZATION: 
        Standardization of drug means confirmation of its identity, determination of its 
quality, purity and detection of nature of adulterant by various parameters like 
morphological, microscopically, physical, chemical and biological evaluations [140]                                                                                                                                    
STANDARDIZATION OF THE DRUG BA: 
Standardization of drugs helps to prove its identity and determination of its 
quality and potency. Standardization of the Herbo- mineral formulation was based on 
the qualitative and quantitative analysis through physico‐chemical investigations and 
instrumental analysis. The physico-chemical analysis of the prepared Herbo- Mineral 
drug have been done at The Tamilnadu Dr M.G.R Medical University, Anna salai, 
Guindy, and elemental analysis have been done at Tamilnadu test House, Vanagaram, 
Chennai 95.  (FTIR, SEM, ICP-MS, XRD). 
4.2.1. ORGANOLEPTIC CHARACTER  
The organoleptic characters of the sample drug were evaluated as per the 
standard procedure7.1gm of the BA was taken and the colour, texture, particle size and 
other morphology were viewed by naked eye under sunlight. Then the result was noted. 
4.2.2. PHYSICO‐CHEMICAL ANALYSIS: 
Physico‐chemical investigations like pH value, Loss on drying at 105°C, 
solubility test, Determination of total ash, Determination of acid insoluble ash, 
Determination of water soluble ash, Determination of water soluble extractive, 
Determination of alcohol soluble extractive, have been done at The Tamilnadu Dr 
M.G.R Medical University, Anna salai, Guindy, as per the guide lines of WHO [141]. 
pH value:  
        Potentiometrically, pH value is determined by a glass electrode and a suitable pH 
meter. The pH of the BA was written in results column.  
Loss on Drying: 
An accurately weighed 2gram of Bhramasthiram formulation was taken in a 
tarred glass bottle. The crude drug was heated 1050 c for 6 hours in an oven till a 
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constant weight. The percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
Solubility test: 
A pinch of sample[BA] was taken in a dry test tube and it 2ml of the solvent was 
added and shaken well for about a minute and the result are observed. the test was done 
for solvent like distilled water, Ethanol, petroleum, ether, propylene glycol, Toluene, 
Benzene, chloroform, Ethyl alcohol, Xylene, Carbon tetra chloride, and the result are 
observed individually. 
Determination of total Ash: 
Weighed accurately 2gram of Bhramasthiram formulation was added in crucible 
at a temperature 6000c in a muffle furnace till carbon free ash was obtained. It was 
calculated with reference to the air dried drug. 
Determination of acid insoluble ash: 
Ash above obtained was boiled 5min with 25ml of hydrochloric acid and filtered 
using an ash less filter paper. Insoluble matter retained on filter paper was washed with 
hot water and filter paper was burnt to a constant weight in a muffle furnace. The 
percentage of acid insoluble as was calculated with reference to the air dried drug. 
Determination of water soluble ash: 
Toal Ash 1gram was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with water and ignited for 15 min at a 
temperature not exceeding 4500c in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate. 
Determination of water soluble extractive: 
5 gram of air dried drug. Coarsely powered Bhramasthiram was macerated with 
100ml of distilled water in a closed flask for twenty-four hours, shaking frequently. The 
solution was filtered and 25 ml of filtered was evaporated in a tarred flat bottom shallow 
dish, further dried at 1000c and weighted. The percentage of water soluble extractive 
was calculated with reference to the air dried drugs. 
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Determination of alcohol soluble extractive: 
2.5gram of air dried drugs coarsely powdered Bhramasthiram was macerated 
with 50ml. alcohol in closed flask for 24 hours. With frequent shaking.it was filtered 
rapidly talking precaution against loss of alcohol .10ml of filtrate was the evaporated 
in a tarred flat bottom shallow dish, dried at 1000 c and weighed. The percentage of 
alcohol soluble extractive was calculated with reference to air dried drug. 
4.2.3. BIO-CHEMICAL ANALYSIS 
The bio-chemical analysis was done to identify the acid and basic radicals 
present in the BA. 
Methodology of chemical analysis: 
Preparation of extract: 5gram of BA was taken in a 250 ml clean beaker and 50 ml of 
distilled water was added, boiled well and allowed to cool and filtered in a 100 ml 
volumetric flask and made up to 100 ml with distilled water.  
4.2.4 PRELIMINARY BASIC AND ACIDIC RADICAL STUDIES[142] 
Table 11. Preliminary Basic and Acidic Radical Studies  
S.no PROCEDURE OBSERVATION INFERENCE 
1 
Test for potassium:    
A pinch of BA 2ml of sodium nitrate 
and 2ml of cobalt nitrate solution in 
30% glacial acetic was added 
Formation of yellow 
colored precipitate 
Presence of 
potassium 
2 
Test for calcium:  
To 2ml of extract in a clean test tube. 
Then acetic acid and potassium 
chromate solution were added. 
Formation of yellow 
precipitate 
Presence of 
calcium. 
4. 
Test for Ammonium: 
2ml of extract was taken in a test 
tube and add few ml of Nessler’s 
reagent 
Appearance of 
brown colour 
Presence of 
Ammonium 
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5. 
Test for Sodium:  
2 pinches of BA were mixed with 
HCl and made into paste. And 
introduced into the blue flame of 
Bunsen burner 
Appearance of 
intense yellow 
colour 
Presence of 
Sodium 
6. 
Test for Iron (Ferrous): 
2ml of extract was taken in a clean 
dried test tube and conc. HNO3 and 
ammonium thiocyanate were added. 
Appearance of blood 
red colour 
Presence of 
Iron 
7. 
Test for Zinc: 
 2ml of extract was taken in a test 
tube and potassium Ferro cyanide 
solution was added.  
Formation of white 
colour precipitate 
Presence of 
Zinc 
8. 
Test for Aluminium: 
2ml of extract was taken in a test 
tube and sodium hydroxide was 
added to it. 
Formation of White  
colour precipitate 
Presence of 
Aluminium 
9. 
Test for Lead: 
2ml of extract was taken in a test 
tube and add 2ml of potassium 
iodide solution 
Formation of yellow 
colour precipitate 
Presence of 
Lead 
10. 
Test for Copper: 
To a small portion of the extract 
dilute hydrochloric acid was added 
and then hydrogen sulfide gas is 
passed through the solution 
 
Formation of black 
precipitate 
 
Presence of 
Copper 
11. 
Test for Mercury:  
2ml of the extract was taken in a test 
tube and treated with 2ml of sodium 
hydroxide solution 
Formation of yellow 
precipitate 
Presence of 
Mercury 
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12. 
Test for Arsenic:  
2ml of the extract was taken in a test 
tube and treated with 2ml of sodium 
hydroxide solution. 
Formation of 
brownish precipitate 
Presence of 
Arsenic 
             Results were noted and tabulated in Table no: 17  
 
 
Table12.  Test for acid radicals 
S.no PROCEDURE OBSERVATION INFERENCE 
1 
Test for Sulphate:  
2ml of extract was taken in 
clean, dry test tube and 5% 
barium chloride solution was 
added to it 
Formation of white 
precipitate 
Presence of 
Sulphate 
2 
Test for Chloride: 
 The extract was taken in a test 
tube and then treated with silver 
nitrate solution 
Formation of white 
precipitate 
Presence of 
Chloride 
3 
Test for Phosphate:  
The extract was taken in a test 
tube and treated with ammonium 
molybdate and conc. HNO3 
Formation of 
yellow precipitate 
Presence of 
Phosphate 
4 Test for Carbonate: The 
substance was taken in a clean 
dry test tube and then treated 
with conc.HCl 
Formation of  
effervescence 
Presence of 
Carbonate 
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5 Test for fluoride & oxalate: 
2ml of the extract was taken in a 
test tube and add 2ml of dil. 
Acetic acid, 2ml calcium 
chloride solution and then heated   
Formation of cloudy 
appearance 
Presence of 
Fluoride & Oxalate 
6 Test for Nitrate:1gm of BA was 
heated with copper turnings and 
conc.H2S04 and observe the test 
tube vertically down 
Characteristic 
changes 
Presence of Nitrate 
 Results were noted and tabulated in Table no:18 
4.2.5 ANTI-MICROBIAL ACTIVITY 
 AVAILABILITY OF BACTERIAL LOAD [143]:  
Enumeration of bacteria by plate count – agar plating technique 
 The plate count technique is one of the most routinely used procedure because 
of the enumeration of viable cells by this method.  
Principle:   
 This method is based on the principle that when material containing bacteria is 
cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium.  
The number of colonies, therefore are the same as the number of organisms contained 
in the sample. 
Dilution:   
A small measured volume is mixed with a large volume of sterile water or saline 
called the diluent or dilution blank. Dilutions are usually made in multiples of ten. A 
single dilution is calculated as follows:    
Dilution =         Volume of the sample 
                     Total volume of the sample and the diluent 
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Requirements: 
 Sample or Bacterial suspension 
 K9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes (7) 
 Nutrient agar medium (200 ml) 
 Colony counter  
 
Procedure: 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
2. Prepare the initial dilution by adding 1 ml of the sample into a 9 ml dilution 
blank labelled 10-1 thus diluting the original sample 10 times. 
3. Mix the contents by rolling the tube back and forth between hands to obtain 
uniform distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to 
the dilution blank 10-2 with a sterile and fresh 1 ml pipette diluting the 
original specimen to 100 times. 
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
6. Repeat this procedure till the original sample have been diluted 10,000,000 
times using every time a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes are to 
be used for each dilution. 
8. Add approximately 15 ml of the nutrient medium, melted and cooled to 
450c, to each petri dish containing the diluted sample. Mix the contents of 
each dish by rotating gently to distribute the cells throughout the medium. 
9. Allow the plates to solidity. 
10. Incubate these plates in an inverted position for 24-48 hours at 370c. 
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Observation: 
 Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates. 
Calculate the number of bacteria per ml of the original suspension as follows: 
                Number of colonies (average of 3 replates) 
Organisms per millimetre =                           Amount of plated × dilution  
Results were noted and tabulated in Table no: 16 
 
 
4.2.6. SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra-Red) 
DEFINITION: 
       FTIR offers quantitative and qualitative analysis for organic and inorganic samples. 
Fourier Transform Infrared Spectroscopy (FTIR) identifies chemical bonds in a 
molecule by producing an infrared absorption spectrum. The spectra produce a profile 
of the sample, a distinctive molecular fingerprint that can be used to screen and scan 
samples for many different components. FTIR is an effective analytical instrument for 
detecting functional groups. 
APPLICATIONS: 
 Quantative scans 
 Qualitative scan solids, liquids, gasses 
 Organic samples, inorganic samples 
 Unknown identification  
 Impurities screening 
 Formulation 
 Pharmaceuticals  
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INSTRUMENT DETAILS 
Principle:  
SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT IR - Fourier Transform Infra-Red Spectroscopy [144]. 
FTIR (Fourier Transform Infra-Red Spectroscopy) is a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications although 
it can also characterize some inorganics.  
Examples include paints, adhesives, resins, polymers, coatings and drugs. FTIR is an 
effective analytical instrument for detecting functional groups. 
APPLICATIONS: 
 Quantative scans 
 Qualitative scan solids, liquids, gasses 
 Organic samples, inorganic samples 
 Unknown identification  
 Impurities screening 
 Formulation 
Principle:  
Spectrophotometric tests are commonly used in the Identification of chemical 
substances and quantification of polymorphic forms. The test procedures are applicable 
to substances that absorb IR radiation.  
The IR absorption spectrum of a substance compared with that obtained 
concomitantly for the corresponding reference standard / reference substance provide 
conclusive evidence of the identity of the substance being tested.  
 Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›):  
 Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg, 
unless otherwise specified, of finely powdered and dried potassium bromide. If 
the substance is a hydrochloride it is preferable to use potassium chloride.  
 Carefully grind the mixture and spread it uniformly in a suitable die.  
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Figure12.  FTIR INSTRUMENT 
     
    Figure 13. FTIR MECHANISM 
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 Submit it to the pressure of about 800 mPa (8 tons/cm2).  
 Examine the disc visually and if any lack of uniform transparency is observed, 
reject the disc and prepare again.  
 Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in 
individual standard test procedure.  
 When sample and standard are measured for concordance, the transmittance 
obtained at the start of the scan range, should not deviate by more than 10% 
between them (For eg. If the standard shows a transmittance of 75%, the sample 
transmittance can be between 65% and 85%). 
FT-IR was the most advanced and the major advantage was its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated  
 
 
ICP-MS - INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY  
Analysis of Trace Metal and Inorganic Materials 
Inductively Coupled Plasma Mass Spectrometry is a technique routinely used 
to analyse trace levels of a wide range of inorganic elements.    
The ICP-MS allows for the detection and quantification of elements with atomic 
mass ranges 7 to 250.  This covers Lithium to Uranium.   
The typical detection limits are in the parts per billion (ppb) range and even 
parts per trillion (ppt) in some cases.  
 
The ICP-MS analysis methods available at LPD Lab Services allow the 
detection, identification and quantification of a wide array of elements using a Perkin 
Elmer ELAN 6000 ICP-MS 
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Figure 14. ICPMS- INSTRUMENT 
  
 
 
  
 
 
   
                    
Figure 15.  ICP MS MECHANISM  
Analysis: Analyze according to the manufacturer's suggestions for program and m/z. 
Calculate and report results based on the original sample size.  
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Applications of ICP-MS 
 Monitoring of trace metals in drinking water, ground water, rainwater, 
wastewater or industrial effluent streams. 
 Trace elements in product / raw materials or from washed or rinsed surfaces. 
 Analysis of additives and purity in metal alloys. 
 Analysis of low level contaminants in chemical products, beverages, foods, 
cosmetics, pharmaceuticals. 
 Analysis of soluble / leachable material from solid samples such as medical 
devices, polymers, PCB`s. 
 Analysis can be performed on a diverse range of sample. [145] 
 
SEM - Scanning Electron Microscope  
DEFINITION:      
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high magnifications, 
generates high-resolution images and precisely measures very small features and 
objects. 
SEM ANALYSIS APPLICATIONS 
The signals generated during SEM analysis produce a two-dimensional image and 
reveal information about the sample including: 
External morphology (texture) 
 Chemical composition (when used with EDS) Orientation of materials making 
up the sample 
 The EDS component of the system is applied in conjunction with SEM analysis 
to: 
 
 Determine elements in or on the surface of the sample for qualitative 
information. 
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 Measure elemental composition for semi-quantitative results. 
 Identify foreign substances that are not organic in nature and coatings on meta.l 
 SEM Analysis with EDS – qualitative and semi-quantitative results. 
 Magnification – from 5x to 300,000x. 
 Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in 
height. 
 Materials analyzed – solid inorganic materials including metals and minerals. 
 Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens.  
 
 In most SEM microscopy applications, data is collected over a selected area of 
the surface of the sample and a two-dimensional image is generated that 
displays spatial variations in properties including chemical characterization, 
texture and orientation of materials.  
 
 The SEM is also capable of performing analyses of selected point locations on 
the sample. This approach is especially useful in qualitatively or semi-
quantitatively determining chemical compositions, crystalline structure and 
crystal orientations. 
 
 The EDS detector separates the characteristic X-rays of different elements into 
an energy spectrum and EDS system software is used to analyses the energy 
spectrum in order to determine the abundance of specific elements.  
 
 A typical EDS spectrum is portrayed as a plot of X-ray counts vs. energy (in 
Kev). Energy peaks correspond to the various elements in the sample.  
 
THE SEM ANALYSIS PROCESS 
Energy Dispersive X-ray Spectroscopy can be used to find the chemical 
composition of materials down to a spot size of a few microns and to create element  
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 Figure16. SEM INSTRUMENT 
 
      
 
 
  
 
 
 
 
  
                          
 
 
Figure 17.SEM MECHANISM 
 
composition maps over a much broader raster area. Together, these capabilities 
provide fundamental compositional information for a wide variety of materials, 
including polymers. 
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In scanning electron microscope high-energy electron beam was focused 
through a probe towards BA. Variety of signals was produced on interaction with the  
surface of the sample. This results in the emission of electrons or photons and 
it was collected by an appropriate detector. 
The types of signal produced by a scanning electron microscope include:  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays light 
 specimen current 
 Transmitted electrons. 
 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample. [146] 
 
XRD - X-ray Powder Diffraction (XRD 
X-ray powder diffraction (XRD) is a rapid analytical technique primarily used 
for phase identification of a crystalline material and can provide information on unit 
cell dimensions. 
 The analyzed material is finely ground, homogenized, and average bulk 
composition is determined. 
 
 
DEFINITION 
X-ray powder diffraction is most widely used for the identification of 
unknown crystalline materials (e.g. minerals, inorganic compounds). 
Determination of unknown solids is important to studies in geology, environmental 
science, material science and biology. 
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APPLICATIONS:  
 Characterization of crystalline materials   
 Identification of fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically  
 Determination of unit cell dimensions.  
With specialized techniques, XRD can be used to:  
 Determine crystal structures using Rietveld refinement  
 Determine of modal amounts of minerals (quantitative analysis)  
 Characterize thin films samples by:  
 Determining lattice mismatch between film and substrate and to inferring stress 
and strain  
 Determining dislocation density and quality of the film by rocking curve 
measurements  
 Measuring super lattices in multilayered epitaxial structures  
 Determining the thickness, roughness and density of the film using glancing 
incidence X-ray reflectivity measurements  
 Make textural measurements, such as the orientation of grains, in a 
polycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction:   
Strengths:  
 Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral in most cases, it provides an unambiguous mineral determination  
 Minimal sample preparation is required  
 XRD units are widely available  
 Data interpretation is relatively straight forward.  
 
Limitations:  
 Homogeneous and single phase material is best for identification of unknown  
 Must have access to a standard reference file of inorganic compounds   
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 Requires tenths of a gram of material which must be ground into a powder  
 For mixed materials, detection limit is ~ 2% of sample for unit cell determinations, 
indexing of patterns for non-isometric crystal systems is complicated. 
 
 
 
 
 
 
 
  
      Figure 18.XRD - X-ray Powder Diffraction 
    
 
  Figure 19. XRD Mechanism 
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Sample Collection and Preparation:  
Determination of an unknown requires: the material, an instrument for grinding, 
and a sample holder.  
 Obtain a few tenths of a gram (or more) of the material, as pure as possible  
 Grind the sample to a fine powder, typically in a fluid to minimize inducing 
extra strain (surface energy) that can offset peak positions, and to randomize 
orientation. Powder less than ~10 µm (or 200-mesh) in size is preferred  
 Place into a sample holder or onto the sample surface. [147] 
 
 
4.3. TOXICOLOGICAL STUDIES 
 
4.3.1.Acute oral toxicity 
Acute oral toxicity study of Bhramasthiram[BA]-(OECD guideline – 423) 
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423. [148]  
IAEC No: IAEC/XLIV/20/CLBMCP/2016, C.L.BaidMetha College of Pharmacy, 
Thoraipakkam, Chennai.  
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity of 
the test substance. 
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods. 
 The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification 
purposes and hazard assessment. 
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 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test. 
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%. 
 The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability. 
 
Principle of the Test: 
It was the principle of the test that based on a stepwise procedure with the use 
of a minimum number of animals per step, sufficient information is obtained on the 
acute toxicity of the test substance to enable its classification. The substance was 
administered orally to a group of experimental animals at one of the defined doses. 
  The substance was tested using a stepwise procedure, each step using three 
animals of a single sex. Absence or presence of compound-related mortality of the 
animals dosed at one step will determine the next step, i.e. 
 No further testing is needed 
 Dosing of three additional animals, with the same dose 
 Dosing of three additional animals at the next higher or the next lower 
dose level. The method will enable a judgment with respect to 
classifying the test substance to one of a series of toxicity classes. 
Methodology: 
Selection of Animal Species 
 The preferred rodent species was the wistar albino rat, although other rodent 
species may be used. Healthy young adult animals are commonly used laboratory 
strains should be employed. Females should be nulliparous and non-pregnant. Each 
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animal, at the commencement of its dosing, should be between 6 to 8 weeks old and the 
weight (150-200gm) should fall in an interval within±20 % of the mean weight of any 
previously dosed animals. 
 
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hour’s light, 12 hours dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water.  
Animals may be group-caged by dose, but the number of animals per cage must 
not interfere with clear observations of each animal. 
Preparation of animals:   
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions. 
Test Animals and Test Conditions: 
Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
TANUVAS, Madhavaram, Chennai.  
All the animals were kept under standard environmental condition (22±3°C).  
The animals had free access to water and standard pellet diet (Sai meera foods, 
Bangalore). 
Preparation for Acute Toxicity Studies 
  Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the, BHRAMASTHIRAM (BA). 
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
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IAEC approved Number : IAEC/XLIV/20/CLBMCP/2016 
Test Substance  : BHRAMASTHIRAM (BA) 
Animal Source  : TANUVAS,Madhavaram, Chennai.   
Animals   : Wister Albino Rats (Female-3+3) 
Age    : 6-8 weeks 
Body Weight on Day 0 : 150-200gm. 
Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual 
                  marking by using Picric acid. 
Number of animals       : 3 Female/group, 
 Route of administration : Oral 
Diet : Pellet feed supplied by Sai meera foods Pvt Ltd,   
  Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
                  provided with bedding of husk. 
Housing temperature :  between 22ºC + 3ºC.    
Relative humidity  :  between 30% and 70%, 
Air changes    : 10 to 15 per hour and 
Dark and light cycle   : 12:12 hours. 
Duration of the study : 14 Days 
Administration of Doses: 
 BHRAMASTHIRAM (BA) was suspended in water and administered 
to the groups of wistar albino rats in a single oral dose by gavage using a feeding needle. 
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The control group received an equal volume of the vehicle.  
Animals were fasted 12 hours prior to dosing. Following the period of fasting, 
the animals were weighed and then the test substance was administered. Three Female 
animals are used for each group. The dose level of 5, 50, 300 and 2000 mg/kg body 
weight was administered stepwise. After the substance has been administered, food was 
withheld for a further 3-4 hours. The principle of laboratory animal care was followed. 
Observations were made and recorded systematically and continuously as per the 
guideline after substance administration.  
The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. Finally, the number of 
survivors was noted after 24 hrs and these animals were then monitered for a further 14 
days and observations made daily. The toxicological effect was assessed on the basis of 
mortality. 
Limit test 
The limit test is primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having 
toxicity only above regulatory limit doses. A limit test at one dose level of 2000 
mg/kg body weight was carried out with three animals per step. The test substance-
related mortality was not produced in animals, so further testing at the next lower 
level need not be carried out. 
Observations: 
The Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 4 
hours, and daily thereafter, for a total of 14 days, except where they need to be removed from 
the study and humanely killed for animal welfare reasons or are found dead. It should be 
determined by the toxic reactions, time of onset and length of recovery period, and may 
thus be extended when considered necessary. The times at which signs of toxicity 
appear and disappear are important, especially if there is a tendency for toxic signs to 
be delayed. 
 All observations are systematically recorded with individual records being 
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maintained for each animal. 
a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 
hours following drug administration on day 1 of the experiment and daily twice 
thereafter for 14 days. 
b. Body weight 
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study.  
Weight changes were calculated and recorded. At the end of the test, surviving animals 
were weighed and humanly killed. 
c. Cage-side observation 
  These include changes in skin and fur, eyes and mucous 
membranes and also respiratory, circulatory, autonomic and central nervous systems, 
somato motor activity and behavioral patterns.  Attention should be directed to 
observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
 All animals (including those which die during the test period are removed 
from the study) will be subjected to gross necropsy.   
 Gross necropsy includes examination of the external surface of the body, 
all orifices, cranial, thoracic and abdominal cavities and their contents, 
brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and 
uterus of all animals. 
Histopathology 
Microscopic examination will be carried out in organs to show the evidence of 
any toxicity in gross pathology. 
 
Data and reporting 
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All data were summarized in tabular form, (Table-23-26) showing for each test 
group the number of animals used, the number of animals displaying signs of toxicity, 
the number of animals found dead during the test, description of toxic symptoms, 
weight changes, food and water intake. 
Test substance and Vehicle 
In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing BA  2% Water solution and it was found suitable 
for dose accuracy. 
Justification for choice of vehicle 
The vehicle selected as per the standard guideline was pharmacologically inert 
and easy to employ for new drug development and evaluation technique [59]. 
 
4.3.2. 28-Days Repeated Oral Toxicity (407) Study Of Bhramasthiram  
 
28-Days Repeated Oral Toxicity (407) Study of  
Bhramasthiram (BA) 
 
Test Substance  : BHRAMASTHIRAM (BA) 
Animal Source  : TANUVAS, Madhavaram, Chennai.   
Animals   : Wister Albino Rats (Male -24, and Female-24) 
Age    : 6-8 weeks 
Body Weight              : 150-200gm. 
Acclimatization  : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number   and    individual 
  marking by using   Picric acid 
Diet    : Pellet feed supplied by Sai Meera Foods Pvt Ltd,    
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      Bangalore. 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
       provided with bedding of husk. 
Housing temperature :  between 22ºC±3ºC.    
Relative humidity  :  between 30% and 70%, 
Air changes    : 10 to 15 per hour 
Dark and light cycle   : 12:12 hours. 
Duration of the study : 28 Days. 
 
Groups of animals 
GROUPS No.of Rats 
Group I Vehicle control (water) 20 (10 male, 6 female) 
Group II Bhramasthiram (2mg /kg) 20 (10 male, 10 female) 
Group III Bhramasthiram(10 mg/kg) 20 (10 male, 10 female) 
Group IV Bhramasthiram( 20mg/kg) 20 (10 male, 10 female) 
 
Justification for Dose Selection: 
The results of acute toxicity studies in Wistar albino rats indicated that 
BHRAMASTHIRAM was non-toxic and no behavioural changes was observed up to the 
dose level of 2000 mg/kg body weight. 
 On the basis of body surface area ratio between rat and human, the doses selected as 
per OECD guideline three dose levels were selected for the study.  
They are low dose (5X), high dose (10X). X is calculated by multiplying the 
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acute toxicity dose 2000mg) and the body surface area of the rat (0.018), 5X dose is 
(10mg/kg), 10X dose is (20mg/kg) The oral route was selected for use because oral route 
is considered to be a proposed therapeutic route. 
Preparation and Administration of Dose: 
 BHRAMASTHIRAM(BA) at three doses respectively was suspended with water, 
it was administered to animals at the dose levels of X, 5X, 10X. The test substance 
suspensions were freshly prepared every two days once for 28 days.  
The control animals were administered vehicle only.  The drug was administered orally 
by using oral gavage once daily for 28 consecutive days. 
 
Methodology 
Randomization, Numbering and Grouping of Animals: 
80 Wistar Albino Rats (40M + 40F) were selected and divided into 4 groups. Each 
group consist of 20 animals (Male -10 and Female-10). First group treated as a control 
and other three group were treated with test drug (low, high) for 28 days. Animals were 
allowed acclimatization period of 7 days to laboratory conditions prior to the initiation 
of treatment. Each animal was marked with picric acid. The females were nulliparous 
and non-pregnant. 
Observations: 
Experimental animals were kept under observation throughout the course of study 
for the following: 
Body Weight: 
 Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study. From the data, group mean body weights and percent body weight gain 
were calculated. 
Food and water Consumption: 
  Food and water consumed per animal was calculated for control and the treated 
dose groups. 
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Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality: 
All animals were observed twice daily for mortality during entire course of      
study. 
Functional Observations:  
At the end of the 4th week exposure, ‘sensory reactivity’ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and ‘grip 
strength’ were assessed. 
Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animals 
fasted over-night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Biochemistry and potassium EDTA (1.5 mg/ml) for 
Hematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 
10 minutes. 
Hematological Investigations 
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV). 
Biochemical Investigations 
Serum was used for the estimation of biochemical parameters. Samples of 
control and experimental rats were analyzed for protein, bilirubin, urea, BUN, 
creatinine, triglyceride, cholesterol and glucose levels was carried using standard 
methods. Activities of glutamateoxaloacetatetransaminase/Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) 
and   alkaline   phosphatase   were   estimated   as   per   the colorimetric procedure. 
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Necropsy: 
All the animals were sacrificed by excessive anesthesia on day 29. Necropsy of 
all animals was carried out. 
Histopathology 
 Histopathological investigation of the vital organs was done. The organ pieces (5-
6µm thick) of the highest dose level of 300 mg/kg were preserved and were fixed in 
10% formalin for 24 hours and washed in running water for 24 hours. Samples were 
dehydrated in an auto technique and then cleared in benzene to remove absolute alcohol.   
Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” moulds.  
It was followed by microtome and the slides were stained with Hematoxylin-
eosin. The organs included heart, kidneys, liver, ovary, pancreas, brain, spleen and 
stomach, of the animals were preserved they were subjected to Histopathological 
examination. 
Statistical analysis: 
Findings such as body weight changes, water and food consumption, 
hematology and blood chemistry were subjected to One-way ANOVA followed 
by dunnet’S multi comparison test using a computer software programme – 
GRAPH PAD VERSION-3 version. [149]  
 
4.4. PHARMACOLOGICAL ACTIVITY 
4.4.1. IN-VITRO ANTICANCER ACTIVITY DETERMINATION BY MTT 
        ASSAY 
KB (oral cancer cells), HeLa (cervical cancer cells) was initially procured from 
National Centre for Cell Sciences (NCCS), Pune, India and maintained Dulbeccos 
modified Eagles medium (DMEM (Sigma Aldrich USA). 
The HeLa cell and KB cell  line was cultured in 25 cm2 tissue culture flask with 
DMEM supplemented with 10% FBS L-glutamine, sodium bicarbonate and antibiotic 
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solution containing: Penicillin (100U/ml), Streptomycin (100µg/ml), and 
Amphotericin B (2.5µg/ml).  
Cultured cell lines were kept at 37ºC in a humidified 5% CO2 incubator (NBS 
Eppendorf, Germany). 
The viability of cells was evaluated by direct observation of cells by Inverted 
phase contrast microscope and followed by MTT assay method. 
Cells seeding in 96 well plate: 
Two days old confluent monolayer of cells were trypsinized and the cells were 
suspended in 10% growth medium, 100µl cell suspension (5x104 cells/well) was 
seeded in 96 well tissue culture plate and incubated at 37ºC in a humidified 5% CO2 
incubator. 
Preparation of plant extracts and compound stock: 
1 mg of BA was weighed and dissolved in 1ml of DMEM and dissolved 
completely by cyclomixer. After that the solution was filtered through 0.22 µm 
Millipore syringe filter to ensure the sterility. 
Anticancer Evaluation: 
After 24 hours the growth medium was removed, freshly prepared each plant 
extracts in 5% DMEM(Dulbecco’s modified eagle medium) were five times serially 
diluted by two fold dilution (100µg, 50µg, 25µg, 12.5µg, 6.25µg in 100µl of 5% 
MEM) and each concentration of 100µl were added in triplicates to the respective 
wells and incubated at 37ºC in a humidified 5% CO2 incubator. Not treated control 
cells were also maintained. 
Anticancer Assay by Direct Microscopic observation: 
Entire plate was observed at an interval of each 24 hours; up to 72 hours in an 
inverted phase contrast tissue culture microscope (Olympus CKX41 with Optika Pro5 
CCD camera) and microscopic observation were recorded as images. Any detectable 
changes in the morphology of the cells, such as rounding or shrinking of cells, 
granulation and vacuolization in the cytoplasm of the cells were considered as 
indicators of cytotoxicity. 
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Anticancer Assay by MTT Method: 
Fifteen mg of MTT (Sigma, M-5655) was reconstituted in 3 ml PBS until 
completely dissolved and sterilized by filter sterilization. 
After 24 hours of incubation period, the sample content in wells were 
removed and 30µl of reconstituted MTT solution was added to all test and cell 
control wells, the plate was gently shaken well, then incubated at 37ºC in a 
humidified 5% CO2 incubator for 4 hours.  
After the incubation period, the supernatant was removed and 100µl of 
MTT Solubilization Solution (dimethyl sulphoxide DMSO Sigma Aldrich, USA) 
was added and the wells were mixed gently by pipetting up and down in order to 
solubilize the formazan crystals.  
The absorbance values were measured by using microplate reader at a 
wavelength of 540 nm (Laura B. Talarico et al., 2004) [150]. 
The percentage of growth inhibition was calculated using the formula: 
     Mean OD sample x 100 
% of viability = 
    Mean OD of control Group 
 
APPENDIX 
Instruments and reagents used: 
DMEM media    - Sigma Aldrich, USA D5648  
Fetal Bovine Serum  - Gibco, US orgin-  
0.25% Trypsin   -  Invitrogen, USA 25200-056 
Micropipettes   -  F1 Thermoscientific USA 
CO2 Incubator   -  Eppendorf, GERMANY 
Phase Contrast Microscope -  Olympus, JAPAN with Optika Pro 5   
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Camera 
MTT    -  Sigma Aldrich M5655 
ELISA Reader   -  ERBA, GERMANY 
Culture Plates and Flasks -  NUNC, Thermoscientific USA 
Image Magnification  - 10X 
 
 
 
 
 
 
 
 
Figure 20. Microplate Reader 
 
 
          Figure 21.  Phase Contrast Microscope                          Figure 22. CO2 Incubator            
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 4.4.2. IN VITRO ANTI- TUMOUR ACTIVITY 
 Cell culture materials 
The human cervical carcinoma a cell line KB cell line, SiHa, used in the 
study was obtained from National Centre for Cell Science (NCCS), Pune, India. 
The cells were grown in DMEM containing 2m ML-glutamine supplemented with 
10% fetal bovine serum and 100U/ml of penicillin-streptomycin. The cells were 
incubated in a humidified 5 %CO2 incubator at37°C. 
 
 
Cell growth analysis 
SiHa cells were seeded at a density of 1 × 105 cells/ml in24-well plates in 
triplicates. Next day, the cells were dosed with different concentrations of BA (0, 10, 
20, 40 and 80 g/ml) and grown for 24, 48 and 72 h. The cells were harvested and 
counted for viability using trypan blue dye exclusion method. 
Colony formation assay 
The cells were plated at a seeding density of 1 × 103 cells/ ml in 6-well plates. 
After 24 h, the cells were exposed to various concentrations of BA: 0, 10, 20, 40, and 
80 g/ ml. Plates were incubated at 37°C in a5%CO2 incubator for one week.  
This was followed by fixing the colonies with 4%paraformaldehyde and 
staining with0.5%crystal violet [77]. The colonies were photographed with SonyDSC-
S75cyber-shotcamera. 
Soft agar assay 
Control SiHa cells (5×103cells/ml) as well as cells treated with different 
concentrations of BA (10-80 g/ml) were mixed at 40°C with 0.35% agarose (DNA 
grade, GIBCOBRL, CA, USA) in culture medium and gelled at room temperature for 
20min over a previously gelled layer of 0.5% agarose in culture medium in 6-
wellplates. After incubation for 10days, colonies were photographed directly using an 
Axiovert200M microscope (CarlZeiss, Germany) and counted. 
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Measurement of Apoptosis 
The cells were plated at a seeding density of 5 × 105 cells/ well and treated with 
different concentrations of NMC (0-80 g/ml). After 24 h of treatment, the cells were 
harvested and washed with PBS twice. Cells were stained with Annexin V-FITC 
following the manufacturer's instructions (Annexin V-FITC apoptosis kit #3, In vitro- 
gen) and analyzed for apoptosis by FACS using Cell Quest Software. 
 
Statistical analysis 
All experiments were performed in triplicates and repeated at least five times 
and the data were presented as mean ±SD. Statistical analysis was conducted with the 
Sigma Stat3.5program (Systat Software, Inc.) using one- way ANOVA. The level used 
for comparisons was =0.05. 
4.4.3. ANTIOXIDANT ACTIVITY [151,152] 
Method: 
After the end of sub-acute toxicity study, the intermediate dosage group of 
animals were sacrificed and organs such as liver and kidneys were excised out and 
analyzed for oxidative stress markers. The concentration of oxidative stress markers 
such as Lipid peroxide, Glutathione, Glutathione peroxidase and Catalase were 
analyzed. Lipid peroxides (Thiobarbituric Acid Reactive Substances – TBARS) in 
tissues were assayed by the method of Yagi. [84] The colour formation with 
Thiobarbituric acid (TBA) was used as index. Reduced glutathione (GSH) was 
estimated by the method of Ellman in which yellow colour developed when Dithionitro-
bis-benzoic acid (DTNB) added to the compounds sulfhydryl groups. [85] 
Glutothione peroxidase (GPx) estimated by the method of Rotruck et al, 1973 
in which H2O2 reduced to water whereas organic hydroperoxides reduced to alcohol at 
the expense of GSH. [86] [87] The activity of Catalase (CAT) was determined by the 
method of Sinha. [88] In this assay, Dichromate in Acetic acid heated in the presence of 
Hydrogeperoxide converted to Perchromic acid and then to Chromic acetate. The 
formed chromic acetate was measured at 620 nm. 
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The radical scavenging activity of different extracts was determined by using 
DPPH assay according to Chang et al [2001]. 
The decrease in the absorption of the DPPH solution after the addition of the 
sample was measured at 517 nm. Ascorbic acid (10mg/ml DMSO) was used as 
reference. 
PRINCIPLE 
            1, 1-diphenyl-2-picryl hydrazyl is a stable free radical with pink colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-
A) can be written as,  
                                     DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
REAGENT PREPARATION 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of ethanol.  
PROCEDURE 
Different volumes of sample such as 1.25μL - 20μL (12.5 μg/mL- 200µg/mL) 
from a stock concentration of 10 mg/mL were made up to a final volume of 20µl with 
DMSO and 1.48ml DPPH (0.1mM) solution was added. A control without the test 
compound, but an equivalent amount of distilled water was taken. The reaction mixture 
incubated in dark condition at room temperature for 20 minutes. After 20 minutes, the 
absorbance of the mixture was read at 517nm. 3ml of DPPH was taken as control. 
[151,152] 
CALCULATION 
% inhibition =  
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5. RESULTS AND DISCUSSION 
One of the Siddha Herbo-mineral formulation, Bhramasthiram has been 
exposed to several modern scientific studies to establish its efficacy to scientific people 
and public. The study includes literary collections, physicochemical and 
phytochemical analysis, instrumental analysis, toxicological study and 
pharmacological studies are done to justify the Anticancer activity of Bhramasthiram 
against various cell lines study. The drug Bhramasthiram has been selected for Anti-
cancer activity in reference with the text “The pharmacopeia of Siddha Research 
Medicines” Literary collections about the drug from various text books were done. 
Siddha literatures related to the drug bring the evidence and importance of its utility 
in treating the cancer. [152,153] 
 The desirable consequences of Bhramasthiram are displayed and discussed for 
its anticancer nature. 
From review of literature 
Discussion on Gunapadam review 
 The general properties& many preparations of Veeram  is used to kill certain 
cancer growth as per Siddha classical text. 
 Sodium chloride are potential to inhibit the many tumerous growth 
 The poem for general properties of Vellai saranai directly indicates to cure  the 
cancer and tumour. 
Discussion on modern drug review 
 Mercuric chloride has cyto-toxic effect [154].  
 The bioactive compounds from oxalis cornuculata, which are potential to inhibit 
cancer cell proliferation and tumour growth. 
 Trianthema decandra contains anticancer, anti tumour and anti-oxidant activity. 
 Pistia stratiotes are potential to inhibit cancer cell proliferation. 
Discussion on pharmaceutical review 
 “Nth;ghU jioghU kpQ;rpdf;fhy;   
      nky;y nky;y gw;g nre;Jhuk; ghNu” 
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These lines stressed about potentiality and medicinal values of higher order 
medicinal (Padhangam) preparation [16]. 
10 years of shelf life denotes its long time efficacy. 
Discussion of pharmacological review 
 The cell lines for my anticancer activity were HeLa, KB and SiHa. They are the 
genomes of HPV 16 and HPV 18 respectively. These HPV 16 and HPV 18 are the 
responsible for 93% of Oral and Cervical cancer [3]. 
 So, the analysis of pharmacological activity through HeLa and SiHa   cell lines 
are the novel methods for validation. They explained about the effective anticancer 
Activity of BA. 
Discussion on materials and methods 
 The selection of trial drug was taken from the book The pharmacopeia of 
Siddha Research Medicines, written by Dr.M. Shanmugavelu, L.I.M., 
H.P.I.M., was approved by the Department of AYUSH as Per Classical Siddha 
literature. 
 This illustrates that BA is one of the best medicine in Siddha system.  
 The ingredients were bought from the authenticated vender and they were 
identified and authenticated by the experts in Post Graduate Department of 
Gunapadam, GSMC, Chennai. So the ingredients were perfect and original. 
 The preparation of medicine was done at the well-equipped lab of the Post 
Graduate Department of Gunapadam. So the principles of GMP were adhered 
during the process. 
 The analytical parameters were conducted at registered and licensed 
laboratories only. Thus the result of Bhramasthiram under various analytical 
procedures shows accuracy of it. 
 The Siddha Herbo-mineral formulation Bhramasthiram had been subjected to 
various studies for its scientific validation and safety assessment. Literary 
collections, physicochemical and Elemental analysis, Toxicological study, 
Pharmacological studies are done to prove its efficacy. 
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Discussion on Standardization techniques 
Siddha parameters 
 The system of regeneration standardizes its medicinal preparations itself by 
some exclusive ways to ensure the safety and efficacy of them. For the preparatory 
medicine Padhangam, the perfect Siddha system handled the following procedure as 
the part of standardization. 
The outcome of Bhramasthiram according to Siddha standardization techniques 
are represented here. 
Table 13.  Results of Siddha standardization 
 
S.No 
 
 Paramaeter 
Results of ideal 
Padhangam 
 
Results of BA 
 
Interpretation 
 
1. 
 
Colour  
 
White 
 
White in colour 
 
White in  colour. 
 
2. 
 
Floating on 
water 
 
Floats on water 
 
Floats on water 
 
Lightness of the drug. 
 
3. 
Finger print test Impinged in the 
furrows of 
fingers 
Impinged in the 
furrows of fingers 
Indicates fine particles of 
powder. 
 
4. 
 
Lustre  
 
Lustreless  
  
Lustreless  
Change of specific 
metallic character of  
raw material after 
Sublimation. 
 
5. 
 
 
Taste  
 
Nospecific taste 
 
No specific taste 
Change of metallic 
character of raw material 
after Sublimation.  
 
Colour: 
    It is White in colour. The absence of shining indicates there is no free form of metals. 
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Floating on water:   
Bhramasthiram floats on water. It is due to its less specific gravity.  So, it 
possesses the property of padhangam. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24.Floating of water 
  
Finger print test: 
Bhramasthiram impinged on the crevices of finger. This indicates the particles 
are fine and it is in micro size. 
 
 
 
 
 
 
 
 
 
Figure 25.Finger print test of Bhramasthiram 
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Lusterless and tasteless:  
It is lusterless and tasteless. 
Taste:  
No specific taste in the Bhramasthiram.  
 It is due to change of specific mineral character of raw drug material after 
sublimation. 
Table 14.  Physical characterization of Bhramasthiram 
 
Table 15. Results of Physico chemical analysis 
S.no  Parameter Result  
1. pH 4.07 
2. Specific Gravity 0.973 
3. Loss on drying at 105º Celsius Less than 1% 
4. Total ash 1.45% 
5. Water soluble ash Less than 1% 
6. Acid insoluble ash Less than 1% 
7. Partical size Completely passes through sieve no.108 
 
Discussion on physic-chemical analysis 
Solubility 
 Solubility is one of the important parameters to attain desired concentration of 
drug in systemic circulation the required pharmacological response. 
S.no Parameter Result 
1. Colour White in colour 
2. State of the drug Powder 
3. Consistency Fine powder 
4. Solubility Well soluble in water, DMSO. 
Sparingly  soluble in acids (Hcl and H2So4) 
5. Sense on touch Fine  
6. Sense on taste Tasteless 
7. Sense of smell No significant smell is observed 
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 The oral bioavailability depends on several factors including aqueous solubility, 
drug permeability etc. 
 The most frequent causes of low oral bioavailability are attributed to poor 
solubility and low permeability [154]. 
 BA is soluble in major solvent, sparingly soluble in some of the solvents thereby 
it proves its efficiency of solubility in the stomach indirectly, increased in bio-
availability. 
 
pH (potential hydrogen): 
 Bhramasthiram shows acidic ph. 
 The PH is measured of hydrogen ion concentration.It is the measure of the acidic 
or alkaline nature.7.0 is neutral, above 7.0 is alkaline and below is acidic 
  This pH level plays a role in enzyme activity by maintaining the internal 
environment thus regulating the homeostasis. 
 It is also an important factor for drug absorption [155]. Because of the acidic 
nature, the drug is more readily absorbed in an acid medium like stomach which 
enhances the bioavailability of the drug. 
 The result conclude that the oral bioavailability of the drug Bhramasthiram is 
very high. 
Specific gravity 
 The trial drug BA shows specific gravity which is lesser than water. It shows its 
nature of absorption. 
Loss on drying  
 Loss on drying(LOD) gives the total amount of volatile content and 
moisture(water)present in the drug. 
 The stability of a drug and its shelf-life are dependent on moisture content. 
 The low moisture content of BA indicates that it has long shelf life. Moisture 
content increased can adversely affect the active ingredient. But, BA moisture 
doesn’t damage it. So the low moisture content of BA offers maximum microbial 
stability. 
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Ash Values 
Total Ash value 
 Ash is one of the components in the proximate analysis of biological materials 
consisting mainly of salty, inorganic constituents. 
  Low total Ash value of BA indicates the richness of organic substances like 
Sodium, Chloride, Calcium, Potassium. These organic compounds are 
responsible for the mineral supplements and therapeutic effect of 
Bhramasthiram. 
 
Acid insoluble ash 
 Lower the acid insoluble ash value better will be the drug quality [156].  
 The drug possesses a low value (Less than 1%) of acid insoluble ash indicating 
that the preparation did not contain any sand, dust and stones. 
 
Water soluble ash 
 Decreased water soluble ash value (Less than 1%) indicates easy facilitation of 
diffusion and osmosis mechanisms. 
 This nature might be helpful for the better absorption 
 
 
RESULT OF BIO CHEMICAL ANALYSIS 
 
Table 17. Results and acidic radical studies: 
 
 
 
 
 
 
 
S.No Parameters Result 
1 Test for Chloride Positive  
2 Test for Nitrate Positive 
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Table 17. Result of Basic radicals 
 
 
 
 
       
     
The biochemical analysis reveals the presence of chloride, nitrate, potassium, 
calcium, sodium, iron, zinc, copper, mercury. 
 
DISCUSSION: 
Numerous in vitro and vivo studies have suggested favourable effects of several 
vitamins and minerals play vital role on angiogenesis, immunity, cell differentiation, 
proliferation, and apoptosis. 
Nitrates 
Nitrates and nitrites occur naturally in fruit and vegetables, which are regarded 
as an important part of a healthy diet due to the powerful evidence of beneficial health 
effects against cancer. Nitrates play an important role inhibition of tumour growth. [157] 
Calcium: 
More recent studies reveal that calcium and vitamin D3 reduce the aggregation 
of the cancer. Vitamin D, and has been found to participate in regulating apoptosis, cell 
proliferation, and differentiation. Many in vitro and vivo studies have suggested 
favourable effects of calcium on protective effects against many cancer types, including 
colorectal, breast, endometrial, prostate and ovarian. However, in this study, there was 
relationship between reduce the risk of HNC and calcium supplement. [158] 
 
Sl.no Parameter Result  
1 Test for Potassium Positive 
2 Test for Calcium Positive 
5 Test for Sodium Positive 
6 Test for Iron (Ferrous) Positive 
7 Test for Zinc Positive 
10 Test for Copper Positive 
11 Test for Mercury Positive 
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Sodium: 
Sodium has cytotoxic effect. Increased sodium level depresses the cancer cell 
growth. [159] 
Iron:  
 Iron plays an important role in forming complexes with molecular oxygen in 
hemoglobin and myoglobin. These two compounds are general oxygen 
transport proteins in vertebrates. 
  Iron is also important in the process of cellular respiration oxidation and 
reduction in plants and animals.  
 Iron-containing enzymes, proteins and heme prosthetic groups participate in 
many biological oxidations and in transport. [160] 
Zinc:  
Zinc is needed for immune function, wound healing and blood clotting. Some 
experiments show that the Zinc slows the growth of cancer cells in the laboratory.  
Mercury:  
Miles (1926) introduced perchloride of mercury as an antiseptic agent in rectal 
surgery. Goligher et al. (1951), Morgan (1955) and Keynes (1961) introduced the 
technique of flushing the colon and rectum in restorative cancer surgery. Royle (1964) 
described alleged mercury intoxication after using 200 ml of 1: 500 perchloride of 
mercury solution as an anti-cancer agent in renal surgery.  
In all cases the uptake of mercury into the blood has been well below the toxic 
levels defined by Lane (1954). Studies of the urinary output have confirmed the safety 
of this technique. It is therefore concluded that mercury perchloride is a safe anti-cancer 
agent when used as described in large bowel surgery. H Brendan Devlin et al.  
Chloride: 
Chloride has cytotoxic effects. the presence of these radicals helps BA for its 
therapeutic effect. The human CLCA2(calcium activated chloride channels 
regulator 2) enhances chloride in breast cancer cells and reduces pH to 6.7. This 
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observation gives some chloride channels are able to promote apoptosis by reducing 
intracellular pH. 
 CFTR is involved in multiple molecular pathways that modulate cell 
inflammation and apoptotic signaling, so it is possible that mutations in this gene could 
also modify the risk of development of cancer. Mutations in the CFTR gene could also 
have a protective role in some tumours such as lung cancer, melanoma, colon, and 
breast cancer. Furthermore, low expression of CFTR polymorphisms may contribute to 
a reduced risk of prostate cancer. 161] 
Copper 
Copper plays important Role in inhibition of proteasome activity, reduction of 
androgen receptor (AR) protein expression, suppression of cell proliferation, and 
induction of apoptotic cell death were observed in both prostate cancer cell lines treated 
with CQ-Cu complex, but not with CQ alone. Furthermore, animal studies of mice 
bearing human C4-2B xenografts showed that treatment with CQ (10 mg/kg/day) for 
30 days resulted in significant inhibition of tumor growth (66%) compared to the 
control, associated with proteasome inhibition, induction of apoptosis, suppression of 
AR expression, and inhibition of angiogenesis in CQ-treated tumor tissues.[162] 
Copper with iron 
The transition metals such as iron (II) and copper (I) oxidized by H2O2 can 
generate the hydroxyl radical (Fenton Reaction). It is suggested that inhibition of the 
antioxidant enzymes and induction of apoptosis and necrosis in cancer cells caused by 
the ROS production can be a potential treatment for cancer. .[163] 
Potassium 
Overexpression of the G-protein–activated inwardly rectifying potassium 
channel GIRK1 (KCNJ3) is correlated with the presence and degree of breast cancer 
lymph node metastases (Stringer et al., 2001). The  pharmacological inhibition or 
genetic suppression of potassium channels reduces growth in multiple cancer types 
(Pardo and Stühmer, 2014; Urrego et al., 2014. Induction of the expression and activity 
of a constitutively open mutant sodium channel also leads to rapid and robust cell killing 
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in multiple tumor cell types (Lemaire and Halperin, 2009. . In hyperkalemic diseases 
(Parkinson, Addison) have reduced cancer rates. [158] 
 
Zinc 
The regulatory effects of zinc on the NF-kB pathway makes zinc highly 
significant in the prevention of cancer cell growth patterns. Zinc is associated with 
inhibiting angiogenesis in tumor cells as well as the secretion of inflammatory 
cytokines.  
Zinc deficiency can promote a variety of human cancers including esophageal, 
cervical as well as cancers related to the digestive tract, head, and neck. Zinc 
supplementation has been shown to reduce the number of tumours and carcinogenic 
severity.  
Zinc is especially important in prostate, Bladder, skin and breast cancers. Zinc 
is observed to lower inflammation, suppress abnormal tissue growth, and lower the 
incidence of larger skin lesions and more deleterious tumours Zinc has been found to 
stimulate apoptosis in abnormal cells.[164] 
 
AVAILABILITY OF MICROBIAL LOAD 
DISCUSSION: 
These herbo-mineral drug are prepared from plant material they are prone to 
contamination. The contamination of herbo-mineral drugs by micro-organism not only 
cause bio deterioration but also reduces the efficacy of drugs. 
The toxic effects produced by microbes makes the  herbo mineral drugs unfit 
for human consumption because the contaminated drug may develop unwanted disease 
instead of disease being cured.  
Here, the contaminations of Padhangam have been examined by bacterial and 
fungal load. 
 Total bacterial load in 10-4 dilution is 8 and in 10-6 dilution is 1. 
 Total fungal load in 10-2 dilution is nil and in 10-3 dilution is nil.  
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 Here, the contamination of BA is within the WHO norms. Hence, the drug is 
collected, prepared, stored and packed and decontaminated prior to formulation. 
 Table 18. Result of Anti-Microbial load 
 
 INSTRUMENTAL ANALYSIS: 
FTIR (FOURIER TRANSFORM INFRA RED SPECTROSCOPY) 
Fig No: 25.Peak values of FTIR 
           
 
 
Bacteria Fungai 
10-4 10-6 10-2 10-3 
8 1 Nil Nil 
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Table 20. Result of FTIR  analysis of Bhramasthiram  
S.no Absorption peak(cm-1) Stretch  Functional group 
1 3452 N-H 
Stretch 
Alkenes,1º,2ºamines, aromatics 
2 3003 C-H  Aromatics 
3 3556 O-H Alchol,Phenol 
4 2929 C-H Alkenes 
5 1764 C-C Carboxylic acid 
6 1753 C-O Esters,Saturated,Aliphatic 
7 1737 C-O Esters,Saturated,Aliphatic 
8 1725 C-O α,β Unsaturated aldehyde Aliphatics 
9 1710 C-O α,β Unsaturated aldehyde ketones 
10 1691 C-O α,β Unsaturated aldehyde ketones 
11 1678 C-C Alkenes, 
12 1641 C-C  Alkenes, 1º,2ºamines 
13 1630 C-C    Aromatics 
14 1467 C-H  Alkanes 
15 1461 C-C  Aromatics 
16 1442 C-H Alkanes 
17 1426 C-C Aromatics 
18 1665 C-C Alkenes 
19 2002 C-H Alkenes 
20 1658 C-Br Alkyl halide 
21 1582 C-C Aromatics 
22 1483 C-C Aromatics 
23 1401 C-C Aromatics 
24 1325 C-N Aromatic amines 
25 1390 C-H Alkanes 
26 1381 C-H Alkanes 
27 1366 C-H Alkanes 
28 1344 N-O Nitro carbons 
29 1160 C-N Aliphatic amines 
30 945 O-H Carboxylic acid 
31 731 O—C Alkyl halides 
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DISCUSSION: 
 The wavenumbers from 4000 cm-1 to 1500 cm-1 gives details for identification 
of functional group. 
 The wavenumber from 1500 cm-1 to 400 cm-1 provides particulars about 
molecular fingerprint. 
 The above result showed the presence of functional group like alcohols, 
phenols, alkanes, alkenes,1ºamines, aliphatic amines, Alcohol, carboxylic acid, 
ester, ethers, alkyl halides in BHRAMASTHIRAM. 
 They may be responsible for the presence of anticancer action of BA in Oral and 
cervical cancer. 
Phenols  
 Phenols of BA possess highly Anti-oxidant property which enhances its effect 
against the disease. 
 The effect of phenols is currently of great awareness due to their anti-oxidative 
and possible anti-carcinogenic activities. 
 Phenolic compounds play an important role in prevention and treatment for 
cancer and other human disease. Phenolic compounds from medicinal herbs 
contain phenolic acids, flavonoids, tannins, stilbenes, curcuminoids, 
coumarins, lignans, quinones, and others.  
 Various bioactivities of phenolic compounds are responsible for their chemo 
preventive properties (e.g., antioxidant, anti-carcinogenic, or anti-mutagenic 
and anti-inflammatory effects, anti-ulcer, anti-spasmodic and anti-depressant) 
and also contribute to their inducing apoptosis by arresting cell cycle, 
regulating carcinogen metabolism and ontogenesis expression, inhibiting 
DNA binding and cell adhesion, migration, proliferation or differentiation, and 
blocking signaling pathways.[165] 
 A major focus has been the inhibitory effects of phenolic on the stress-
activated NF-KB and AP-1 signal cascades in cancer cells which are regarded 
as major therapeutic targets. 
 Phenolic  compounds can enhance the body's immune system to recognize and 
destroy cancer cells as well as inhibiting the development of new blood vessels 
RESULTS AND DISCUSSION 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 145 
 
(angiogenesis) They also attenuate adhesiveness and invasiveness of cancer 
cells thereby reducing their metastatic potential.  
 Free radicals react easily with phenols to abstract the hydrogen atom from the 
OH group.  
 Phenolic acid and flavonoids also work as reducing agents, free radical 
scavengers and quenchers of single oxygen formation (Ali Ghasemzadehet 
al.2011) 
 Phenols are the most important groups of secondary metabolites and bioactive 
compounds.  
 Hydroquinone is one of the phenolic group inhibits the free radical reactions. 
(cho7Alcohol HTI) They are also an antioxidant substance capable of 
scavenging free superoxide radicals, anti-aging and reducing the risk of cancer. 
Alcohol  
OH group of BA has higher potential towards inhibitory activity against 
microorganisms. 
Alkanes  
Alkane derivate like bis (4-amino-5-mercapto-1,2,4-triazol-3-yl) possess anti-
cancer activity. [166] 
Carboxylic acid 
 Benzene-poly-carboxylic Acid Complex (BP-CI) is a novel anticancer complex 
against human cancer cells. 
 Docosahexaenoic acid (DHA) is an omega-3 fatty acid. Its structure is a 
carboxylic acid (-oic acid) with a 22- carbon chain (Docosa-is Greek for 22) and 
six (hexa-) cis double bounds[167]. 
 DHA was revealed to increase the efficacy of chemotherapy in prostate cancer 
cells and a chemo protective effect in a mouse model was reported. 
 It may also be used as a non- toxic adjuvant to increase the efficacy of 
chemotherapy. 
 In mice, DHA was found to reduce growth of human colon carcinoma cells 
 The cytotoxic effect of DHA was caused by decrease in cell growth regulators. 
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Alkyl halide:      
High proportion of low molecular weight alkyl halides may be weakly 
carcinogenic . 
Aldehydes 
Aldehyde dehydrogenes (ALDH) have great value as prognostic indicator for 
many tumour and cancers including lung, breast ovarian, pancreatic, and colon and 
prostate cancer. ALDH+ cells were capable of regenerating prostate cancer tumor cell 
types in culture and in mouse xenograft. ALDH1A1 caused decreased 
phosphorylation/activation of CHK1 (Ser 317), PARP and Fanconi Anemia DNA repair 
pathway proteins and increased γH2AX levels  in response to carboplatin treatment in 
ovarian cancer cells lines.  
Loss of ALDH1A1 also disrupted the cell cycle profile of ovarian cancer cells. 
These findings indicate that ALDH1A1 enhances activation of DNA strand break 
resistance and repair, suggesting an important role for this protein in resistance to DNA 
damage induced by X-ray irradiation and certain chemotherapeutic drugs..[168] 
Ether: 
 Certain ether lipids such as 1-0-octadecyl-2-0 methyl-rec-glycero-3-
phosphocholine represent a new class of anti -neoplastic agents. These ether 
lipids have been shown to be cytotoxic for a wide variety of tumours. 
 
Aromatics: 
 Aromatics oils contain the chemical constituent limonene and related 
terpenoids, which have been shown to be effective in the treatment of 
cancer. [169] 
Essential oil 
Garlic contain major organo sulphur compounds(OSCs) such as   diallyl sulfide 
(DAS), diallyl disulfide (DADS) and diallyl trisulfide (DATS), these were used as 
experimental materials to investigate their modulation effects on cell viability and cell 
cycle in human liver tumor cells (J5). According to the results of DATS significantly 
decreased the cell viability as compared with the control Garlic and onion contains 
aromatics and essential oil. These oil were responsible for cancer. 
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A recent study found odds ratios among persons with high versus low intakes of garlic 
and onions that correlated with starkly reduced risk of colorectal adenoma [51]. Persons 
who consume a high proportion of garlic decreasing susceptibility to stomach and colon 
cancers [52].  human studies reveal garlic’s anti-tumorigenic potential in stomach, 
colonrectal, breast, lung, and endometrial cancers. Very limited evidence supports a 
relation between garlic consumption and reduced risk of colon, prostate, esophageal, 
larynx, oral, ovary, or renal cell cancers. [170] 
 
XRD DISCUSSION:  
Figure 26:  XRD Image of Bhramasthiram 
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The crystalline structure, the size and shape of the particles are highly dependent 
on the route of synthesis and highlights the efficacy of the drug. The nanomaterial 
characteristics may enhance bio absorption of the drug. XRD pattern of 
Bhramasthiram shows the good crystallinity after sublimation process. The major 
diffraction peaks are identified after XRD analysis BA concluded that HgS in Nano 
crystalline range (21-28) is association with organic molecules probably plays an 
important role in making it biocompatible and nontoxic at therapeutic doses. 
 
Other elements present in BA act as additional supplement and possible helps in 
increase the efficacy of the formulation and provide evidence supporting an 
electrophilic hypothesis of carcinogenesis [171]. 
SEM (Scanning Electron Microscope): 
 The following image is done by magnification via aperture shows maximum depth 
focused. Zoom magnification denotes rapid surveying of the specimen. 
 
             
 
 
 
 
 
 
  
 
Figure 27:  XRD Image of Bhramasthiram 
 
 
98nm 
`110nm 
RESULTS AND DISCUSSION 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 149 
 
 
 
 
 
 
 
 
 
Figure 28:  XRD Image of Bhramasthiram 
 
Discussion on SEM reports 
In addition, the particle size and chemical elements were assessed by Scanning 
Electron Microscope SEM is one of the most widely used instruments in research areas 
The above SEM study shows of microscopic resolution of 5.00kx and 10.00kx showed 
objects of sizes ranging from 20µm.The difference in morphology as evident from the 
micrograph is due to presence of various substances in the sample. Size and surface of 
micro particles can be easily manipulated to achieve both passive and active drug 
targeting. They control the release of drug during the transportation and at the site of 
localization, alters drug distribution in the body and subsequent clearance of the drug 
so as to achieve increased drug therapeutic efficacy thereby bio-availability and 
reduced side effects. 

Advantages of Nanoparticles: 
 Enhancing solubility of hydrophobic drugs. 
 Prolonged circulation time, 
 Preventing undesirable side effects, 
 Minimizing nonspecific uptake, 
 Specific cancer targeting [172] 
 Improving intra cellular penetration 
264nm 
 
125nm 
139nm 
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 The test drug Bhramasthiram contains Nano particles. Thus it enhances 
bioavailability and facilitates absorption. 
Nano technology is a promising way from cancer management towards cancer 
elimination. 
Nano particles have high surface area to that of volume ratio thereby it facilitates 
the attachment of functional groups and binding to tumour cell. 
The particles of Nano size show that the drug can easily enter into the cells at the 
molecular levels to treat the disease rapidly and increase the therapeutic effect.   
 
 
ICP-MS RESULTS OF DISCUSSION 
Table 20.Results of ICP-MS 
S.no Elements Detectable levels 
1. Arsenic BDL 
2. Mercury 0.993mg/L 
3. Cadmium BDL 
4. Lead BDL 
5. Selenium 1.3mg/L 
 
Table 21. AYUSH guidelines limit for heavy metals is as follows 
Heavy metal limit Maximum permissible 
Arsenic (As) 3 ppm (3 mg/kg) 
Cadmium (Cd) 0.3 ppm (0.3 mg/kg) 
Lead (Pb) 10 ppm (10 mg/kg) 
Mercury (Hg) 1 ppm (1 mg/kg) 
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ICP-MS interpretation of BA: 
In the results of heavy metal analysis, the trial drug BA shows Arsenic, 
Cadmium, Lead in below detectable level. But there was a mild presence of mercury in 
a level of 0.993mg/L, because of the content of trial drug. 
 
Mercury: 
Miles (1926) introduced per chloride of mercury as an antiseptic agent in rectal 
surgery. Gallagher (1951), Morgan (1955) and Keynes (1961) introduced the technique 
of flushing the colon and rectum in restorative cancer surgery. 
Royle (1964) described alleged mercury intoxication after using 200 ml of 1: 
500 per chloride of mercury solution as an anti-cancer agent in renal surgery. In all 
cases the uptake of mercury into the blood has been well below the toxic levels defined 
by Lane (1954).  
Studies of the urinary output have confirmed the safety of this technique. It is 
therefore concluded that mercury per chloride is a safe anti-cancer.So  it is in  large 
bowel surgery [173].  
 
Selenium 
Selenium is a powerful mineral.it plays a crucial role in cell defene against 
cancer. Selenium also protect the body against contaminates such as mercury, cadmium 
and silver, speed the elimination of cancer cells and slow tumour growth.  
It also plays a role in recycling antioxidants, such as vitamin e, then lower risk 
of cancer by preventing free radicals from damaging cells. 
Selenium supplement decreased risk and growth rate of tumour. [174] Selenium 
supplement may also be able to halt the growth of polyps in the colon and reduce the 
risk of lung and liver cancer. [175][176] 
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 TOXICOLOGICAL STUDIES 
Acute oral toxicity in rats  
Observation done:  
 Table no: Dose finding experiment and its behavioral signs of Toxicity for 
Bhramasthiram 
Table 22. Acute toxicity behavioral signs of Bhramasthiram 
SL 
 CONTROL 
GROUP 
OBSERVATION 
TEST 
GROUP 
OBSERVATION 
1 Body weight Normal Body weight Normal 
2 
Assessments 
of posture 
Normal 
Assessments 
of posture 
Normal 
3 
Signs of 
Convulsion, 
Limb paralysis 
Normal 
Signs of 
Convulsion, 
Limb paralysis 
Absence  
4 Body tone Normal Body tone Normal 
5 Lacrimation Normal Lacrimation Normal 
6 Salivation Normal Salivation Normal 
7 
Change in skin 
color 
No significant color 
change 
Change in skin 
colour 
No significant color 
change 
8 Piloerection Normal Piloerection Normal 
9 Defecation Normal 
 
Defecation Normal 
 
10 
Sensitivity 
response 
Normal 
Sensitivity 
response 
Normal 
11 Locomotion Normal Locomotion Normal 
12 
Muscle 
gripness 
Normal 
Muscle 
gripness 
Normal 
13 Rearing Mild Rearing Mild 
14 Urination Normal Urination Normal 
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Table 23. Gross behavior of animals 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - + - 
2. 
2000mg 
 
+ - - + - + - - - - - - - - - - - - + - 
1.Alertness 2. Aggressiveness 3. Pilo erection 4. Grooming   5. Gripping   6. Touch 
Response 7. Decreased Motor Activity   8. Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12. Musclerelaxant 13. Hypnosis 14. Analgesia15.Lacrimation 
16. Exophthalmos 17. Diarrhoea 18. Writhing   19. Respiration   20. Mortality 
                              
             Table 24.Body Weight Observation of Acute toxicity in Wister albino rats 
exposed Bhramasthiram 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One    way ANOVA followed by Dunnett’s test) 
 
Table 25.Water intake(ml/day) of Wistar albino rats group exposed to 
Bhramasthiram 
 
               
 
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
1 7 14 
CONTROL 280.2±42.30  281.4 ± 64.12 282.6 ±26.18 
HIGH DOSE 280.3± 21.24 280 ± 4.64 280.4 ± 2.86 
P value (p)* NS NS NS 
DOSE 
 
DAYS 
1 7 14 
CONTROL 61 ± 1.12 62±2.22 63.9±1.14 
High DOSE 62.4±4.4 63±1.14 63.8±2.12 
P VALUE(P)* NS NS NS 
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Table 26.Food  intake (gm/day) of Wistar albino rats group exposed to    
Bhramasthiram 
 DOSE 
 
DAYS 
1 7 14 
CONTROL 56.24±2.22 56.2±7.42 58.4±3.46 
High DOSE 55.6±1.63 55.7±2.62 55.1±5.38 
P VALUE(P)* NS NS NS 
N.S- Not Significant, **(p >0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
Acute toxicity discussion: 
 In the acute toxicity study, the rats were treated with different concentration of 
BHRAMASTHIRAM from the range of 2mg/kg to 2000mg/kg. 
 However, behavioural changes, body weight, water intake, food intake does not 
produce much significant thus the result is not significant.  
 These results showed that a single oral dose of the extract showed no mortality 
of these rats even under higher dosage levels indicating the high margin of 
safety of this extract. 
  In acute toxicity test drug BHRAMASTHIRAM was found to be non-toxic at the 
dose level of 2000mg/ kg body weight.  
REPEATED DOSE 28-DAYS ORAL TOXICITY STUDY OF 
BHRAMASTHIRAM  
Table27. Body weight of wistar albino rats group exposed to 
Bhramasthiram 
NS- Not Significant, ** (p> 0.01)<,*(p >0.05), n = 20 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
DOSE 
 
DAYS 
1 15 28 
CONTROL 280.2±10.03  280.2 ± 10.24 280.6 ± 24.61 
LOW DOSE(2 mg) 281.6 ± 11.20 281.5 ± 16.14 280.8± 52.10 
MIDDOSE(10 mg) 280.8 ±12.10 280.9 ±18.9 281.7 ± 8.60 
HIGH DOSE(20 mg) 280.5± 7.10 280.8 ± 8.30 280.9 ± 04.32 
P value (p)* NS NS NS 
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Table28: Water intake (ml/day) of Wistar albino rats group exposed to 
Bhramasthiram 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n =20 values are mean ± S.D (One    
way ANOVA followed by Dunnett’s test 
 
 
Table 29. Food intake (gm/day) of Wistar albino rats group exposed to 
Bhramasthiram 
 
 
 
 
 
 
 
 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 20 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
 
 
 
DOSE 
 
DAYS 
1 15 28 
CONTROL 98.4 ± 1.25 98.3 ± 1.02 98.8±2.30 
LOW DOSE(2 mg/kg) 98.2 ± 6.40 98.3 ± 1.50 98.5±1.14 
MID DOSE(10 mg/kg) 98.8  ± 3.40 98.9 ± 9.06 98.9 ± 6.5 
HIGH DOSE(20 mg/kg) 99.6 ± 1.30 99.5 ± 2.20 99.9±6.52 
P value (p)* NS NS NS 
DOSE 
 
DAYS 
1 15 28 
CONTROL 190.4 ± 2.25 191.03±6.14 191.3±4.20 
Low dose(2mg/kg) 191.2±1.12 191.2±1.02 191.4±4.14 
Mid dose(10mg/kg) 190.9 ± 3.65 190.7 ± 2.05 190.5 ± 8.23 
High dose(20mg/kg) 189.6 ± 1.20 189.2±4.21 189.5±6.40 
P value (p)* NS NS NS 
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Table 30. Haematological parameters of Wistar albino rats group exposed to 
Bharamasthiram 
Category Control Low dose 
(2mg/kg) 
Mid dose 
(10mg/kg) 
High dose 
(20mg/kg) 
P 
value 
(p)* 
Haemoglobin(g/dl) 10.2±0.24 10.10±0.36 9.11±0.26 8.28±0.26 * 
Total WBC (×103   l) 14.52±0.05 14.62±0.13 14.68±0.07 15.40±6.16 N.S 
Neutrophils(%) 26.15±0.01 27.11±0.22 27.12±0.26 28.20±2.30 N.S 
lymphocyte (%) 79.10±1.06 81.23±1.02 82.13±1.03 82.26±4.46 N.S 
Monocyte (%) 0.9±0.03 0.8±0.05 0.8±0.06 0.9±0.07 N.S 
Eosinophil(%) 3.2±0.04 3.6±0.06 3.7±0.08 3.8±0.08 N.S 
Platelets cells103/µl 604.16±2.66 601.10±4.26 594.09±3.24 590.06±4.6 * 
Total RBC 106/ µl 8.49±0.01 8.47±0.50 7.07±0.25 6.04±0.32 N.S 
PCV% 37.65±0.6 38.30±1.32 38.72±0.5 38.56±2.24 N.S 
MCHC g/dL 38.4±1.42 38.26±0.47 38.16±0.43 38.34±2.24 N.S 
MCV fL(µm3) 54.04±4.60 53.06±3.43 53.05±2.43 53.34±2.14 N.S 
N.S- Not Significant, ** (p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One way  
ANOVA followed by Dunnett’s test) 
 
 
Table 31. Liver Function Test of Wistar albino rats group exposed to Bhramasthiram 
Treatment 
T Bilirubin 
(mg/dL). 
Triglyceride
s (mg/dL) 
Cholesterol 
(mg/dL) 
Protein 
SGPT/AL
T (U/L) 
ALP 
(U/L) 
Control 0.50±0.07 66.24±7.74 66.61±4.45 7.14±0.12 89.64±6.57 215.08±10.48 
Low dose 
(2mg/kg) 
 
0.57±0.16 68.34±6.22 64.10±6.46 6.84±0.24 91.11±3.39 230.46±1.68 
Mid dose 
(10mg/kg) 
0.58±0.44 68.22±6.33 63.03±0.44 6.57±0.42 93.65±5.46 231.36±3.99 
High dose 
20mg/kg) 
0.65±0.15 70.24±9.32 59.12±2.43 6.36±0.42 94.31±1.23 233.40±6.96 
N.S- Not Significant, ** (p < 0.01), *(p <0.05), n = 20 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
RESULTS AND DISCUSSION 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 157 
 
 
Table32. Bio chemical Test of Wistar albino rats group exposed to 
Bhramaasthiram 
Biochemical 
Parameters 
Control Low dose 
(2mg/kg) 
Mid dose 
(10mg/kg) 
High dose 
(20mg/kg) 
P 
value 
(p)* 
Glucose (r) (mg/dl) 123.64±10.24 123.08±9.24 123.32±9.14 123.4±2.47 N.S 
T.cholesterol(mg/dl) 66.61±4.45 65.10±6.26 66.05±5.23 67.12±2.43 NS 
Trigly(mg/dl) 66.24±7.74 68.34±6.22 68.34±6.22 68.34±6.22 N.S 
LDL 72.4±2.14 72.13±2.54 70.66±3.12 70.42±10.2 NS 
VLDL 11.24±1.30 11.20±2.21 11.10±1.21 11.16±12.16 NS 
HDL 27.14±6.12 28.42±2.30 28.46±3.20 29.17±2.14 NS 
Ratio 1(T.CHO/HDL) 3.41±1.16 3.32±1.40 3.36±1.36 3.54±2.03 NS 
Ratio 2(LDL/HDL) 1.92±1.14 1.95±1.12 1.93±1.16 1.96±09.02 NS 
Albumin (g/dL) 5.43±0.16 5.49±0.52 5.48±0.46 5.46±9.48 NS 
NS- Not Significant** (p < 0.01), * (p<0.05), n = 20 values are mean ± S.D (One way ANOVA  
followed by Dunnett’s test) 
 
 
Table 33. Renal function test of Wistar albino rats group exposed to 
Bhramasthiram 
Parameters Control Low dose 
(2mg/kg) 
Mid dose 
(10mg/kg) 
High dose 
(20mg/kg) 
P 
value 
(p)* 
Urea (mg/dl) 26.70±0.19 27.60±0.26 
27.36±0.35 
28.18±1.24 N.S 
Creatinine(mg/dl) 0.22±0.02 0.38±0.04 0.57±0.06 0.63±0.07 N.S 
Bun(mg/dl) 21.10±0.20 23.16±0.90 25.18±0.90 27.74±1.22 NS 
Uric acid(mg/dl) 6.04±0.34 7.03±0.51 7.35±0.90 8.42±0.20 N.S 
NS- Not Significant, ** (p < 0.01), * (p <0.05) , n = 20 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Sub-acute toxicity discussion: 
Results 
Observations 
Overall observations were similar in both sex rats.these studies were done with 
certain doses like low dose(2mg),5x(10mg),10x(20mg).The values are in non 
significant. 
Clinical signs of toxicity 
No clinical signs of toxicity were observed. 
Mortality 
No mortality was observed after 28 days repeated dose administration of BA. 
All animals survived to study termination period. 
Body weight 
Increased in body weights were compared to their initial weight. No significant 
alterations were observed in body weight. 
Food and water consumption 
No effect of treatment was noted with in the the non-significant in result. 
Physiological activities 
 No changes in the general behaviours 
Blood analysis 
a. Hematology 
No treatment related effects were observed. However, there is a slight variation 
in the result. 
b. Biological parameters 
c. There is a slight difference has been noted but it is normal within the limit. No 
treatment related effects were observed  
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d. Histological examination 
 Histopathology studies were carried out on liver, kidney and spleen and 
recorded. Blood samples for hematological and blood chemical analyses 
were taken from common carotid artery.  
 All rats were sacrificed after the blood collection. The internal organs and 
some tissues were observed for gross lesions. All tissues were preserved in 
10% neutral buffered formaldehyde solution for histopathological 
examination 
 Histological examination of organs did not show as much pathological 
changes. 
Sub-acute toxicity discussion: 
 The repeated 28days oral toxicity studies of BA showed did not produced any 
toxicity signs in wistar albino rats. Daily administration of BA at different doses 
2mg/kg,10mg/kg,20mg/kg for 28 days was tolerated by the rats without any 
mortality and morbidity, indicates the drug tolerance. Dose selected for the Sub 
acute toxicity study was 10mg, 20mg/kg of BHRAMASTHIRAM. 
 
 No physical changes were observed throughout the doing period. No mortality 
was observed during the whole experiment.  
 
 
 No abnormal deviations were observed. No significant changes were observed 
in the values of different parameters studied when compared with controls and 
values obtained were within normal biological and laboratory limits. 
 
 No significant changes in red blood cell (RBC), white blood cell (WBC), packed 
cell volume (PCV), Erythrocyte sedimentation rate (ESR) in all the treated 
groups as compared to respective control groups. 
 
  Hence the herbo mineral formulation of BA can be considered to be safe drug 
for prolonged duration use as reveled by toxicological studies. 
 
RESULTS AND DISCUSSION 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 160 
 
Discussion 
The above studies show histopathology slides of sub-acute toxicity. Even 
though there is less toxic effect seen in the vital organs. after administration of the test 
drug Bhramasthiram thus the safety of the drug is revealed, so that it can be 
administered for long time without any side effect. 
 PHARMACOLOGICAL ACTIVITIES 
Table 34. ANTI-CANCER ACTIVITY OF CELL LINE- HeLa CELL LINE 
IC 50 BA shows the 50% incubatory concentration at 50μg/ml.Graph-1 
Graph-1 
Sample  
Concentration 
(µg/mL) 
OD value 
I 
OD value 
II 
OD value 
III 
Average 
OD 
Percentage 
Viability 
Control 0.5898 0.6278 0.6013 0.6063 100.00 
Sample code: BA 
6.25 
0.5812 0.5836 0.5847 0.5832 96.18 
12.5 
0.5033 0.5064 0.5013 0.5037 83.07 
25 
0.4919 0.4926 0.4933 0.4926 81.25 
50 
0.2929 0.2984 0.2956 0.2956 48.76 
100 
0.2829 0.2874 0.2756 0.1535 38.67 
96.18
83.07 81.25
48.76
38.67
10
20
30
40
50
60
70
80
90
100
6.25 12.5 25 50 100
%
 O
F
 V
IA
Y
A
B
IL
Y
 
CONCENTRATION
Anti Caner Ativity of HeLa Cell line
RESULTS AND DISCUSSION 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 161 
 
    
Table 35. ANTI-CANCER ACTIVITY OF CELL LINE- KB CELL LINE 
IC 50 BA shows the 50% incubatory concentration at 50μg/ml. 
 
 Graph-2 
  
Sample  
Concentration 
(µg/mL) 
OD value I OD value II OD value III Average OD Percentage 
Viability 
Control 0.3859 0.3922 0.3642 0.3808 100 
Sample code: BA 
6.25 
0.2852 0.2919 0.2888 0.2886 75.80 
12.5 
0.2259 0.2437 0.2361 0.2352 61.77 
25 
0.2143 0.2126 0.2219 0.2163 56.79 
50 
0.1736 0.2040 0.1820 0.1865 48.98 
100 
0.1626 0.1685 0.1659 0.1657 43.50 
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Graph -1 and 2 shows the drug dose and % of Inhibition of HeLa, KB cells after 
the Bhramasthiram extract treatment. It can be observed by the result of MTT assay 
that the IC dose of Bhramasthiram is 50µg/ml. As the dose increases the HeLa cell & 
KB cell viability decreases. And also It was found that the % of growth inhibition 
increasing with increasing concentration of Bhramasthiram steadily up to 6.25 µg/ml 
on HeLa cell line (Table1&2-and graph -1, graph2) and that IC value on HeLa cell line 
was 50 and R value was 0.6063 and IC value on a KB cell line was 50 and R value was 
0.3808 
 
Cytotoxic effect by MTT assay: 
 MTT is a yellow water soluble tetrazolium salt. Succinate dehydrogenase, a 
mitochondrial enzyme in living cells, cleaves the tetrazolium ring, converting 
the MTT to an insoluble purple formazan. therefore, the amount of formazan 
produced is directly proportional to the number of viable cells. 
 
 This assay is based on the metabolic reduction of 3- (4, 5- dimethylthiazol-2-yl) 
-2, 5-difeniltetrazol (MTT) by mitochondrial enzyme succinate dehydrogenase 
in a coloured compound blue (formazan), allowing to determine the 
functionality of the mitochondrial treated cells.  
 
 This method has been widely used to measure survival and cell proliferation. 
The amount of living cells is proportional to the amount of formazan produced.  
 
 Cell lines derived from NCCS, Pune were free from any kind of bacterial and 
fungal contamination. 
 
 To determine the cytotoxic effect of novel Siddha formulation Bhramasthiram 
against the Hela and KB cell lines. The experiment was screened at different 
concentrations to determine IC50 using MTT assay a chart was plotted using 
the % cell viability in Y axis and concentration of the test sample in X-axis. 
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Bhramasthiram at different doses (6.5-100µg in100 µl of 5% MEM) was 
administered for 24 hrs. It was found that the number of cells decreases as the dose 
increases and at approximately 50 µg/ml dose of extract, 50% of the cells (Hela,KB) 
were less as compared to normal control as shown in figure (). The percentage of cells 
viability was determined by calculating the O.D of treated against the control. Reading 
optical density (OD) is performed in a spectrophotometer at a wave length of 540nm. 
Comparison values are made on a basis of 50% inhibition of growth (IC50) in treated 
cells with specific agents. Results are tabulated in Table34&35- and schematically 
represented in Graph-1 &2  
 
Analysis of Membrane Morphological Characteristics by Haematoxylin /Eosin (H/E) 
Staining  
Morphological changes such as changes to the cell membrane, loss of 
membrane asymmetry and cell shrinkage, are the early stage of apoptosis was analyzed 
by H/E staining. The IC dose (50µg/ml) treated cancer cells show features of apoptosis 
whereas treated with same amount of dose, to normal treated cells appeared without 
any significant changes.   
 
 Since the discovery of the Cisplatin anti-tumor activity, great efforts have 
focused on the rational design of metal-based anticancer agents that can be 
potentially used in cancer chemotherapy.  
 Over the last four decades, a large number of metal complexes have been 
extensively investigated and evaluated in vitro and in vivo . 
 The key focuses of these studies lie in finding novel metal complexes which 
could potentially overcome the hurdles of current clinical drugs including 
toxicity, resistance and other pharmacological deficiencies. 
 Herbo-mineral and Minerals compounds have been used in medicine for several 
thousands of years.  
 The medicinal uses and applications of metals and mineral complexes are of 
increasing clinical and commercial importance. Monographs and major 
reviews, as well as dedicated volumes, testify to the growing importance of the 
discipline [177]. 
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 The field of inorganic chemistry in medicine may usefully be divided into two 
main categories: firstly, ligands as drugs which target metal ions in some form, 
whether free or protein-bound; and secondly, metal-based drugs and imaging 
agents where the central metal ion is usually the key feature of the mechanism 
of action. 
 Several pieces of evidence indicate that iron deprivation could be an excellent 
therapeutic approach:  
(i) dietary iron restriction markedly decreases tumour growth in rodents. 
(ii)  The antibodies which block transferrin-binding to cellular receptors 
inhibit cancer cell growth in vitro and in vivo [178][179] 
 Oncologists and scientists engaged in the research of cancer treatments should 
conduct a comprehensive study on the efficacy of mercuric perchloride which 
is being used as an anti-cancer drug in the age old Siddha system [180]. 
 Three years of research has shown that metal (mercury, arsenic and copper) 
based Siddha drug is a safe alternative for Cisplatin therapy or arsenic trioxide 
in selected cases of cancer treatments wherein the patients cannot bear the 
adverse effects. He found that mice treated with Siddha drugs showed better 
health than what did in cisplatin therapy in terms of appetite, haemoglobin, red 
blood cells and white blood cells [181]. 
 
 Miles (1926) introduced perchloride of mercury as an antiseptic agent in rectal 
surgery. Goligher (1951), Morgan (1955) and Keynes (1961) introduced the 
technique of flushing the colon and rectum in restorative cancer surgery.  
 Royle (1964) described alleged mercury intoxication after using 200 ml of 1: 
500 perchloride of mercury solution as an anti-cancer agent in renal surgery. In 
all cases the uptake of mercury into the blood has been well below the toxic 
levels defined by Lane (1954).  
 Studies of the urinary output have confirmed the safety of this technique. It is 
therefore concluded that mercury perchloride is a safe anti-cancer agent used as 
described in large bowel surgery.  
 Studies have shown that phenols present in herbal plants such as Trianthema 
decandra, pistia stratiotes, oxalis cornuculata have cytotoxic effects on 
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different tumours. Mechanisms of these compounds are carried out through 
apoptosis.  
 Thus from the above study, it is evident that the cytotoxic property of 
Bhramasthiam may be due to the synergistic interactions between the mineral 
complex and plant derivatives. 
 
ANTI-TUMOUR ACTIVITY 
Discussion 
To test the effect of on the growth kinetics, SiHa cells were treated with different 
concentrations of BA:0,10,20,40 and 80μg/ml and were grown for 24,48 and 72h. At 
the end of each treatment, the cells were stained with trypan blue, and the viable cells 
that excluded the dye were counted. It was observed that there was a dose-dependent 
decrease in the growth kinetics of BA treated cells compared to the untreated control 
cells (Fig.10A). 
 
  Moreover, it was found that at around 80 μg/ml concentration of BA treatment, 
there was a significant decrease (~2-fold) in the growth kinetics compared to that 
observed in the untreated control cells (p≤0.05 for 24h; p≤0.001 for 48h and 72h). 
 
This was further confirmed by colony forming assay wherein at a lower seeding 
density, cells were treated with different concentrations of BA for one week. At 80 
μg/ml concentration of BA, the cells exhibited relatively lesser colonies compared to 
the control cells (Fig.10B).  
 
Consistent with the slow growth rate, it was observed that BA extract induced 
a dose-dependent decrease in the number of soft agar colonies.  Interestingly, at 80 
μg/ml BA treatment, the number of soft agar colonies was reduced by ~3-fold (p ≤ 
0.001) compared to the untreated control cells (Fig10C.). 
 
All these data indicated that BA altered the growth kinetics of SiHa cells in a 
significant manner that could be a positive indicator for testing its anti-tumor activity 
in cervical cancer cells. 
RESULTS AND DISCUSSION 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM Page 166 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28-ANTI-TUMOUR ACTIVITY OF BA 
Figure 28  BA alters growth kinetics of cervical cancer cells. (A) The cells were treated 
with various concentrations (0-80 µg/ml) of BA for 24, 48 and 72 h, and the number 
of viable cells were counted using the trypan blue dye exclusion assay. The growth 
kinetics has been presented in the figure taken at different time points. Data represent 
mean ± SD of five different experiments. . (B) The cells (1 × 103/ml) were grown in 
6-well plates and treated with various concentrations (0-80 μg/ml) of BA for one 
week. The cells were then stained with crystal violet and photographed. The 
experiments were repeated five times. (C) The cells (5 × 103) were treated with 
various concentrations (0-80 μg/ml) BA and grown in soft agar for 10 days, and the 
colonies were counted. Colonies were counted from at least 10 different areas, and 
the average of each is plotted. The data rep- resent mean ± SD of five independent 
experiments.  
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Apoptosis 
To further elucidate the anti-cancer mechanism of BA in cervical cancer cells, 
we performed apoptosis studies. After treating t h e  cells with different doses of BA, 
the percent apoptotic cells were assessed by Annexin V-FITC and propidium iodide 
staining, followed by flow cytometric analysis(Figure.26). It was observed that at 
concentrations of 40 and 80μg/ml BA,  there was a significant increase in the 
percentage of cells undergoing apoptosis. Interestingly at 80μg/ml BA 
concentration, there was ~2.6-fold(p≤0.001) increase in the population of cells 
undergoing apoptosis compared to the untreated control cells. 
     Figure.29 Apoptosis 
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Figure 29 BA induces apoptosis in SiHa cells through dysregulation of 
mitochondrial membrane potential. (A) SiHa cells were treated with different 
concentrations of BA (0-80 µg/ml) followed by Annexin V-FITC and PI staining to 
analyze the effect of BA in apoptosis. This was determined by FACS analysis showing 
the percentage of early (lower right quadrant) and late (upper right quadrant) apoptotic 
cells. (B) Flow cytometric analysis of the rapid calcium release in SiHa cells. 
Conclusion 
Bhramasthiram showed promising anticancer activity in oral cancer cell lines 
killing cancer cells by apoptosis. Further, Bhramasthiram demonstrated promising anti-
tumor activity in the growth kinetics of HeLa and SiHa cell in without significant 
toxicity to normal tissues underscoring the pre-clinical efficacy of Bhramasthiram, as 
a potential anti-cancer therapeutic candidate for  cancer management. 
ANTIOXIDANT ACTIVITY: (IN VITRO STUDY) 
 Antioxidants are substances that can prevent or slow damage to cells caused by 
free radicals, unstable molecules that the body produces as a reaction to 
environmental and other pressures. They are sometimes called "free-radical 
scavengers." 
 Antioxidants are said to help neutralize free radicals in our bodies, and this is 
thought to boost overall health. 
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 Antioxidants can protect against the cell damage that free radicals cause, known 
as oxidative stress. 
Free radicals and their chemical reactions: 
 A free radical can be defined as any molecular species capable of independent 
existence that contains an unpaired electron in an atomic orbital. The presence 
of an unpaired electron results in certain common properties that are shared by 
most radicals.  
 Radicals are weakly attracted to a magnetic field and are said to be 
paramagnetic. Many radicals are highly reactive and can either donate an 
electron to or extract an electron from other molecules, therefore behaving as 
oxidants. As a result of this high reactivity, most radicals have a very short half-
life (10−6 seconds or less) in biological systems, although some species may 
survive for much longer. 
 Oxidative stress has been linked to heart disease, cancer, arthritis, stroke, 
respiratory diseases, immune deficiency, emphysema, Parkinson's disease, and 
other inflammatory or ischemic conditions. 
Result: 
Table 36. DPPH assay on BHRAMASTHIRAM 
Concentrations (µg/ml) Absorbance Percentage of inhibition 
Bhramasthiram Drug Standard Drug 
 
Standard 
Control 0.3896 1.7983 - - 
12.5 0.3103 1.4044 20.35 21.90 
25 0.2546 1.0782 34.65 40.04 
50 0.1754 0.7121 54.98* 60.40** 
100 0.1512 0.2921 61.19 83.75 
200 0.1344 0.0692 65.50 96.15 
  *µg/ml: microgram per millilitre. Drug:   BA (12.5-200µg/µl). Standard: Ascorbic  
   acid   (10mg/ml DMSO) 
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IC50 Value – GC- 165.728µg/ml (Calculated ED50 PLUS V1.0 Software) 
 
Discussion on Antioxidant activity in DPPH assay: 
 DPPH assay were used for the determination of antioxidant activity of the 
different extracts. DPPH stable free radical method is an easy, rapid and 
sensitive way to survey the antioxidant activity of BA extract.   
 The antioxidant molecules can quench DPPH free radicals by providing 
hydrogen atom or by electron donation and a colorless stable molecule 1, 1 
diphenyl-2- picrylhydrazil is formed and as a result of which the absorbance at 
517nm of the solution is decreased.  
 
 In the present study, the Bhramasthiram extract was analyzed was able to 
decolorize DPPH and the free radical scavenging activity was expressed as the 
percentage decrease in absorbance and Ascorbic acid (10 mg/ ml DMSO) was 
used as a reference and result was expressed as the percentage decrease in 
absorbance.  In the present study, the extract of BA was found to possess 
concentration dependent scavenging activity on DPPH radicals.  
 
 The values of DPPH free radical scavenging activity of the BA extract were 
given in (Table.33) expressed in the percentage. The extract of BA showed the 
highest DPPH scavenging activity (65.50%) at 200µg/ml and the lowest 
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percentage of inhibition (20.35%) at 1.25µg/ml.  Ascorbic acid (Standard) 
showed highest percentage of inhibition (96.15%) at 200µg/ml and the lowest 
percentage of inhibition (21.90%) at 1.25µg/ml.  
 
 This indicated that % of inhibition increased with increase in concentration of 
both the standard and BA extract. The BA extract has less free radicle scavenging 
activity compared to the standard. From the present study, it was concluded that 
the BA extract has good anti-oxidant activity at higher concentrations. 
 
 It is known that oxidative stress induced cell damage not only through damage 
to proteins, lipids and DNA. It may also alter signaling pathways redox sensitive 
to changes involved in the response of apoptosis.  
 
 The antioxidants are currently the subject of many studies because, in addition 
to some interest in the preservation of comestibles, they could be useful in the 
prophylaxis and treatment of diseases in which oxidative stress is implicated. 
Many studies realized on natural products have proven that they are especially 
phenolic compounds who are responsible for their antioxidant activity. 
 
 Several studies have shown the link between the traditional drug formulations 
rich in antioxidants and the incidence of certain diseases such as cancer, 
diabetes, heart disease and other diseases related to aging.  
 
 Phenolic compounds could prevent cancer by the action antioxidant and / or the 
modulation of several functions of proteins. Phenolic compounds can prevent 
carcinogenesis by affecting the molecular events in the triggering, promotion 
and progression stages. 
 
 Some phenolic compounds (phenolic acids, flavonoids, quinones, coumarins) 
have proved an effective antioxidant activity and also had anticancer activities/ 
anti-carcinogenic/ anti-mutagenic. 
 
 Here, the reactive oxygen species (ROS) may be the triggers apoptotic process. 
In recent years they have been described numerous properties of these 
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compounds such as the ability to inhibit cell cycle, proliferation cellular and 
oxidative stress, and induce detoxification enzymes, apoptosis, and stimulate 
the immune system. 
 
From the present study, it was concluded that the BA extract has a marked low level 
antioxidant activity at higher concentrations. Antioxidant capacities of the extracts were 
expressed in terms of IC50 value of the extracts and low IC50 value corresponds to a 
high antioxidant capacity. 
Hence the in vitro study of DPPH assay free radicle scavenging activity shows a 
less antioxidant property and IC50 value (90.5584µg/ml g/ml) of the extracts are high 
in level. So it need different assays and in vivo studies to evaluate the antioxidant 
property of BA. It is therefore hypothesized that Bhramasthiram of its antioxidant 
power could “to repair" Cancer cells. 
 
 
CONCLUSION 
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6. CONCLUSION 
The most ancient wisdom and science of life, Siddha, has a long history and its 
basic principles are valid even today. Less or minimal effectiveness and severe toxic 
side effects of current cancer therapies draw the global attention towards herbo-mineral  
medicine to arrest the insidious nature of this disease. In addition, more than 80% of the 
world’s population cannot afford modern medicines. Western medicine provides 
symptomatic treatment and largely ignores the underlying conditions, whereas Siddha 
medicine treats the disease from root of origin. Siddha plays an important 
complementary role to western medicine in treatment efficiency.  
 
Cancer is the second most common malignancy found among men and women 
worldwide and some are highly resistant to radiotherapy. The other chemotherapy 
drugs also deliver intolerable side effects which are worse than the disease. This 
paved way for a novel anticancer drug which cures cervical, oral cancer in a non-
invasive way. 
 
           The intention of this study is to provide a solution for the above need. For a 
nonviolent anticancer drug to cervical, oral cancer, Bhramasthiram was chosen from 
the Siddha literature as a trial drug “The pharmacopeia of Siddha Research 
Medicines” written by Dr.M. Shanmugavelu, & Dr.G.D. Naidu L.I.M.,H.P.I.M.  
to validate the safety and its efficacy of drug to treating Anti-cancer,anti-tumour,and 
anti-oxidant activity  in animal model. 
 
The trail drug was subjected various studies through which the efficacy of the 
drug is proved. 
           The procedure for drug preparation and its techniques for standardization 
revealed GMP. The trial drug BA has satisfied all parameters of testing protocol for 
Padhangam which was assigned by AYUSH. It showed the accurate production and 
potency of Bhramasthiram. 
            Physico-chemical analysis the drug shows revealed better bio-availability and 
richness of its mineral content. Favouring this study the biochemical analysis shows 
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the presence of inorganic matters sodium, potassium, calcium, zinc, iron, chloride are 
influences the anti-cancer activity. 
FTIR analysis revealed the presence of O-H Groups C-C,N-H group,  which 
indicates the functional groups present in the sample.FTIR interprets the moleculate 
structure of the sample. 
SEM analysis showed the size of the drug in micro particles which denotes 
that the trial drug could have potent drug delivery. 
XRD analysis disclosed the percentage of elements presence in the drug. 
Heavy metal analysis shows Mercury present with in the permissible amount, 
and other elements such as Lead, Cadmium, Arsenic are absent which indicates the 
purity of the drug and also the safety of the drug. 
            . 
            The anti-microbial activity of trial drug was also considered for its potential. 
       
      Under OECD guidelines, the acute and 28 days repeated oral toxicity studies 
proved the safety of Bhramasthiram at particular dose level. It is very useful in 
therapeutic dose determination. 
 
            The pharmacological studies concluded that the drug are effective has 
anticancer effect on HeLa cell lines and KB cell lines anti-tumour effect on SiHa cell 
lines and quantitative measurement of antioxidants by DPPH assay 
            Factors like safety, efficacy, long self like, bio-availability, presence of 
significant elements, anions and cations and minerals favouring the activity justifies 
the main perspective of this study. 
 
            Bhramasthiram anti-cancer effect could be validated scientifically. Due to its 
Non-toxic anti-cancer effect, it would benefit the health community and the world. 
 
  
SUMMARY 
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7. SUMMARY 
           Trial drug Bhramasthiram was selected from the classic literature “The pharmacopeia 
of Siddha Research Medicines” written by Dr.M.Shanmugavelu, L.I.M.,H.P.I.M. for its anti-
cancer, anti-tumour, anti-oxidant activities. 
           The dissertation started with an introduction explaining about the Siddha concept, 
prevalence of cervical, oral cancer and role of the test drug in treating cervical, oral cancer. 
The ingredients of the test drug was identified and authenticated by siddha experts. The drug was 
prepared as per the procedure and subjected to various studies to reveal its potency and 
effectiveness against the disease. 
The physico chemical shows potency of the Bhramasthiram. 
The biochemical analysis reveals the presence of chloride, Nitrate, Potassium, Calcium, 
Sodium, Iron, Zinc, Copper, Mercur.Thus from these results we come to know the effectiveness 
of the drug is due to the presence of these constituents and it has a synergistic effect in acting 
against the disease. 
The FTIR analysis construe the result that showed the presence of functional groups like 
alcohol, alkanes, esters, aromatics amines which might be responsible for the presence of anti-
cancer action of the drug. SEM picture described its morphology and the particle size. 
 Toxicological study was made according to OECD guidelines comprising both acute and 
repeated oral dose 28days toxicity studies in wistar albino rats. It showed the safety of the 
drug which attributes its utility in long time administration. 
 
 Pharmacological studies were completed. It revealed the anti-cancer, anti-tumor and anti-
oxidant activities of Bhramasthiram. 
 Results and discussion gives the essential validations to prove the potency of the drug. 
 Conclusion gives a Compiled form of the study and explains the synergistic effect of all 
the key ingredients and activities that supports the study.  
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FUTURE SCOPE  
 
 
8. FUTURE SCOPE 
 
The trial drug Sadhakuppai Chooranam has its own potency in treating Anxiety, 
Depression and Catalepsy in animal model which has been established in this study. An 
incredible action of this drug value against the disease of Neurosis has been revealed 
from this study of Sadhakuppai  Chooranam. This must be implicated in the future 
clinical studies and preclinical chronic toxicity studies. So it could be used worldwide in 
treatment of Neurosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ANTI – ANXIETY ACTIVITY OF SKC   137 
 
 
 
 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 177 
 
 
177 
 
BIBILOGRAPHY 
1. Arthur C. Guyton et al., Text book of medical physiology Ninth 
edition,1996,prism books pvt ltd .Baavangudi, Bangalore. Page no: 
2. Cooper GM, Sunderland(MA) The Development and cause of cancer. ISBN-
10: 0-87893-106-6 cancer available at 
https://www.ncbi.nlm.nih.gov/books/NBK9839. 
3. Head and Neck cancer available at http://www.cancer.gov/types/head-and-
neck/head-neck-fact-sheet. 
4. ICO Information Centre on HPV and cancer (Summary Report 2014-08-22). 
Human Papillomavirus and Related Diseases in India. 2014 
5. Nawal M Nour,obstetrics gynecology.rev obstet gynecol.2009;2(4) page no 
240-244.PMID:20111660. 
6. Schiffman M, Castle P E, Jeronim I, Rodrigue AC,Wacholde S.Human 
papillomavirus and cervical cancer. Lancet.2007;370:890-907. 
7. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV 
Information Centre). Summary report on HPV and cervical cancer statistics in 
india 2007.Available at:http://www.WHO.int/hpvcentre. 
8. All cancer excluding non-melanoma skin cancer available at 
http://globocan.iarc.fr/pages/fact_sheets_cancer.aspx 
9. Cancer statistics. available at http://ocf.org.in/professional/Incidence and 
Prevalence.aspx 
10. http://oralcancerfoundation.org/treatment/chemotherapy 
11. http://www.cancerresearchuk.org/about_cancer/type/mouth_cancer/treatment/
chemotherapy/drugsformouthcancer. 
12.  Sathishkumar T, Putrunoyum Siddha maruthuvamum, Thamarai 
noolagam,Publication 292, Chennai, 2006:106. 
13. Kannusamy Pillai,Pathartha guna villagam,Edition-2003,Jeyam 
Print,Madhurai-001,Pageno 527. 
14. N.Kandasamy Pillai, History of Siddha Medicine,Thamarai noolagam,Vol-12th 
edition,Page no:68. 
15. Kannusamy Pillai,Pathartha guna sindhamani, Edition-2003,Jeyam 
Print,Madurai-001,Page no :523. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 178 
 
 
178 
 
16. Sambasivam pillai dictionary,siddha medical dictionary,2011 ii edition dept of 
indian medicine based on siddha &Indian Medical Sciences. 
17. Shailaja R,Concept of Nano Technology in siddha medical literature,world 
journal of pharmaceutical research,vol 5 issue 10,276-284,Issn 2277-7105. 
18.  R.Thiagarajan, Gunapaadam Thathu-Jeeva Vaguppu, Indian medicine and 
Homeopathy department, Chennai, 9th edition. Page.No: a- 243 , . 
19. Anvarbatcha Riyasdeen,S,Vaiyapuri et al., Chloroform Extract of 
RasagendiMezhugu, a Siddha Formulation, as Complementary and Alternative 
Medicine for HPV-Positive Cervical cancer, available at 
www.hindawi.com/journals/ecam/2012/136527. 
20. Hakkim P. Mohammed Abdulla Sahib, Anuboga Vaithya Navaneetham, 
part-8, Thamarai Noolagam, Chennai, 1995, Page no: 62. 
21. Mercury(II) chloride available at http://en.m.wikipedia.org. 
22. Vernacular name for sodium 
23. R.Thiagarajan,LIM, Siddha Materia Medica, Department of Indian Medicine 
and Homeopathy, Chennai. 1st edition,  Page no: a- 316, b-42. 
24. Murugesan Mudhaliyar K.S. Gunapadam Mooligai Vaguppu,Indian Medicine 
and Homeopathy DEpt,Chennai-106.7th edition,2008.page no. 
25. Orient Longman Indian medicinal plants a compendium of 500 species,vol   Ist 
published 1996,reprinted 1997,published by orient Longman 
Limited,Annasalai,Chennai-600002.page no:275. 
26. Ram avatar sharma, aruna kumari. Phytochemistry, pharmacology and 
therapeutic application of oxalis corniculata linn. - a review,international 
journal of pharmaceutical science,2004;vol(6):ISSN 0975-1491.  
27. The Wealth of India 2003,council of scientific and Industrial Research,New 
delhi, vol IV: N-Pageno 259. 2.Wallis T.E, Text book of 
Pharmacognosy,1985,CBS Publishers and Distributors,Shahdara,Delhi,India. 
28. Yoga Narasiman SN,Medicinal plant of india,2000,vol II,Tamilnadu Regional   
Research      Institute, (Ay),Bangalore,India,pgno:715 
29. Shalini karunanithi, Vijaya Bharathi Rajikishore, Vandhana Ganesh Pol et al., 
The    
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 179 
 
 
179 
 
Pharmacognostical And Phytochemical Studies On Leaves Of Oxalis 
Cornuculata,The   journal of phytopharmacology. 2016;5(6):225-229. 
30. Karthiriya A., Das K.,Kumar E.P and Mathai K.B Evalution of antitumour and     
 antioxidant activity of oxalis corniculata Linn.against Ehrich Ascites 
Carcinoma 
        on  Mice.Iran J Cancer prev.2010;3(4):57-165. 
31.  Ashok K. Jain,et all. Nutritive aspects of oxalis cornuculata used by tribal of 
Central India during scarcity of Food, The journal of American 
science,2016;vol  6(11):ISSN:1545-1003 
32. R.Geethalakshmi1, D.V.L.Sarada2 and K.Ramasamy Trianthema decandra L: 
A review on its phytochemical and pharmacological profile. International 
journal of engineering science and  technology.2010;vol 2(5):976-979. 
33. Anupama,Biskhapra(Trianthema decandra information)uses and side 
effects.available    at  
http://www.bimbima.com/herbs/trianthemadecandra/3601. 
34. Naeem Khan,Alia Sultana et al., Nutritional composition,vitamins,minerals, 
and toxic heavy metals analysis of Trianthema Portulacastrum l., awild edible 
plant  fromPeshhawar,Khyber.Americanjournalof 
iotechnology.2013;vol.12(42):ISSN-1684-5315. 
35.  Pharmacognostic studies on root of Trianthema Decandra. Available at 
http:/publications/317379089_pharmacognosticstudies_onRoots_of_Trianthe
ma_decandra_linn_aizoaceae [accessed May 14 2018]. 
36. Rodriguez R,Julio C Palma J Nutritive value of water lettuce(pistia stratiotes) 
and its possibility in animal feed.Zootecnia tropical,2000;vol(18):213-226. 
37. The Wealth of India 2003,council of scientific and Industrial Research,New 
Delhi, vol   VIII Ph-Re: pg no 259. 2.Wallis T.E, Text book of 
Pharmacognosy,1985, CBS  Publishers and 
Distributors,Shahdara,Delhi,India. 
38. Vengaiah PC, Ravichandrababu D etal.,Jaggery from Palmyrah 
palm(Borassus  
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 180 
 
 
180 
 
flabellier) present status and scope. Indian  journal of traditional 
knowelge,2013;vol  12(4):page no-714-717.  
39. 39.Paul of Aegina, 7th Century AD, quoted in Moss, Ralph W. (2004). "Galen 
on Cancer". CancerDecisions. Archived from the original on 16 July 2011. 
Referenced from Michael Shimkin, Contrary to Nature, Washington, D.C.: 
Superintendent of Document, DHEW Publication No. (NIH) 79–720, p. 
35.40. 
40. Ayothidasa V.Kaviraja Pandidar. Pulipani Maha Munivar 
Thiruvaymalartharuliya Vaidhiyam 500, B.Ratnanayagar and 
sons,Chennai,1965,Edition:1,Vol1,Page nO:196. 
41. Mohan R.C. Agathiyar Vaithiya Vallathi 600, Thamarai Noolagam, 
N.G.O.Colony,Chennai,2001, Edition:1,page no:128. 
42. Sathishkumar T.Putru Noyum siddha Maruthuvamum, Thamarai 
Noolagam,Publication 292,Chennai,2006,Vol:1,Edition 1998,Page no-106. 
43. Kannusamy Parambariya Vaithiyam , Page no -87. 
44. Venugopal P.M.Magalir Maruthuvam,the department of indian medicine and 
homeopathy,Chennai,2008,page no:114,a,page no:116.b. 
45. History of Cancer. Available at https://en.wikipedia.org/wiki/history of cancer. 
46.  Latest world cancer statistics. international agency for research on 
cancer,2013 Dec. Available at http://www.news-medical.net/health/cancer-
history.aspx 
47. Cancer cause and risk factors and the elements of cancer control.Avialble at 
https://www.ncbi.nlm.nih.gov/books/NBK54025. 
48. Cancer classification.availble at http://www.medicalnewstoday.com 
49. http://www.healthcommunities.com/cancer-treatment-and-care/cancer-
staging 
50. Jeffry F etal., Epithelial-myoepithelial carcinoma. 2009, Cytology third 
edition. available at https://www.sciencedirect.com/topics/medicine and 
dentistry. 
51. Shannon Johnson and kristeen cherne.,Oral  Cancers available at 
https://www.healthline.com/health/oral-cancer. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 181 
 
 
181 
 
52.  Jame Abraham, Jame Gulley Bethesda handbook of clinical oncology, 2nd 
edition, 2005,   p.no:5-28. 
53. Human papilloma virus(HPV)Jo’s Cervical cancer Trust,Apr 27,2017 
Available at:http://www.jostrust.org.uk/about-cervical cancer. 
54. Uthamarayan K.S.H.I.B.M The Department of Indian Medice and 
Homeopathy, Chennai,1936,pageno:763. 
55. Cervical cancer Wikipedia medical news today,Nov 24,2015,Available 
at:http://en.wikipedia.org/wiki/Timeline_of_cervical_cancer. 
56.  Vaidhya Vidhavmani C.Kannusamy Pillai,Sikicha Ratna Deepam ennum 
Vaithya nool,B.R Rathinayagar & sons,Chennai,1931,Page no:a-248,b-182. 
57. Human papilloma virus(HPV)Jo’s Cervical cancer Trust,Apr 27,2017 
Available at:http://www.jostrust.org.uk/about-cervical cancer/HPV. 
58. Cervical cancer-Medical News Today Mar 31,2017 Available 
at:http://www.medicalnewstoday.com/articles/159821.php.  
59. Kobe .J. Medical Science, volume-55, page no.5, E106-E115, 2009. 
60. Frederick O. Stephens  karl Reinhard Aigner, Basics of Oncology, Page 
no:321-325 
61. Cervical cancer Treatment(PDQ)-patient version Nationl cancer 
institute.Jul14,2016 , Available At 
        http://www.cancer.gov/types/cervical/patient/cervical- treatment. Pdq 80.b 
62. Howkin’s sand Bourne. Shaw text book of Gynecology, Jaypee Brothers,14th 
edition,2004,page no:279. 
63. Radiation therapy for cervical cancer-American cancersociety, 
Dec,2016,availableat:http://www.cancer.org/cancer/cervical-
cancer/treating/radition.html. 
64. Ramachandran S.P.Veera Mamunivar Vagada Thirathu,Thamarai 
Noolagam,1994,Chennai,Vol:1,Edition:1,Page no:57. 
65. S.P.Ramachandran, Ramadevar ennumYakobu vaidhya chintamani-700, 
Thamarai    noolagam, Chennai, 1996, Page no:  258 b. 
66. Agathiyar Vaithiya Rathina Churrukkam – 360, B. Rathina Nayagar & sons, 
Chennai, 1993, page no: 72. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 182 
 
 
182 
 
67. S.P. Ramachandran, Koshayeee Anubogha Vaithiya Bramma Ragasiyam, part 
2, Thamarai Noolagam, 1999, Chennai, Page no: 123,770-b 
68. S.P.Ramachandran, Agathiyar kanma kaandam-300, Thamarai noolagam, 
1995, Chennai, Page no: 20. 
69. S. P. Ramachandran, Agathiyar vaithiya pillai thamizh, Thamarai noolagam, 
Chennai, 1998, Page no: 76 a, 91 b. 
70.  C. Kannusamy pillai, Pathartha Gunavilakkam- Thathu Jeeva Varkam, B. 
Rathina Nayagar& sons, Chennai, 1997, Page no: 55,38-b. 
71. S. P. Ramachandran, Agathiyar chendhooram- 300, Thamarai noolagam, 
Chennai, 1998, Page no:  47. 
72. Kannusamy mudhaliyar, Aathma ratcha mirtham ennum vaithiya 
sarasangaragam, B. Rathinanayagar and sons, Chennai, 2006, page no:496 
472-a,463-b. 
73. S. P. Ramachandran, Agathiyarpallu- 200, Thamarai noolagam, Chennai, 
2000, Page no: 21 a. 
74. S.P.Ramachandran, Veeramamunivar vagada thirathu, Thamarai noolagam, 
1994, Chennai, Page no: 29a, 57b. 
75. Mahadeva pandidar T.R.Pranaraksharmirtha Sindhu vaithya ratna 
Sangaragam,1994,Page no:187. 
76. Vaidhya vidhyamani, C.Kannusamy Pillai, Sikicha ratna deepam ennum 
vaithya nool, B.Rathina nayagar and sons, Chennai, 1931, Page no: 97.  
77. Ayothidasa kaviraja pandidar, Pulipani mahamunivar vaithiyam, B.Rthina 
nayagar and sons, Chennai, 1965, Page no: 57. 
78. Hakkim P. Mohammed Abdulla Sahib, Anubogavaithya navaneetham, part-8, 
Thamarai noolagam, Chennai, 1995, Page no: 62. 
79. S.P.Ramachandran, Agathiyar rana vaidhyam, Thamarai noolagam, Chennai, 
2nd edition, 2000, Page no: 51a, 54 b. 
80. Hakkim P. Mohammed Abdulla Sahib, Anuboga vaithya navaneetham, part-
10, Thamarai noolagam, Chennai, 1995, Page no: 50. 
81. S.P.Ramachandran, Ramadevar ennumYakobu vaidhya chintamani-700, 
Thamarai noolagam, Chennai, 1996, Page no: 181a, 258 b, 377c. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 183 
 
 
183 
 
82. S.P.Ramachandran,Rama Devar Ennum Yakobu Vaidhya Chintamani-700, 
Thamarai Noolagam,Chennai,1996,Page no:377c.  
 
83. Hakkim P. Mohammed Abdulla Sahib, Anuboga vaithiya navaneetham, part-
7, ThamaraiNoolagam, Chennai, 1995, Page no: 30 a, 124 b, 25 c, 78 d, 125 e 
84.  Hakkim P. Mohammed Abdulla Sahib, Anubogavaithya navaneetham, part-6, 
Thamarai noolagam, Chennai, 1995, Page no: 40.  
85. Hakkim P. Mohammed Abdulla Sahib, Anuboga Vaithiya Navaneetham, part-
4, Thamarai Noolagam, Chennai, 1995, Page no: 51 c. 
86. S. P. Ramachandran, Agathiyar chendhooram- 300, Thamarai noolagam, 
Chennai, 1998, Page no: 38 a, 47 b. 
87. Rajalakshmi Etal., A Comparative Study To Evalute The Anti-Cancer Activity 
Of Siddha Drug”Veera Rasa Pathangam”And “Panchapachna 
Chendooram”With The Standard Drug Tazol.International Journalof  Current 
Research In  Chemistry Andpharmaceutical Sciences,2017,Vol 4(12) :Page no 
29-33.ISSN:2348 5221.    
88. S.P.Ramachandran, Agathiyar vaithya ratna churukam, May 1994, Thamarai 
noolagam, Page no: 152-153. 
89.   S. P. Ramachandran, Agathiyar chendhooram- 300, Thamarai noolagam, 
Chennai, 1998, Page no: 38 a, 47 b. 
90. Hakkim P. Mohammed Abdulla Sahib, Anubogavaithya navaneetham, part-10, 
Thamarai noolagam, Chennai, 1995, Page no: 53. 
91. K. D. Tripathi, Essential of Medical Pharmacology, 5th edition, Jaypee brothers 
medical publishers (P) Ltd., Chennai, 2003, page no: 770. 
92. Anticancer drugs available at http://medical- Dictionary.the freedictionary. 
Com/Anticancer+ Drugs>Anticancer drugs. 
93. Formulary of Siddha medicines IMCOPS, 34-37, krishnamoorthy salai, 
Thiruvanmiyur, Chennai. Page no: 242. 
94. D.Wilkins,Advantages and Disadvantages of in vitro model system, Microbial 
ecology in health and disease home> vol 12, Nol (2000)  
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 184 
 
 
184 
 
95. Authenticated Cancer Cell Lines, SIGMA-ALDRICH available 
at>http;//www.Sigmaaldrich com/Europe/life-science-offers/cell-cycle/sigma-
ecacc-cell/cancer-cell lines.html//sthash.L.VrgpHdl.dpuf. 
96. Cancer cell- Based assays-FLUOFARAMA avoiable at>59 
http;//www.fluofarma. com/cancer-cell-based-assays-cro-services.htmlS.K. 
Gupta, Drug Screening Methods, Publicer Jaypee brothers, 3rd 
edition,2016,page no: 171. 
97.  Pharmacology dutta.  Vivo model for cell line studies. 
98.  R.Thiagarajan,LIM, Siddha Materia Medica, Department of Indian Medicine 
and Homeopathy, Chennai. 1st edition,  Page no: 42. 
99.  Lohar, Protocol for Testing Ayurveda Siddha Unani Medicines, Department 
of AYUSH, January 2008 page no: 33. 
100. Jayanthi Abraham A,pritha Chakraborty, Anish Mathew et al.,Cytotoxicity 
and  antimicrobialeffects of pistia stratiotes leaves.international journal of 
drug dev. &    research 2014;vol 6:ISSN 0975-9344. 
101. Megha jha,N. Ganesh, and varsha Sharma. In vitro evalution of free radicals 
scavenging activity of pistia stratiotes.international journal of chem tech 
research 2010;2:180-184. 
102. Prem Kumar VG,Shyamsundar D.Antidermatophytic activity of pistia 
stratiotes.Indian  journal of pharmacology.2005;37:127-8. 
103. Achola KJ, Indalo AA.Pharmacologic  activities of pistia stratioes. 
pharmaceutical  biology.1997;35(5):329-333. 
104. Nipaney PC.influence of temperature on biogas production from pistia    
stratiotes.biological wastes.1987;19:267-74. 
105.  Sundeep Kumar H.K,Anindya bose,Arundhuti Raut et al.,evaluation of 
anthelmintic activity of pistia stratiotes.journal of basic and clinical 
pharmacy.2010;vol(001):104-105. 
106. Rahman M.A,Haque E,etall.,evalution of antinociceptive and antidiarrhoeal 
properties of pistia stratiotes leaves.journal of pharmacology and 
toxicology.2011;vol(6):596-601. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 185 
 
 
185 
 
107. Iqbal MC, Meiyalaghan S, Wijesekara KB, Abeyrante KP. Antifungal activity 
from water extracts of some common weeds. Pakistan Journal of Biological 
Science 2001; 4: 843-845.  
108.  Dighe S, Kuchekar BS, Wankhede Sagar B. Pharmacological Evaluation of 
Oxalis corniculata Linn. for anthelmintic Activity. Research Journal of 
Pharmacology and Pharmacodynamics 2012; 4(1): 1-4 
109.  Taba S, Sawada J, Moromizato Z. Nematicidal activity of Okinawa Island 
plant on the root-knot nematode Meloidogynein cognita (Kofoid and White) 
Chitwood, Plant Soil. 2008; 303: 207-216. 
110.  Jain A, Tiwari P, Bashir M. Nutritive Aspects of Oxalis corniculata Linn. used 
by Tribals of Central India During Scarcity of Food. Botany Research 
International 2010; 3(1): 35-37.  
111. Taranalli AD, Tipare SV, Kumar S. Wound healing activity of Oxalis 
Corniculata whole plant extract in rats. Indian Journal of pharmaceutical 
sciences 2004; 66(4): 444-446. 
112. Sakat S,Tupe P, Juveka A. Gastro protective Effect of Oxalis corniculata 
(Whole Plant) on Experimentally Induced Gastric Ulceration in Wistar Rats. 
Indian J Pharm Sci. 2012; 74(1): 48-53. 
113.  Sharangouda K, Patil SB. Anti-implantation and abortifacient activities of 
Oxalis corniculata in albino rats. Nigerian Journal of Natural Products and 
Medicine 2007; 11:58-60. 
114.  Qureshi R, Waheed A, Arshad M, Umbreen T. Medico-ethnobotanical 
inventory of tehsil Chakwal, Pakistan. Pak. J. Bot. 2009; 41(2): 529-538.  
115.   Kathiriya A, Das K, Kumar EP, Mathai KB. Evaluation of antitumor and 
antioxidant activity of Oxalis corniculata Linn. against ehrlich ascites 
carcinoma on mice. Iranian journal of cancer prevention 2010; 4: 157-165.  
116. Watcho P, Nkouathio E, Telesphore B, Nguelefack SIW, Kamanyi A. Anti 
diarrhoeal activity of aqueous and methanolic extracts of Oxalis corniculata 
klotzch. in rats. Cameroon Journal of experimental Biology 2005; 01: 6-49. 
117.  Senthil Kumar K.Kand Raj kapoor B. Study on phytochemical profile and anti-
epileptic activity of Oxalis corniculata Linn. International Journal of 
Biological & Pharmaceutical Research 2010; 1:34-37.  
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 186 
 
 
186 
 
118.  Das K, Kathiriya AK, Kumar EP, Benson MK, Einstein JW. Evaluation of 
hepatoprotective activity of aqueous and ethanolic extract of Oxalis 
corniculata against intoxication of thioacetamide induced rats. Revista 
Brasileira de Farmacognosia 2012; 22(2): 412-417.  
119. Tassa BD, Gogoi G, Das S. A comparative study of the hypolipidaemic and 
antioxidant activities of ethanolic extracts of leaves of Phlogacanthus 
thyrsiflorus, Oxalis corniculata Linn. and Fragaria vesca in albino rats. Asian 
Journal of Pharmaceutical and Biological Research 2012; 2 (1): 12-18.  
120. Seraphim ER, Sinha MP. Impact of phyto estrogens on endocrine glands of 
albino rats II. Adrenal. The Bioscan. 2010; 5(1): 63–66. 
121.  Kathiriya A, Das K, Kumar EP, Mathai KB. Evaluation of antitumor and 
antioxidant activity of Oxalis corniculata Linn. Against Ehrlich ascites carcinoma 
on mice, Iranian J Cancer Pre 2010; 4:157-165. Full Text  
122. Tassa BD, Gogoi G, Das S. A comparative study of the hypolipidaemic and 
antioxidant activities of ethanolic extracts of leaves of Phlogacanthusthyrsiflorus, 
Oxalis corniculata Linn.  
123. Sampath Saravanan, R.Sambathkumar, M.Senthilkumar, 
T.Sivakumar,V.Kumar and K.Asok kumar, Anti inflammatory effect of 
chloroform extract of the leaves of Trianthema decandra , J Ethnopharmacol 
2004; 91; 47-55. 
124.  Jaswanth, A. Jagannathan, K. Robert, S. .H. Loganathan, V.;Manimaran, S. 
Ruckmani, K. Antibacterial Activity of root extract of Trianthema decandra. 
Ancient science of life 2002 ; 21 : 158-159 
125.  Geethalakshmi R, Sarada DVL. Alpha amylase Inhibitory activity of 
Trianthema decandra L. International Journal of Biotechnology and 
Biochemistry. 2010; 6(3):369-376. 
126.  Singaravel Sengottuvelu, Duraisamy Srinivasan, Hepatoprotective activity of 
Trianthema decandra on carbon tetrachloride-induced hepatotoxicity in rats. 
International Journal of Green Pharmacy. 2008; 2(2):122-125.  
127. Geethalakshmi R, Sarada DVL. Evaluation of antimicrobial and antioxidant 
activity of essential oil of Trianthema decandra L. Journal of Pharmacy 
Research. 2013; 6(1):101-106. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 187 
 
 
187 
 
128. Veeresh, Pramod Kumar. Gc-ms analysis and aphrodisiac activity of 
Triamthema decandra linn. World journal of pharmaceutical and life sciences. 
2016; 2(6):323-331.  
129. Veeresh, Pramod Kumar, V Rama Mohan Gupta. Adaptogenic activity of 
Alcoholic extract of Trianthema  decandra L. Adv. Pharmacol. Toxicol. 2016; 
17(3):49-65 . 
130. Dr. S. Rajalakshmi *1 dr. M. Mohammed musthafa2. Comparative study to 
evaluate the anti-cancer activity of Siddha drugs “Veera Rasa Padhangam” and 
“Panchamuga Chendhuram” with the standard drug taxol. International journal 
of current research in chemistry and pharmaceutical sciences.2017;vol(4): 29-
33P-ISSN: 2348-5213: E-ISSN: 2348-5221) 
131.   Rajalakshmi P,savariraj C.et al.,.preparation and standardization studies on 
veera mezhugu-a siddha anti cancer formulation.International journal of 
pharmacy and pharmaceutical science.2014;vol(6)ISSN-0975-1491. 
132. Mudiganti ram Krishna Rao,Ganesan et al.,Kodasurri veeravaippyu a siddha 
preparation  against Carrageenan induced paw edema and cotton pekllet 
induced granuloma in albino rats.Der Pharmacia Lettre,2013;vol5(6):page no 
99-104. 
133. Sathish Kumar, M.R.K.Rao,et al., AnAntibacterial screening of Kodasuri 
veeravaippu- a siddha salt preparation International Journal of Pharmaceutical 
Sciences Review and Research.2013;vol20(1):140-141 
134.   Seethalakshmi G,Suvetha etal.,Siddha system of Medicne  for treating 
Vathasthmbam.International journal of current Research in medical 
sciences.2017;vol3(10):page no 1-3 ISSN:2454-5716. 
135.  Murugesan Moonandi2. PAVALAM: A VALUABLE SIDDHA MINERAL 
DRUG International Journal of  Research Ayurveda Pharm.2014;vol 5(3):page 
no 367-369. 
136. Thomas M Walter1*, T Sasi Priya2, A Shakthi Paargavi2, NS Priya Devi2, and 
S Thanalakshmi2. A Review of Herbs to Treat Skin Disorders in Traditional 
Siddha Medicine. research and reviews: journal of pharmacology and 
toxicological studies. 2013:page no -7-12.E-ISSN:2322-0139 p-issn:2322-
0120 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 188 
 
 
188 
 
137.    Jeyavenkatesh. J and v. Elango*. A review on siddha poly herbo mineral 
preparation kanakalinga karpura mezhugu . Asian journal of innovative 
research.2017;vol 2(2):page no 21-25. 
138.  Dr.M.Shanmugavelu etal., The pharmacopeia of Siddha Research 
Medicines. G.D. Naidu president, I.L.W.A. ltd, printed at I LWA 
press,Coimbatore-18. Page no:18-21. 
139.   Drug standardization and quality assurance and contributuion to development 
of ayurvedic pharmacopeia.  Glimpses of CCRAS contributions,Volume 4 
page no 47-52. 
140.  Lohar DR. Protocol for testing: Ayurvedic, Siddha and Unani 
Medicines.Pharmacopoeial Laboratory for Indian Medicine, Ghaziabad 
141.   WHO guidelines guidelines for physicochemical analysis anonymous 1998. 
142.  VAnonymous, 1998, Bio chemical Standards of Unani formulations, 
Part3,CCRUM,New Delhi,P.no.58-60 
143.  Anija, Text Book Of Microbiology, volume:2, page no:197 
144. Fourier Transform Infra-red Spectroscopy available 
at:https://www.lpdlabservices.co.uk/analytical_techniques/chemical_analysis/
ftir.php 
145.  Inductively Coupled Plasma Mass Spectrometry (ICP-MS) available 
at:https://serc.carleton.edu/research_education/geochemsheets/techniques/IC
PMS.html 
146. Scanning Electron Microscope available at: 
https://serc.carleton.edu/research_education/geochemsheets/techniques/SEM
.html 
147.  X-ray powder diffraction available 
at:https://serc.carleton.edu/research_education/geochemsheets/techniques/X
RD.html 
148.  Organization for Economic Cooperation Development (OECD) Guideline,  
423, 2000. Guideline Document on Acute Oral Toxicity.  Environmental 
Health and Safety Monograph Series on Testing and Assessment No. 24.76.  
Schlede E., Mischke U., Diener W. and Kayser D 1992;66: 455-470 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 189 
 
 
189 
 
149. OECD Guidelines for the Testing of Chemicals (No. 407, Section 4: Health 
Effects) "Repeated Dose 28-Day Oral Toxicity in Rodents" (Adopted on 12 
May 198 1 and Updated on 27 July 1995.) 
150. National Centre for Cell Sciences (NCCS), Pune, India and maintained 
Dulbeccos modified Eagles medium (DMEM (Sigma Aldrich USA). 
151.  CHANG et al. — Free radical scavenging activity of Phellinus merrillii 415 1,1-
diphenyl-2-picrylhydrazyl radical. Chem. Pharm. Bull. 37: 2016-2021.  
152. H. Chang et al., DPPH assay: 2001. 
153.    Muhammed Said,Amin Badshah  et al.,Molecules 2013,18,1037810396. 
154.  Yuchuan gong, David grant et al., Solvent systems and their selection in 
Pharmaceutics and Biopharmaceutics, Abstract, Springer New York, 2007, Book 
DOI: 10.1007/978-0-387. 
155.    Saeed Qureshi, October 19, 2012, Drug Dissolution test/predominance of drugs 
absorption from the intestinal site compared to the gastric site, Page no: 1. 
156.  Langer’s Handbook of chemistry, 8th edition, Handbook Publishers, 10c, 1952 flinn 
scientific Inc, manual 2004. 
157. Peng Song et al.,Dietary Nitrates,Nitrites, and Nitrosamines intake and the risk of 
gastric cancer:A meta analysis.Nutrients 2.2015 dec;vol 7(12):9872-9895. 
158. Qian Li,1,2 Shu-chun Chuanget al., Vitamin or mineral supplement intake and the risk of 
head and neck cancer: pooled analysis in the INHANCE consortium.international journal 
of cancer. oct.-2012.131(7)1686-1699.PMC-3376697. 
159. Jansson B etal., Potassium,Sodium,and cancer a review,journal of Environ pathol 
taxicol oncol.1996;vol15(2-4):page no:65-73. 
160. Wang F, Elliott RL and Head JF: Inhibitory effect of Deferoxamine mesylate and 
low iron diet on the 13762NF rat mammary adenocarcinoma. Anticancer Res 19: 
445-450. 
161.  MartaPerettia1 et al., Chloride channels in cancer: Focus on chloride intracellular 
channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel 
therapeutic targets.Avaliable at  https://doi.org/10.1016/j.bbamem.2014.12.012. 
162. Thelander L, Graslund A. Mechanism of inhibition of mammalian ribonucleotide reductase 
by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine 
free radical of the enzyme in an oxygen-requiring reaction. J. Biol. Chem. 1983;258:4063–
4066. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 190 
 
 
190 
 
163.   Bymes RW, Mohan M, Antholine WE, Xu RX, Petering DH. Oxidative stress 
induced by a   copper thiosemicarbazones complex. Biochem. 1990;29:7046–
7053. [PubMed] 
164.   Xi Huang and Lily Yeh Jan, Targeting potassium channels in cancer. Journal of cell 
biology.2014 july 21;206(2):page no-151-162. 
165.  Wu-Yang Huang,Yi-Zhong Cai &Yanbo Zhang, Natural Phenolic Compounds From 
Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention. Nutrion 
and cance 2009, vol 62 Pages 1-20 | Received 12 Dec 2008, Accepted 14 Apr 2009, 
Published online: 29 Dec 2009 
166. Snehal A.Chavan, Avinash g, et al., Synthesis and Anti-Cancer Activity of Bis-(N-
Glucosylated Trriazolothiadiazolyl) Alkanes via Cyclocondensation reaction 
involving c-s and c-n bond formation, 190: 12,2315-2324. 
167.  Fares F, Azzam N et al., Benzene-Poly-Carboxylic Acid Complex, a novel anti-cancer 
agent induces apoptosis in human cancer cells, Plos one:2014,feb11,9(2). 
168.  Lugli A, Iezzi G, Hostettler I, et al. Prognostic impact of the expression of putative cancer 
stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J 
Cancer 2010;103:382-90. 10.1038/sj.bjc.6605762 [PMC free article] [PubMed] 
169.    Shaida sina, nd , the use of aromatic therapies in the treatment of cancer, 
anxiety/depression/mental health, aromatherapy, oncology, pain medicine, Feb 
5,2006. 
170.  Wu CC etal., Differential effects of allyl sulfides from garlic essential oil on cell cycle 
regulation in human liver tumor cells. Department of Nutrition and Health Science. 
Food Chem Toxicol. 2004 Dec;42(12):1937-47. 
171.  GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 
411:342-348. 
172.  Sowjanya K, Department of Industrial Pharmacy, A review on current advancements 
in nanotechnology, Journal of Nanomedicine and Nanotechnology, available at 
http://www.omicsonline.org/journal/nanomedicine and nanotechnology. 
173.    Jürgen Pohl,# 1 Marc Halphen. Impact of the Quality of Bowel Cleansing on the 
Efficacy of Colonic Cancer Screening: A Prospective, Randomized, Blinded 
Study.Plos One.2015;10(5):e0126067. 
BIBLOGRAPHY 
 
 
ANTI-CANCER ACTIVITY OF BHRAMASTHIRAM  Page 191 
 
 
191 
 
174. Costello A.J Randomized,controlled chemopreventive  trial of selenium in famial 
prostate cancer:rationale,recuriment and design issues.urology.2005;57:182-184. 
175. Chinbrow M,Nelson M ,inhibition of miotic cyclin B and cdc2 kinase activity by 
selenomethionine in synchronized colon cancer cells.Anticancer drugs.2001;12:43-
50. 
176. Combs GF Jr.Selenium in global food Sytem. Br J Nutr.2001;85:517-547. 
177. Guo, Z.; Sadler, P.J. Angew Chem., Int. Ed. Engl. 1999, 38, 1512-1531. 
178. Kemp JD, Cardillo T, Stewart BC, KeJing, Y.; Dai, J.; Chalmers-Redman, R. M.; 
Tatton, W. G.; Waxman, S. Blood 1999, 94, 2102–2111. 
179. Wang F, Elliott RL and Head JF: Inhibitory effect of deferoxamine mesylate and 
low iron diet on the 13762NF rat mammary adenocarcinoma. Anticancer Res 19: 
445-450, 1999. 
180. http://cat.inist.fr/?aModele=afficheN&cpsidt=19999781 
181. http://www.pharmabiz.com/NewsDetails.aspx?aid=81610&sid=1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 INGREDIEANTS OF BHRAMASTHIRAM 
 
 
 
 
 
 
 
 
  
  
   
 
 
 
 
C.Oxalis cornuculata 
  D.Sodium chloride 
B.Pistia Stratiotes A.Hydragyrum perchloride  
 E. Trianthema decandra 
 Fig.No. Ingredients of Bhramasthiram 
   
 
 
 
 
   
       
       
  
 
  A.Aagayathamarai 
PURIFICATION OF HYDRAGYRUM PERCHLORIDE 
D.Inginition 
B.Veeram 
C.Sealding 
E.After purified Veeram 
        
 
 
 
 
 
 
 
 
PROCESS OF UPPU PARPAM 
  J.Incineration 
 F. Salt G.Trianthema decandra 
I. Iginition (1st process ) 
H.Sealding 
  
 
 
 
 
      
 
 
 K. Uppu parpam(1st process end) 
     K. Uppu parpam(1th process end) 
M.Sealding N.Incineration 
O. Uppu parpam(10th process end) 
 L.Vellai saranai 
  
    
 
 
 
 
 
 
 
   P. Uppu parpam with puliyarai Q.Grinding 
R.Veeram is covered by Uppu 
parpam 
S.Pasting upper pot 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T. Sealding U.Incineration 
W.Sublimation X.End product 
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